BROAD_ID	CPD_NAME	CPD_NAME_TYPE	CPD_SAMPLE_ID	DOS_LIBRARY	SOURCE_NAME	CHEMIST_NAME	VENDOR_CATALOG_ID	CPD_SMILES	USERCOMMENT	pert_id	pert_iname
BRD-A51829654-001-01-4	BRL-15,572	common	SA82481	NA	Biomol International Inc.	NA	AC-536	OC(CN1CCN(CC1)c1cccc(Cl)c1)C(c1ccccc1)c1ccccc1	NA	BRD-A51829654	BRL-15572
BRD-K04046242-001-03-6	equilin	primary-common	SA82922	NA	Prestwick Chemical Inc.	NA	Prestw-850	C[C@]12CC[C@H]3C(=CCc4cc(O)ccc34)[C@@H]1CCC2=O	NA	BRD-K04046242	equilin
BRD-K11927976-050-01-1	ER-27319	to-be-curated	SA792875	NA	Tocris Bioscience	NA	2471	Cc1ccc2c(c1C)n(CCCN)c1ccccc1c2=O	NA	BRD-K11927976	ER-27319
BRD-K14282469-001-01-5	PAPP	primary-common	SA82523	NA	Biomol International Inc.	NA	AC-846	Nc1ccc(CCN2CCN(CC2)c2cccc(c2)C(F)(F)F)cc1	NA	BRD-K14282469	LY-165163
BRD-K10065684-001-02-5	dantron	INN	SA38456	NA	AnalytiCon Discovery GmbH	NA	NP-009848	Oc1cccc2C(=O)c3cccc(O)c3C(=O)c12	NA	BRD-K10065684	dantron
BRD-K02275692-003-03-4	cefotiam	INN	SA83591	NA	Prestwick Chemical Inc.	NA	Prestw-482	CN(C)CCn1nnnc1SCC1=C(N2[C@H](SC1)[C@H](NC(=O)Cc1csc(N)n1)C2=O)C(O)=O	NA	BRD-K02275692	cefotiam
BRD-K06980535-003-04-4	promazine	INN	SA58898	NA	MicroSource Discovery Systems Inc.	NA	1500509	CN(C)CCCN1c2ccccc2Sc2ccccc12	NA	BRD-K06980535	promazine
BRD-K03842655-001-02-1	penitrem A	primary-common	SA82097	NA	Biomol International Inc.	NA	KC-157	CC(=C)[C@H]1O[C@H]2CC[C@]3(C)[C@]4(C)[C@@H](CC[C@@]3(O)[C@]22O[C@@H]2[C@H]1O)[C@@H]1OC(C)(C)[C@H]2C[C@@H]3C(=C)Cc5c(Cl)cc6[nH]c4c1c6c5[C@]23O	NA	BRD-K03842655	penitrem-a
BRD-K05181084-003-02-9	NGB 2904	to-be-curated	SA792953	NA	Tocris Bioscience	NA	2635	Clc1cccc(N2CCN(CCCCNC(=O)c3ccc-4c(Cc5ccccc-45)c3)CC2)c1Cl	NA	BRD-K05181084	NGB-2904
BRD-K09132007-001-01-8	D4476	common	SA793007	NA	Tocris Bioscience	NA	2902	NC(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccccn1)-c1ccc2OCCOc2c1	NA	BRD-K09132007	D-4476
BRD-K04976539-001-01-0	aminogenistein	common	SA63301	NA	EMD Biosciences	NA	155100	Nc1ccc(cc1)-c1cc(=O)c2cc(O)ccc2o1	NA	BRD-K04976539	aminogenistein
BRD-K00675675-003-01-2	CL-82198	to-be-curated	SA792950	NA	Tocris Bioscience	NA	2632	O=C(NCCCCN1CCOCC1)c1cc2ccccc2o1	NA	BRD-K00675675	CL-82198
BRD-K11373525-003-01-3	ZD 7155	to-be-curated	SA792374	NA	Tocris Bioscience	NA	1211	CCc1cc2N(Cc3ccc(cc3)-c3ccccc3-c3nnn[nH]3)C(=O)CCc2c(CC)n1	NA	BRD-K11373525	ZD-7155
BRD-K12357156-001-01-5	AG 490	to-be-curated	SA791958	NA	Tocris Bioscience	NA	414	Oc1ccc(C=C(C#N)C(=O)NCc2ccccc2)cc1O	NA	BRD-K12357156	AG-490
BRD-K18194590-065-02-3	mephentermine	INN	SA59100	NA	MicroSource Discovery Systems Inc.	NA	1503250	CNC(C)(C)Cc1ccccc1	NA	BRD-K18194590	mephentermine
BRD-A67862938-034-04-0	naftidrofuryl	INN	SA59478	NA	MicroSource Discovery Systems Inc.	NA	1503419	CCN(CC)CCOC(=O)C(CC1CCCO1)Cc1cccc2ccccc12	NA	BRD-A67862938	naftidrofuryl
BRD-A54927599-001-07-8	KF 38789	primary-common	SA792999	NA	Tocris Bioscience	NA	2748	COc1ccc(C2CC(=NCCS2)c2c(O)cc(C)oc2=O)c(OC)c1	NA	BRD-A54927599	KF-38789
BRD-A53576514-003-03-1	orphenadrine	INN	SA83233	NA	Prestwick Chemical Inc.	NA	Prestw-239	CN(C)CCOC(c1ccccc1)c1ccccc1C	NA	BRD-A53576514	orphenadrine
BRD-K07079548-001-01-9	R(-)-N-allylnorapomorphine	primary-common	SA82651	NA	Biomol International Inc.	NA	AC-820	Oc1ccc2C[C@H]3N(CC=C)CCc4cccc(c34)-c2c1O	NA	BRD-K07079548	BRD-K07079548
BRD-K00610438-003-01-7	altanserin	primary-common	SA792640	NA	Tocris Bioscience	NA	1809	Fc1ccc(cc1)C(=O)C1CCN(CCn2c(=S)[nH]c3ccccc3c2=O)CC1	NA	BRD-K00610438	altanserin
BRD-A64228451-001-03-5	(-)-terreic acid	primary-common	SA81894	NA	Biomol International Inc.	NA	EI-328	CC1C(=O)[C@H]2O[C@H]2C(=O)C1=O	NA	BRD-A64228451	terreic-acid-(-)
BRD-K07220430-001-03-6	cinnarizine	INN	SA82819	NA	Prestwick Chemical Inc.	NA	Prestw-278	C(\C=C\c1ccccc1)N1CCN(CC1)C(c1ccccc1)c1ccccc1	NA	BRD-K07220430	cinnarizine
BRD-K06593056-001-01-4	LE-135	primary-common	SA792710	NA	Tocris Bioscience	NA	2021	CN1c2cc3c(cc2N=C(c2ccc(cc2)C(O)=O)c2ccccc12)C(C)(C)CCC3(C)C	NA	BRD-K06593056	LE-135
BRD-K10843433-001-02-9	phenylbutazone	INN	SA58555	NA	MicroSource Discovery Systems Inc.	NA	1500482	CCCCC1C(=O)N(N(C1=O)c1ccccc1)c1ccccc1	NA	BRD-K10843433	phenylbutazone
BRD-K11634954-300-01-8	GBR 13069	to-be-curated	SA791961	NA	Tocris Bioscience	NA	420	Fc1ccc(cc1)C(OCCN1CCN(CC=Cc2ccccc2)CC1)c1ccc(F)cc1	NA	BRD-K11634954	GBR-13069
BRD-A50311610-300-04-7	meclozine	INN	SA58365	NA	MicroSource Discovery Systems Inc.	NA	1500376	Cc1cccc(CN2CCN(CC2)C(c2ccccc2)c2ccc(Cl)cc2)c1	NA	BRD-A50311610	meclizine
BRD-A77291778-003-04-8	cyclopentolate	INN	SA58249	NA	MicroSource Discovery Systems Inc.	NA	1500212	CN(C)CCOC(=O)C(c1ccccc1)C1(O)CCCC1	NA	BRD-A77291778	cyclopentolate
BRD-A49680073-001-01-9	cucurbitacin I	primary-common	SA63292	NA	Calbiochem	NA	238590	CC(C)(O)\C=C\C(=O)[C@](C)(O)C1[C@H](O)C[C@@]2(C)[C@@H]3CC=C4C(CC(=O)C(=O)C4(C)C)[C@]3(C)C(=O)C[C@@]12C	NA	BRD-A49680073	cucurbitacin-i
BRD-K15567136-001-01-1	papaverine hydrochloride	USAN	SA38815	NA	AnalytiCon Discovery GmbH	NA	NP-014100	COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC	NA	BRD-K15567136	papaverine
BRD-A74667430-001-04-6	etodolac	INN	SA59309	NA	MicroSource Discovery Systems Inc.	NA	1501005	CCc1cccc2c3CCOC(CC)(CC(O)=O)c3[nH]c12	NA	BRD-A74667430	etodolac
BRD-K00603606-003-03-4	ticlopidine	INN	SA83104	NA	Prestwick Chemical Inc.	NA	Prestw-47	Clc1ccccc1CN1CCc2sccc2C1	NA	BRD-K00603606	ticlopidine
BRD-K10207760-236-03-0	lasalocid	INN	SA82725	NA	Prestwick Chemical Inc.	NA	Prestw-828	CC[C@H]([C@H]1O[C@@](CC)(C[C@@H]1C)[C@H]1CC[C@](O)(CC)[C@H](C)O1)C(=O)[C@@H](C)[C@@H](O)[C@H](C)CCc1ccc(C)c(O)c1C(O)=O	NA	BRD-K10207760	lasalocid
BRD-K02404261-001-02-7	caffeine	USP	SA37853	NA	AnalytiCon Discovery GmbH	NA	NP-004763	Cn1cnc2n(C)c(=O)n(C)c(=O)c12	NA	BRD-K02404261	caffeine
BRD-K15791587-003-01-7	L-733,060	to-be-curated	SA792365	NA	Tocris Bioscience	NA	1145	FC(F)(F)c1cc(CO[C@H]2CCCN[C@H]2c2ccccc2)cc(c1)C(F)(F)F	NA	BRD-K15791587	L-733060
BRD-K12219985-001-04-8	glipizide	INN	SA82076	NA	Biomol International Inc.	NA	AC-120	Cc1cnc(cn1)C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1	NA	BRD-K12219985	glipizide
BRD-K09635314-001-01-8	m-3M3-FBS	common	SA792663	NA	Tocris Bioscience	NA	1941	Cc1cc(C)c(c(C)c1)S(=O)(=O)Nc1cccc(c1)C(F)(F)F	NA	BRD-K09635314	m-3M3FBS
BRD-A99449986-001-01-4	MT-21	primary-common	SA63168	NA	EMD Biosciences	NA	475952	CCCCCCCCN1C(=O)C(C(C)=O)=C(C)C1(C)O	NA	BRD-A99449986	MT-21
BRD-K15196155-001-01-5	GPR109b Agonist, IBC 293	to-be-curated	SA792873	NA	Tocris Bioscience	NA	2469	CC(C)n1nnc2cc(ccc12)C(O)=O	NA	BRD-K15196155	IBC-293
BRD-K01648091-001-04-2	LE 300	common	SA792587	NA	Tocris Bioscience	NA	1674	CN1CCc2c(Cc3ccccc3CC1)[nH]c1ccccc21	NA	BRD-K01648091	LE-300
BRD-K14767410-001-01-5	SC-560	primary-common	SA792544	NA	Tocris Bioscience	NA	1550	COc1ccc(cc1)-n1nc(cc1-c1ccc(Cl)cc1)C(F)(F)F	NA	BRD-K14767410	SC-560
BRD-A97739905-001-04-2	ketoprofen	INN	SA59359	NA	MicroSource Discovery Systems Inc.	NA	1501215	CC(C(O)=O)c1cccc(c1)C(=O)c1ccccc1	NA	BRD-A97739905	ketoprofen
BRD-K00184207-001-02-4	6-FORMYLINDOLO [3,2-B] CARBAZOLE	to-be-curated	SA81949	NA	Biomol International Inc.	NA	GR206	O=Cc1c2[nH]c3ccccc3c2cc2[nH]c3ccccc3c12	NA	BRD-K00184207	GR-206
BRD-K00312224-001-03-8	1,3,5-tris(4-hydroxyphenyl)-4-propyl-1H-pyrazole	common	SA792487	NA	Tocris Bioscience	NA	1426	CCCc1c(nn(c1-c1ccc(O)cc1)-c1ccc(O)cc1)-c1ccc(O)cc1	NA	BRD-K00312224	PPT
BRD-A48809242-001-02-9	IB-MECA	primary-common	SA82190	NA	Biomol International Inc.	NA	AC-582	CNC(=O)[C@H]1O[C@H](C(O)[C@H]1O)n1cnc2c(NCc3cccc(I)c3)ncnc12	NA	BRD-A48809242	IB-MECA
BRD-K17497770-001-01-0	butein	common	SA63271	NA	Calbiochem	NA	203987	Oc1ccc(C(=O)\C=C\c2ccc(O)c(O)c2)c(O)c1	NA	BRD-K17497770	butein
BRD-K01624546-001-02-8	DOCOSATRIENOIC ACID (22:3 n-3)	to-be-curated	SA81992	NA	Biomol International Inc.	NA	FA-010	CC\C=C/C\C=C/C\C=C/CCCCCCCCCCCC(O)=O	NA	BRD-K01624546	docosatrienoic-acid
BRD-A72711497-236-02-0	lasalocid	INN	SA59462	NA	MicroSource Discovery Systems Inc.	NA	1503244	CC[C@H](C1OC(CC)(C[C@@H]1C)C1CC[C@](O)(CC)[C@H](C)O1)C(=O)C(C)[C@@H](O)[C@H](C)CCc1ccc(C)c(O)c1C(O)=O	NA	BRD-A72711497	lasalocid
BRD-K02283807-003-01-4	GR 32191	to-be-curated	SA792672	NA	Tocris Bioscience	NA	1958	O[C@H]1C[C@H](OCc2ccc(cc2)-c2ccccc2)[C@H](CC\C=C/CCC(O)=O)[C@H]1N1CCCCC1	NA	BRD-K02283807	GR-32191
BRD-K06014311-001-01-2	DH 97	to-be-curated	SA792380	NA	Tocris Bioscience	NA	1218	CCCCC(=O)NCCc1c(Cc2ccccc2)[nH]c2ccccc12	NA	BRD-K06014311	DH-97
BRD-A51410489-001-01-4	yohimbine hydrochloride	USP	SA37441	NA	AnalytiCon Discovery GmbH	NA	NP-003301	COC(=O)C1C(O)CCC2CN3CCc4c([nH]c5ccccc45)C3CC12	NA	BRD-A51410489	yohimbine
BRD-A69636825-003-02-1	diltiazem	INN	SA58799	NA	MicroSource Discovery Systems Inc.	NA	2300214	COc1ccc(cc1)C1Sc2ccccc2N(CCN(C)C)C(=O)C1OC(C)=O	NA	BRD-A69636825	diltiazem
BRD-A99411506-002-01-3	esculin	primary-common	SA83630	NA	Prestwick Chemical Inc.	NA	Prestw-892	OC[C@H]1OC(Oc2cc3ccc(=O)oc3cc2O)[C@H](O)[C@@H](O)[C@@H]1O	NA	BRD-A99411506	esculin
BRD-A87719232-001-02-4	naproxen	INN	SA83018	NA	Prestwick Chemical Inc.	NA	Prestw-45	COc1ccc2cc(ccc2c1)C(C)C(O)=O	NA	BRD-A87719232	naproxen
BRD-K12765235-304-03-8	carbenoxolone	INN	SA82726	NA	Prestwick Chemical Inc.	NA	Prestw-837	CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C(O)=O)OC(=O)CCC(O)=O	NA	BRD-K12765235	carbenoxolone
BRD-A78303415-001-02-7	hyoscyamine	BAN	SA58344	NA	MicroSource Discovery Systems Inc.	NA	1500346	CN1C2CC[C@@H]1C[C@H](C2)OC(=O)[C@H](CO)c1ccccc1	NA	BRD-A78303415	hyoscyamine
BRD-A55913614-316-04-7	primaquine	INN	SA58432	NA	MicroSource Discovery Systems Inc.	NA	1500500	COc1cc(NC(C)CCCN)c2ncccc2c1	NA	BRD-A55913614	primaquine
BRD-K01815685-001-02-3	indole-3-carbinol	primary-common	SA59853	NA	MicroSource Discovery Systems Inc.	NA	1505320	OCc1c[nH]c2ccccc12	NA	BRD-K01815685	indole-3-carbinol
BRD-K08619574-334-03-9	thioproperazine	INN	SA83133	NA	Prestwick Chemical Inc.	NA	Prestw-149	CN(C)S(=O)(=O)c1ccc2Sc3ccccc3N(CCCN3CCN(C)CC3)c2c1	NA	BRD-K08619574	thioproperazine
BRD-K05151076-001-01-8	ZK 164015	to-be-curated	SA792750	NA	Tocris Bioscience	NA	2183	CCCCCS(=O)(=O)CCCCCCCCCCn1c(c(C)c2cc(O)ccc12)-c1ccc(O)cc1	NA	BRD-K05151076	ZK-164015
BRD-K08252256-236-04-9	diclofenac	INN	SA58265	NA	MicroSource Discovery Systems Inc.	NA	1500237	OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl	NA	BRD-K08252256	diclofenac
BRD-K08806317-050-03-6	timolol	INN	SA83678	NA	Prestwick Chemical Inc.	NA	Prestw-948	CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1	NA	BRD-K08806317	timolol
BRD-K14844937-001-01-6	40 (DMCM)	to-be-curated	SA82549	NA	Biomol International Inc.	NA	AC-769	CCc1c(ncc2[nH]c3cc(OC)c(OC)cc3c12)C(=O)OC	NA	BRD-K14844937	BRD-K14844937
BRD-A68723818-050-04-4	brompheniramine	INN	SA58861	NA	MicroSource Discovery Systems Inc.	NA	1503985	CN(C)CCC(c1ccc(Br)cc1)c1ccccn1	NA	BRD-A68723818	brompheniramine
BRD-A64092382-003-03-5	mexiletine	INN	SA58607	NA	MicroSource Discovery Systems Inc.	NA	1503929	CC(N)COc1c(C)cccc1C	NA	BRD-A64092382	mexiletine
BRD-K10995081-001-05-5	perphenazine	INN	SA83132	NA	Prestwick Chemical Inc.	NA	Prestw-125	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc23)CC1	NA	BRD-K10995081	perphenazine
BRD-A55756846-001-05-5	H7	primary-common	SA82254	NA	Biomol International Inc.	NA	EI-148	CC1CNCCN1S(=O)(=O)c1cccc2cnccc12	NA	BRD-A55756846	H-7
BRD-A45499626-001-01-0	UBP 296	common	SA792721	NA	Tocris Bioscience	NA	2078	NC(Cn1ccc(=O)n(Cc2ccccc2C(O)=O)c1=O)C(O)=O	NA	BRD-A45499626	UBP-302
BRD-K11158509-001-02-0	tyrphostin B44	primary-common	SA59649	NA	MicroSource Discovery Systems Inc.	NA	2300074	C[C@@H](NC(=O)C(=C/c1ccc(O)c(O)c1)\C#N)c1ccccc1	NA	BRD-K11158509	tyrphostin-B44
BRD-A49906757-004-03-1	scopolamin-N-oxide hydrobromide	common	SA83146	NA	Prestwick Chemical Inc.	NA	Prestw-232	C[N+]1([O-])[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1	NA	BRD-A49906757	scopolamine-n-oxide
BRD-A72596465-001-01-3	GW 6471	to-be-curated	SA792786	NA	Tocris Bioscience	NA	2271	CCOC(=O)NCC(Cc1ccc(OCCc2nc(oc2C)-c2ccccc2)cc1)NC(C)=CC(=O)c1ccc(cc1)C(F)(F)F	NA	BRD-A72596465	GW-6471
BRD-A74904029-001-04-0	DRB	primary-common	SA82238	NA	Biomol International Inc.	NA	EI-231	OC[C@H]1O[C@H](C(O)[C@H]1O)n1cnc2cc(Cl)c(Cl)cc12	NA	BRD-A74904029	EI-231
BRD-A88282067-001-02-2	delcorine	common	SA82859	NA	Prestwick Chemical Inc.	NA	Prestw-664	CCN1C[C@]2(COC)CC[C@H](OC)[C@@]34[C@@H]5C[C@H]6[C@H](OC)[C@@H]5[C@@]5(C[C@@H]6OC)OCO[C@]5([C@@H](O)[C@H]23)C14	NA	BRD-A88282067	delcorine
BRD-K08115555-001-02-8	tyrphostin AG-1288	primary-common	SA63247	NA	EMD Biosciences	NA	658510	Oc1cc(C=C(C#N)C#N)cc(c1O)[N+]([O-])=O	NA	BRD-K08115555	tyrphostin-AG-1288
BRD-A80151636-066-02-2	bromocriptine	INN	SA59628	NA	MicroSource Discovery Systems Inc.	NA	1500151	CC(C)CC1N2C(=O)[C@](NC(=O)C3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)[C@@H]2CCCN2C1=O)C(C)C	NA	BRD-A80151636	bromocriptine
BRD-A69815203-001-02-7	ciclosporin	INN	SA59473	NA	MicroSource Discovery Systems Inc.	NA	1502202	CCC1NC(=O)C(C(O)C(C)C\C=C\C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C	NA	BRD-A69815203	cyclosporin-a
BRD-A51820102-008-04-0	econazole	INN	SA59347	NA	MicroSource Discovery Systems Inc.	NA	1501185	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1	NA	BRD-A51820102	econazole
BRD-A81177136-001-03-6	KN-62	primary-common	SA81861	NA	Biomol International Inc.	NA	EI-230	CN(C(Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(CC1)c1ccccc1)S(=O)(=O)c1cccc2cnccc12	NA	BRD-A81177136	KN-62
BRD-A98725278-103-01-9	methysergide	to-be-curated	SA792311	NA	Tocris Bioscience	NA	1064	CCC(CO)NC(=O)C1CN(C)C2Cc3cn(C)c4cccc(C2=C1)c34	NA	BRD-A98725278	methysergide
BRD-K15601958-001-01-3	SEW2871	primary-common	SA792793	NA	Tocris Bioscience	NA	2284	FC(F)(F)c1sc(cc1-c1ccccc1)-c1nc(no1)-c1cccc(c1)C(F)(F)F	NA	BRD-K15601958	SEW-2871
BRD-A50684349-001-01-5	fenoldopam	INN	SA82630	NA	Biomol International Inc.	NA	AC-257	Oc1ccc(cc1)C1CNCCc2c(Cl)c(O)c(O)cc12	NA	BRD-A50684349	fenoldopam
BRD-A64125466-236-02-0	dehydrocholic acid	INN	SA58257	NA	MicroSource Discovery Systems Inc.	NA	1500225	C[C@H](CCC(O)=O)[C@H]1CCC2C3C(CC(=O)[C@]12C)[C@@]1(C)CCC(=O)CC1CC3=O	NA	BRD-A64125466	dehydrocholate
BRD-A75552914-001-04-4	isoxicam	INN	SA59460	NA	MicroSource Discovery Systems Inc.	NA	1503242	CN1C(C(=O)Nc2cc(C)on2)C(=O)c2ccccc2S1(=O)=O	NA	BRD-A75552914	isoxicam
BRD-A50737080-001-01-4	CGK733	common	SA792956	NA	Tocris Bioscience	NA	2639	[O-][N+](=O)c1cc(NC(=S)NC(NC(=O)C(c2ccccc2)c2ccccc2)C(Cl)(Cl)Cl)ccc1F	NA	BRD-A50737080	CGK-733
BRD-A60274948-066-02-9	bromocriptine	INN	SA83329	NA	Prestwick Chemical Inc.	NA	Prestw-121	CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C	NA	BRD-A60274948	bromocriptine
BRD-A49734948-001-03-3	foliosidine	primary-common	SA83530	NA	Prestwick Chemical Inc.	NA	Prestw-667	COc1cc(=O)n(C)c2c(OCC(O)C(C)(C)O)cccc12	NA	BRD-A49734948	foliosidine
BRD-A74269027-003-03-8	isoxsuprine	INN	SA83102	NA	Prestwick Chemical Inc.	NA	Prestw-68	CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1	NA	BRD-A74269027	isoxsuprine
BRD-A62525898-001-02-9	prednisone	INN	SA58636	NA	MicroSource Discovery Systems Inc.	NA	1500499	C[C@]12CC(=O)C3C(CCC4=CC(=O)C=C[C@]34C)C1CC[C@]2(O)C(=O)CO	NA	BRD-A62525898	prednisone
BRD-A54845972-066-01-5	dihydro-ergotamine	to-be-curated	SA791991	NA	Tocris Bioscience	NA	475	CN1CC(CC2C1Cc1c[nH]c3cccc2c13)C(=O)NC1(C)OC2(O)C3CCCN3C(=O)C(Cc3ccccc3)N2C1=O	NA	BRD-A54845972	dihydroergotamine
BRD-A71799696-001-01-5	BH3I-1	common	SA63137	NA	EMD Biosciences	NA	286892	CC(C)C(N1C(=S)S\C(=C/c2ccccc2)C1=O)C(O)=O	NA	BRD-A71799696	BH3I-1
BRD-A59215453-003-03-3	lobelanidine	primary-common	SA82998	NA	Prestwick Chemical Inc.	NA	Prestw-582	CN1C(CC(O)c2ccccc2)CCCC1CC(O)c1ccccc1	NA	BRD-A59215453	lobelanidine
BRD-K18059238-001-02-1	gamolenic acid	INN	SA82000	NA	Biomol International Inc.	NA	FA006	CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O	NA	BRD-K18059238	gamma-linolenic-acid
BRD-A72703248-001-02-7	SK&F 96365	primary-common	SA82110	NA	Biomol International Inc.	NA	CA-230	COc1ccc(CCCOC(Cn2ccnc2)c2ccc(OC)cc2)cc1	NA	BRD-A72703248	SKF-96365
BRD-K93754473-001-02-9	tamoxifen	INN	SA82346	NA	Biomol International Inc.	NA	S-650	CC\C(c1ccccc1)=C(/c1ccccc1)c1ccc(OCCN(C)C)cc1	NA	BRD-K93754473	tamoxifen
BRD-K80334323-001-03-5	noretynodrel	INN	SA83427	NA	Prestwick Chemical Inc.	NA	Prestw-24	C[C@]12CC[C@H]3[C@@H](CCC4=C3CCC(=O)C4)[C@@H]1CC[C@@]2(O)C#C	NA	BRD-K80334323	noretynodrel
BRD-K06234293-001-01-8	LY-364947	common	SA792991	NA	Tocris Bioscience	NA	2718	c1[nH]nc(c1-c1ccnc2ccccc12)-c1ccccn1	NA	BRD-K06234293	LY-364947
BRD-K88429204-001-04-7	pyrimethamine	INN	SA59581	NA	MicroSource Discovery Systems Inc.	NA	1500520	CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1	NA	BRD-K88429204	pyrimethamine
BRD-K07507905-236-01-8	BRL 37344	to-be-curated	SA792240	NA	Tocris Bioscience	NA	948	C[C@H](Cc1ccc(OCC(O)=O)cc1)NC[C@H](O)c1cccc(Cl)c1	NA	BRD-K07507905	BRL-37344
BRD-K86882815-001-01-6	cabergoline	common	SA82670	NA	Biomol International Inc.	NA	AC-1359	CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1	NA	BRD-K86882815	cabergoline
BRD-A93255169-001-06-9	thalidomide	INN	SA82349	NA	Biomol International Inc.	NA	T-115	O=C1N(C2CCC(=O)NC2=O)C(=O)c2ccccc12	NA	BRD-A93255169	thalidomide
BRD-K96119599-001-04-7	leucodin	primary-common	SA59511	NA	MicroSource Discovery Systems Inc.	NA	1504149	C[C@H]1[C@@H]2CCC(C)=C3[C@@H]([C@H]2OC1=O)C(C)=CC3=O	NA	BRD-K96119599	leucodin
BRD-K14807180-001-01-7	SB-221284	to-be-curated	SA792455	NA	Tocris Bioscience	NA	1379	CSc1cc2CCN(C(=O)Nc3cccnc3)c2cc1C(F)(F)F	NA	BRD-K14807180	SB-221284
BRD-K17378184-300-03-4	DO 897/99	primary-common	SA83408	NA	Prestwick Chemical Inc.	NA	Prestw-559	COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1	NA	BRD-K17378184	BP-897
BRD-K81272440-001-02-6	dantrolene	INN	SA82064	NA	Biomol International Inc.	NA	AC-100	[O-][N+](=O)c1ccc(cc1)-c1ccc(\C=N\N2CC(=O)NC2=O)o1	NA	BRD-K81272440	dantrolene
BRD-K88611939-001-01-8	aniracetam	INN	SA59433	NA	MicroSource Discovery Systems Inc.	NA	1503078	COc1ccc(cc1)C(=O)N1CCCC1=O	NA	BRD-K88611939	aniracetam
BRD-K92049597-001-04-2	triamterene	INN	SA59252	NA	MicroSource Discovery Systems Inc.	NA	1500589	Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1	NA	BRD-K92049597	triamterene
BRD-K03015355-003-01-5	HSCI1_000325	to-be-curated	SA63434	NA	EMD Biosciences	NA	344273	CN1CCN(CCCC(=O)O[C@H]2[C@@H](O)[C@H]3C(C)(C)CC[C@H](O)[C@]3(C)[C@@]3(O)C(=O)C[C@@](C)(O[C@]23C)C=C)CC1	NA	BRD-K03015355	forskolin
BRD-K91315211-334-02-3	betahistine	INN	SA83387	NA	Prestwick Chemical Inc.	NA	Prestw-543	CNCCc1ccccn1	NA	BRD-K91315211	betahistine
BRD-K02637541-001-02-4	celecoxib	INN	SA59876	NA	MicroSource Discovery Systems Inc.	NA	1503678	Cc1ccc(cc1)-c1cc(nn1-c1ccc(cc1)S(N)(=O)=O)C(F)(F)F	NA	BRD-K02637541	celecoxib
BRD-A94624445-236-02-2	bucladesine	INN	SA82230	NA	Biomol International Inc.	NA	CN-125	CCCC(=O)Nc1ncnc2n(cnc12)[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1OC(=O)CCC	NA	BRD-A94624445	bucladesine
BRD-K89997465-001-02-0	chlorpromazine	INN	SA58226	NA	MicroSource Discovery Systems Inc.	NA	1500184	CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc12	NA	BRD-K89997465	chlorpromazine
BRD-K90259198-003-04-8	W-7	primary-common	SA82366	NA	Biomol International Inc.	NA	CA-320	NCCCCCCNS(=O)(=O)c1cccc2c(Cl)cccc12	NA	BRD-K90259198	W-7
BRD-K78485176-001-02-9	olmesartan medoxomil	INN	SA59556	NA	MicroSource Discovery Systems Inc.	NA	1505205	CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1	NA	BRD-K78485176	olmesartan-medoxomil
BRD-K95237249-001-04-2	probenecid	INN	SA58434	NA	MicroSource Discovery Systems Inc.	NA	1500502	CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(O)=O	NA	BRD-K95237249	probenecid
BRD-A71816415-236-02-7	pravastatin	INN	SA58775	NA	MicroSource Discovery Systems Inc.	NA	1505803	CCC(C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)C12	NA	BRD-A71816415	pravastatin
BRD-A56987319-001-03-8	SQ-22536	primary-common	SA82342	NA	Biomol International Inc.	NA	CN-140	Nc1ncnc2n(cnc12)C1CCCO1	NA	BRD-A56987319	SQ-22536
BRD-A95939040-008-03-3	sertaconazole	INN	SA83795	NA	Prestwick Chemical Inc.	NA	Prestw-1045	Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1	NA	BRD-A95939040	sertaconazole
BRD-A94709349-001-02-6	metaxalone	INN	SA59546	NA	MicroSource Discovery Systems Inc.	NA	1504229	Cc1cc(C)cc(OCC2CNC(=O)O2)c1	NA	BRD-A94709349	metaxalone
BRD-A57382968-001-06-8	piroxicam	INN	SA82316	NA	Biomol International Inc.	NA	EI219	CN1C(C(=O)Nc2ccccn2)C(=O)c2ccccc2S1(=O)=O	NA	BRD-A57382968	piroxicam
BRD-A90490067-001-01-9	BRD-A90490067	BROAD_CPD_ID	SA792300	NA	Tocris Bioscience	NA	1047	CC12CCC3C(C1CCC2O)C(CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)Cc1cc(O)ccc31	NA	BRD-A90490067	fulvestrant
BRD-A95513702-001-02-2	androsta-1,4-dien-3,17-dione	to-be-curated	SA59670	NA	MicroSource Discovery Systems Inc.	NA	1701001	C[C@]12CCC3C(CCC4=CC(=O)C=C[C@]34C)C1CCC2=O	NA	BRD-A95513702	androsta-1,4-dien-3,17-dione
BRD-K89055274-048-03-7	alverine	INN	SA58170	NA	MicroSource Discovery Systems Inc.	NA	1500109	CCN(CCCc1ccccc1)CCCc1ccccc1	NA	BRD-K89055274	alverine
BRD-K13261168-001-01-4	LY-163,502	to-be-curated	SA82614	NA	Biomol International Inc.	NA	AC-756	CCCN1CCC[C@@H]2Cc3nc(N)ncc3C[C@@H]12	NA	BRD-K13261168	quinelorane
BRD-K08554278-001-02-4	Hoechst 33342	primary-common	SA82262	NA	Biomol International Inc.	NA	GR-303	CCOc1ccc(cc1)-c1nc2cc(ccc2[nH]1)-c1nc2cc(ccc2[nH]1)N1CCN(C)CC1	NA	BRD-K08554278	bisbenzimide
BRD-A91992993-001-01-2	siguazodan	to-be-curated	SA792367	NA	Tocris Bioscience	NA	1148	CNC(NC#N)=Nc1ccc(cc1)C1=NNC(=O)CC1C	NA	BRD-A91992993	siguazodan
BRD-K90553655-001-03-6	testosterone propionate	USAN	SA83062	NA	Prestwick Chemical Inc.	NA	Prestw-401	CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	NA	BRD-K90553655	testosterone
BRD-A68281735-001-02-0	REV-5901	primary-common	SA63076	NA	Biomol International Inc.	NA	EI209-0010	CCCCCC(O)c1cccc(OCc2ccc3ccccc3n2)c1	NA	BRD-A68281735	REV-5901
BRD-A79981887-003-04-0	midodrine	INN	SA59465	NA	MicroSource Discovery Systems Inc.	NA	1503257	COc1ccc(OC)c(c1)C(O)CNC(=O)CN	NA	BRD-A79981887	midodrine
BRD-K96362535-001-02-4	dihydro-beta-tubaic acid	primary-common	SA59678	NA	MicroSource Discovery Systems Inc.	NA	211531	COc1c2CCC(C)(C)Oc2ccc1C(O)=O	NA	BRD-K96362535	tubaic-acid
BRD-A55393291-001-02-4	testosterone	INN	SA58667	NA	MicroSource Discovery Systems Inc.	NA	307023	C[C@]12CCC3C(CCC4=CC(=O)CC[C@]34C)C1CC[C@@H]2O	NA	BRD-A55393291	testosterone
BRD-A49358627-001-03-9	ciprofibrate	INN	SA83680	NA	Prestwick Chemical Inc.	NA	Prestw-1076	CC(C)(Oc1ccc(cc1)C1CC1(Cl)Cl)C(O)=O	NA	BRD-A49358627	ciprofibrate
BRD-A61793559-001-04-0	metolazone	INN	SA58801	NA	MicroSource Discovery Systems Inc.	NA	2300325	CC1Nc2cc(Cl)c(cc2C(=O)N1c1ccccc1C)S(N)(=O)=O	NA	BRD-A61793559	metolazone
BRD-K95309561-001-04-9	dienestrol	INN	SA58269	NA	MicroSource Discovery Systems Inc.	NA	1500241	C\C=C(c1ccc(O)cc1)\C(c1ccc(O)cc1)=C\C	NA	BRD-K95309561	dienestrol
BRD-A58207013-001-01-2	pinacidil	to-be-curated	SA792516	NA	Tocris Bioscience	NA	1503	CC(NC(Nc1ccncc1)=NC#N)C(C)(C)C	NA	BRD-A58207013	pinacidil
BRD-A50675702-001-03-0	fipronil	USP	SA82069	NA	Biomol International Inc.	NA	CM-102	Nc1c(c(nn1-c1c(Cl)cc(cc1Cl)C(F)(F)F)C#N)S(=O)C(F)(F)F	NA	BRD-A50675702	fipronil
BRD-A95445494-001-02-9	maackiain	primary-common	SA37977	NA	AnalytiCon Discovery GmbH	NA	NP-005240	Oc1ccc2C3Oc4cc5OCOc5cc4C3COc2c1	NA	BRD-A95445494	maackiain
BRD-A78877355-003-03-6	nefopam	INN	SA83020	NA	Prestwick Chemical Inc.	NA	Prestw-229	CN1CCOC(c2ccccc2)c2ccccc2C1	NA	BRD-A78877355	nefopam
BRD-K79366068-236-01-5	PSB 069	to-be-curated	SA792926	NA	Tocris Bioscience	NA	2573	Nc1c(cc(Nc2ccc(Cl)cc2)c2C(=O)c3ccccc3C(=O)c12)S(O)(=O)=O	NA	BRD-K79366068	PSB-069
BRD-K92015269-001-01-6	GBR 12783	to-be-curated	SA82643	NA	Biomol International Inc.	NA	AC-271	C(CN1CCN(C\C=C\c2ccccc2)CC1)OC(c1ccccc1)c1ccccc1	NA	BRD-K92015269	GBR-12783
BRD-K91263825-001-02-8	nortriptyline	INN	SA58406	NA	MicroSource Discovery Systems Inc.	NA	1500442	CNCCC=C1c2ccccc2CCc2ccccc12	NA	BRD-K91263825	nortriptyline
BRD-K78838262-001-02-4	austricine	common	SA59508	NA	MicroSource Discovery Systems Inc.	NA	1504139	C[C@H]1[C@H]2[C@H](OC1=O)[C@@H]1C(C)=CC(=O)C1=C(C)C[C@@H]2O	NA	BRD-K78838262	austricine
BRD-A96820077-008-02-2	ungerine	primary-common	SA82901	NA	Prestwick Chemical Inc.	NA	Prestw-689	CO[C@H]1C=C2CCN(C)[C@H]2C2[C@@H]1OC(=O)c1cc3OCOc3cc21	NA	BRD-A96820077	ungerine
BRD-A54029483-001-01-5	IRL-2500	to-be-curated	SA792647	NA	Tocris Bioscience	NA	1838	CN(C(Cc1ccc(cc1)-c1ccccc1)C(=O)NC(Cc1c[nH]c2ccccc12)C(O)=O)C(=O)c1cc(C)cc(C)c1	NA	BRD-A54029483	IRL-2500
BRD-K84595254-001-03-0	strophanthidin	primary-common	SA82821	NA	Prestwick Chemical Inc.	NA	Prestw-710	C[C@]12CC[C@H]3[C@@H](CC[C@]4(O)C[C@@H](O)CC[C@]34C=O)[C@@]1(O)CC[C@@H]2C1=CC(=O)OC1	NA	BRD-K84595254	strophanthidin
BRD-K81209159-001-02-9	herniarin	primary-common	SA36520	NA	AnalytiCon Discovery GmbH	NA	NP-000391	COc1ccc2ccc(=O)oc2c1	NA	BRD-K81209159	herniarin
BRD-K10870738-001-02-4	CDC	primary-common	SA82378	NA	Biomol International Inc.	NA	EI211	Oc1ccc(\C=C(\C#N)C(=O)OC\C=C\c2ccccc2)cc1O	NA	BRD-K10870738	CDC
BRD-A65671304-001-02-6	candesartan cilextil	primary-common	SA58876	NA	MicroSource Discovery Systems Inc.	NA	1504261	CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1	NA	BRD-A65671304	candesartan-cilextil
BRD-A96897502-001-02-0	U-74389F	primary-common	SA82151	NA	Biomol International Inc.	NA	FR-100	CC12CC=C3C(CCC4=CC(=O)C=CC34C)C1CC[C@@H]2C(=O)CN1CCN(CC1)c1cc(nc(n1)N1CCCC1)N1CCCC1	NA	BRD-A96897502	U-74389F
BRD-A91699651-316-04-2	chloroquine	INN	SA58221	NA	MicroSource Discovery Systems Inc.	NA	1500179	CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12	NA	BRD-A91699651	chloroquine
BRD-A55962179-001-01-5	omeprazole	primary-common	SA19145	NA	Maybridge	NA	KM 07219	COc1ccc2nc([nH]c2c1)S(=O)Cc1ncc(C)c(OC)c1C	NA	BRD-A55962179	omeprazole
BRD-A84174393-001-02-0	meloxicam	INN	SA58529	NA	MicroSource Discovery Systems Inc.	NA	1504150	CN1C(C(=O)Nc2ncc(C)s2)C(=O)c2ccccc2S1(=O)=O	NA	BRD-A84174393	meloxicam
BRD-K83597974-003-05-7	pargyline	INN	SA83034	NA	Prestwick Chemical Inc.	NA	Prestw-183	CN(CC#C)Cc1ccccc1	NA	BRD-K83597974	pargyline
BRD-K07691486-001-05-6	roscovitine	primary-common	SA82330	NA	Biomol International Inc.	NA	CC205	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1	NA	BRD-K07691486	roscovitine
BRD-K93658967-001-01-7	aloisine A	primary-common	SA63328	NA	Calbiochem	NA	128125	CCCCc1c([nH]c2nccnc12)-c1ccc(O)cc1	NA	BRD-K93658967	aloisine
BRD-A51714012-001-02-3	venlafaxine	INN	SA58869	NA	MicroSource Discovery Systems Inc.	NA	1504171	COc1ccc(cc1)C(CN(C)C)C1(O)CCCCC1	NA	BRD-A51714012	venlafaxine
BRD-K07888196-001-01-8	tyrphostin AG 538	primary-common	SA63298	NA	Calbiochem	NA	658403	Oc1ccc(\C=C(/C#N)C(=O)c2ccc(O)c(O)c2)cc1O	NA	BRD-K07888196	tyrphostin-AG-538
BRD-K80738081-001-06-2	resveratrol	primary-common	SA82338	NA	Biomol International Inc.	NA	FR-104	Oc1ccc(cc1)\C=C\c1cc(O)cc(O)c1	NA	BRD-K80738081	resveratrol
BRD-A61899133-002-02-2	cianidanol	INN	SA83504	NA	Prestwick Chemical Inc.	NA	Prestw-817	OC1Cc2c(O)cc(O)cc2OC1c1ccc(O)c(O)c1	NA	BRD-A61899133	catechin
BRD-K81029756-001-02-8	L-cis-DILTIAZEM	to-be-curated	SA82080	NA	Biomol International Inc.	NA	CA-207	COc1ccc(cc1)[C@H]1Sc2ccccc2N(CCN(C)C)C(=O)[C@H]1OC(C)=O	NA	BRD-K81029756	diltiazem
BRD-K79437791-001-02-4	acetyl farnesyl cysteine	common	SA82163	NA	Biomol International Inc.	NA	G-200	CC(=O)N[C@@H](CSC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=O	NA	BRD-K79437791	acetyl-farnesyl-cysteine
BRD-K94512704-001-01-3	AMI-193	to-be-curated	SA82450	NA	Biomol International Inc.	NA	NS-104	Fc1ccc(OCCCN2CCC3(CC2)N(CNC3=O)c2ccccc2)cc1	NA	BRD-K94512704	spiramide
BRD-K03600606-001-02-3	catechin pentabenzoate	primary-common	SA59675	NA	MicroSource Discovery Systems Inc.	NA	210235	O=C(O[C@H]1Cc2c(OC(=O)c3ccccc3)cc(OC(=O)c3ccccc3)cc2O[C@@H]1c1ccc(OC(=O)c2ccccc2)c(OC(=O)c2ccccc2)c1)c1ccccc1	NA	BRD-K03600606	catechin
BRD-A96485169-001-02-8	ethyl 1-benzyl-4,5-dioxopyrrolidine-3-carboxylate	common	SA58893	NA	MicroSource Discovery Systems Inc.	NA	2300078	CCOC(=O)C1CN(Cc2ccccc2)C(=O)C1=O	NA	BRD-A96485169	EBPC
BRD-K89375097-300-04-7	pirenzepine	INN	SA59333	NA	MicroSource Discovery Systems Inc.	NA	1501138	CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc23)CC1	NA	BRD-K89375097	pirenzepine
BRD-A51929314-001-01-4	ICI-185,282	to-be-curated	SA792171	NA	Tocris Bioscience	NA	836	OC(=O)CCCC=CCC1COC(OC1c1ccccc1O)C(F)(F)F	NA	BRD-A51929314	BRD-A51929314
BRD-A77349281-001-02-2	RK-682	common	SA82329	NA	Biomol International Inc.	NA	PR-112	CCCCCCCCCCCCCCCC(=O)C1C(=O)OC(CO)C1=O	NA	BRD-A77349281	RK-682
BRD-K89210380-001-03-8	biotin	INN	SA82750	NA	Prestwick Chemical Inc.	NA	Prestw-418	OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12	NA	BRD-K89210380	biotin
BRD-K92778217-001-04-6	mefenamic acid	INN	SA58962	NA	MicroSource Discovery Systems Inc.	NA	1501103	Cc1cccc(Nc2ccccc2C(O)=O)c1C	NA	BRD-K92778217	mefenamic-acid
BRD-K82255054-001-04-3	propofol	INN	SA83783	NA	Prestwick Chemical Inc.	NA	Prestw-931	CC(C)c1cccc(C(C)C)c1O	NA	BRD-K82255054	propofol
BRD-A73368467-003-02-8	fexofenadine	INN	SA59801	NA	MicroSource Discovery Systems Inc.	NA	1504179	CC(C)(C(O)=O)c1ccc(cc1)C(O)CCCN1CCC(CC1)C(O)(c1ccccc1)c1ccccc1	NA	BRD-A73368467	fexofenadine
BRD-K79145749-001-01-8	DIBENZEPINE	to-be-curated	SA82453	NA	Biomol International Inc.	NA	NS-107	CN(C)CCN1c2ccccc2N(C)c2ccccc2C1=O	NA	BRD-K79145749	dibenzepin
BRD-A92826379-009-02-6	lupanine	primary-common	SA59558	NA	MicroSource Discovery Systems Inc.	NA	1505242	O=C1CCCC2C3CC(CN12)[C@@H]1CCCCN1C3	NA	BRD-A92826379	lupanine
BRD-K03981224-001-02-9	ethisterone	INN	SA83215	NA	Prestwick Chemical Inc.	NA	Prestw-261	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]2(O)C#C	NA	BRD-K03981224	ethisterone
BRD-K79930101-300-01-1	GW 583340	to-be-curated	SA792775	NA	Tocris Bioscience	NA	2239	CS(=O)(=O)CCNCc1nc(cs1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1	NA	BRD-K79930101	GW-583340
BRD-K14888893-001-02-3	minoxidil	INN	SA83120	NA	Prestwick Chemical Inc.	NA	Prestw-20	Nc1cc(nc(=N)n1O)N1CCCCC1	NA	BRD-K14888893	minoxidil
BRD-K06159959-001-01-2	CCMQ	to-be-curated	SA792395	NA	Tocris Bioscience	NA	1238	OC(=O)Cc1cc2ccccc2nc1C(O)=O	NA	BRD-K06159959	CCMQ
BRD-K08996725-313-01-7	zolantidine	primary-common	SA792315	NA	Tocris Bioscience	NA	1070	C(CNc1nc2ccccc2s1)COc1cccc(CN2CCCCC2)c1	NA	BRD-K08996725	zolantidine
BRD-A93206962-001-01-2	L 755507	to-be-curated	SA792760	NA	Tocris Bioscience	NA	2197	CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(CCNCC(O)COc2ccc(O)cc2)cc1	NA	BRD-A93206962	L-755507
BRD-K08619838-300-03-2	tremorine	primary-common	SA83093	NA	Prestwick Chemical Inc.	NA	Prestw-331	C(C#CCN1CCCC1)N1CCCC1	NA	BRD-K08619838	tremorine
BRD-A82329351-001-02-2	cycloheximide-N-ethylethanoate	to-be-curated	SA82149	NA	Biomol International Inc.	NA	IM-100	CCOC(=O)CN1C(=O)CC(C[C@@H](O)C2C[C@@H](C)C[C@H](C)C2=O)CC1=O	NA	BRD-A82329351	cycloheximide
BRD-K09416995-001-16-7	lovastatin	INN	SA792533	NA	Tocris Bioscience	NA	1530	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12	NA	BRD-K09416995	lovastatin
BRD-A73859745-236-01-8	glycodesoxycholic acid	primary-common	SA63488	NA	EMD Biosciences	NA	361311	CC(CCC(=O)NCC(O)=O)C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C	NA	BRD-A73859745	glycodeoxycholic-acid
BRD-K89595132-050-02-2	chlorphenamine	INN	SA58225	NA	MicroSource Discovery Systems Inc.	NA	1500183	CN(C)CC[C@H](c1ccc(Cl)cc1)c1ccccn1	NA	BRD-K89595132	chlorphenamine
BRD-A26334849-001-02-1	propafenone	INN	SA82104	NA	Biomol International Inc.	NA	AC-124	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1	NA	BRD-A26334849	propafenone
BRD-A97701745-001-04-6	pindolol	INN	SA58427	NA	MicroSource Discovery Systems Inc.	NA	1500488	CC(C)NCC(O)COc1cccc2[nH]ccc12	NA	BRD-A97701745	pindolol
BRD-K78959463-001-02-5	FPL-64176	primary-common	SA82074	NA	Biomol International Inc.	NA	CA-245	COC(=O)c1c(C)[nH]c(C)c1C(=O)c1ccccc1Cc1ccccc1	NA	BRD-K78959463	FPL-64176
BRD-A83855350-003-01-4	naltrexone	to-be-curated	SA792090	NA	Tocris Bioscience	NA	677	Oc1ccc2CC3N(CC4CC4)CCC45C(Oc1c24)C(=O)CCC35O	NA	BRD-A83855350	naltrexone
BRD-A93000692-001-03-2	ciglitazone	INN	SA792424	NA	Tocris Bioscience	NA	1307	CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1	NA	BRD-A93000692	ciglitazone
BRD-A22783572-065-01-3	vinblastine sulfate	common	SA792405	NA	Tocris Bioscience	NA	1256	CCC1(O)CC2CN(C1)CCc1c([nH]c3ccccc13)C(C2)(C(=O)OC)c1cc2c(cc1OC)N(C)C1C22CCN3CC=CC(CC)(C23)C(C(=O)OC)C1(O)C(=O)OC	NA	BRD-A22783572	vinblastine
BRD-K06426971-001-01-9	Cdk4 inhibitor III	common	SA792941	NA	Tocris Bioscience	NA	2609	Cc1nc2c(s1)C(=O)C=C(Nc1ccc(C)cc1)C2=O	NA	BRD-K06426971	ryuvidine
BRD-K16977723-001-01-0	PP3	common	SA63297	NA	Calbiochem	NA	529574	Nc1ncnc2n(ncc12)-c1ccccc1	NA	BRD-K16977723	PP-3
BRD-K12120659-305-01-4	GR 144053	to-be-curated	SA792411	NA	Tocris Bioscience	NA	1263	NC(=N)c1ccc(cc1)N1CCN(CC1)C1CCN(CC(O)=O)CC1	NA	BRD-K12120659	GR-144053
BRD-K91301684-003-02-2	noscapine	INN	SA58407	NA	MicroSource Discovery Systems Inc.	NA	1500443	COc1ccc2[C@@H](OC(=O)c2c1OC)[C@@H]1N(C)CCc2cc3OCOc3c(OC)c12	NA	BRD-K91301684	noscapine
BRD-K79759585-001-02-1	sildenafil	INN	SA59772	NA	MicroSource Discovery Systems Inc.	NA	1504099	CCCc1nn(C)c2c1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(C)CC1	NA	BRD-K79759585	sildenafil
BRD-A70649075-008-04-3	sulconazole	INN	SA59337	NA	MicroSource Discovery Systems Inc.	NA	1501148	Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1	NA	BRD-A70649075	sulconazole
BRD-K96263742-001-02-3	gw 7647	to-be-curated	SA792590	NA	Tocris Bioscience	NA	1677	CC(C)(Sc1ccc(CCN(CCCCC2CCCCC2)C(=O)NC2CCCCC2)cc1)C(O)=O	NA	BRD-K96263742	GW-7647
BRD-K08287586-001-03-6	butylparaben	USAN	SA83696	NA	Prestwick Chemical Inc.	NA	Prestw-894	CCCCOC(=O)c1ccc(O)cc1	NA	BRD-K08287586	butyl-paraben
BRD-A63894585-001-03-4	clobetasol propionate	USAN	SA82732	NA	Prestwick Chemical Inc.	NA	Prestw-781	CCC(=O)OC1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCl	NA	BRD-A63894585	clobetasol
BRD-A13964793-001-01-8	TC 1	to-be-curated	SA792973	NA	Tocris Bioscience	NA	2669	OC12C3C4C5C3C(C3C5CC4C13)N2CCc1cccc(F)c1	NA	BRD-A13964793	BRD-A13964793
BRD-A03359064-001-01-5	ICI-89406	to-be-curated	SA792167	NA	Tocris Bioscience	NA	832	OC(CNCCNC(=O)Nc1ccccc1)COc1ccccc1C#N	NA	BRD-A03359064	ICI-89406
BRD-K81225797-001-01-5	SCH 58261	to-be-curated	SA792785	NA	Tocris Bioscience	NA	2270	Nc1nc2n(CCc3ccccc3)ncc2c2nc(nn12)-c1ccco1	NA	BRD-K81225797	SCH-58261
BRD-A30815329-001-03-0	felodipine	INN	SA83351	NA	Prestwick Chemical Inc.	NA	Prestw-478	CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(Cl)c1Cl)C(=O)OC	NA	BRD-A30815329	felodipine
BRD-A99177642-001-02-5	deltaline	primary-common	SA82860	NA	Prestwick Chemical Inc.	NA	Prestw-673	CCN1C[C@]2(C)CC[C@H](OC)[C@]34[C@@H]2[C@H](OC(C)=O)[C@@]2(OCO[C@@]22C[C@H](OC)[C@H]5C[C@]3(O)[C@@H]2[C@H]5OC)C14	NA	BRD-A99177642	deltaline
BRD-A13650332-236-03-9	flucloxacillin	INN	SA83717	NA	Prestwick Chemical Inc.	NA	Prestw-1011	Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)C(N2C1=O)C(O)=O)-c1c(F)cccc1Cl	NA	BRD-A13650332	flucloxacillin
BRD-A03816571-001-01-0	CP 55,940	to-be-curated	SA792241	NA	Tocris Bioscience	NA	949	CCCCCCC(C)(C)c1ccc(C2CC(O)CCC2CCCO)c(O)c1	NA	BRD-A03816571	CP-55940
BRD-A30717181-001-02-7	triamcinolone diacetate	USAN	SA59251	NA	MicroSource Discovery Systems Inc.	NA	1500588	CC(=O)OCC(=O)[C@@]1(O)[C@@H](CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)OC(C)=O	NA	BRD-A30717181	triamcinolone
BRD-K79131256-001-03-9	albendazole	INN	SA58834	NA	MicroSource Discovery Systems Inc.	NA	1503903	CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1	NA	BRD-K79131256	albendazole
BRD-K97181089-001-02-7	amiloride	INN	SA82057	NA	Biomol International Inc.	NA	CA-200	NC(=N)NC(=O)c1nc(Cl)c(N)nc1N	NA	BRD-K97181089	amiloride
BRD-K98143437-001-01-7	SB 239063	to-be-curated	SA792676	NA	Tocris Bioscience	NA	1962	COc1nccc(n1)-c1c(ncn1C1CCC(O)CC1)-c1ccc(F)cc1	NA	BRD-K98143437	SB-239063
BRD-K88172511-310-03-8	naltrexone	INN	SA83017	NA	Prestwick Chemical Inc.	NA	Prestw-116	Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O	NA	BRD-K88172511	naltrexone
BRD-A02759312-003-11-2	betaxolol	INN	SA792210	NA	Tocris Bioscience	NA	906	CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1	NA	BRD-A02759312	betaxolol
BRD-K17743697-066-01-0	KB-R7943	primary-common	SA63329	NA	EMD Biosciences	NA	420336	NC(=N)SCCc1ccc(OCc2ccc(cc2)[N+]([O-])=O)cc1	NA	BRD-K17743697	KB-R7943
BRD-A11678676-001-02-6	wortmannin	primary-common	SA81851	NA	Biomol International Inc.	NA	ST-415	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O)C3=O	NA	BRD-A11678676	wortmannin
BRD-K85119730-001-06-5	tolbutamide	INN	SA82115	NA	Biomol International Inc.	NA	AC-117	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1	NA	BRD-K85119730	tolbutamide
BRD-A18497530-001-04-6	5-iodotubercidin	primary-common	SA82285	NA	Biomol International Inc.	NA	EI-293	Nc1ncnc2n(cc(I)c12)C1OC(CO)C(O)C1O	NA	BRD-A18497530	5-iodotubercidin
BRD-K97399794-001-07-0	quercetin	primary-common	SA82325	NA	Biomol International Inc.	NA	AC1142	Oc1cc(O)c2c(c1)oc(-c1ccc(O)c(O)c1)c(O)c2=O	NA	BRD-K97399794	quercetin
BRD-K92073408-001-03-3	norethisterone	INN	SA83220	NA	Prestwick Chemical Inc.	NA	Prestw-253	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C	NA	BRD-K92073408	norethisterone
BRD-A11609859-303-01-2	SB-205607	to-be-curated	SA792222	NA	Tocris Bioscience	NA	921	CN1CCC2(Cc3nc4ccccc4cc3CC2C1)c1cccc(O)c1	NA	BRD-A11609859	SB-205607
BRD-K03384561-001-01-9	linomide	to-be-curated	SA792501	NA	Tocris Bioscience	NA	1461	CN(C(=O)c1c(O)c2ccccc2n(C)c1=O)c1ccccc1	NA	BRD-K03384561	roquinimex
BRD-K92758126-001-06-3	gibberellic acid	primary-common	SA83725	NA	Prestwick Chemical Inc.	NA	Prestw-965	C[C@@]12[C@H]3[C@H](C(O)=O)[C@@]45CC(=C)[C@@](O)(C4)CC[C@H]5[C@]3(OC1=O)C=C[C@@H]2O	NA	BRD-K92758126	MD-920
BRD-A12016240-001-01-7	LY-278584	primary-common	SA82526	NA	Biomol International Inc.	NA	AC-849	CN1C2CCC1CC(C2)NC(=O)c1nn(C)c2ccccc12	NA	BRD-A12016240	LY-278584
BRD-A02176148-001-02-2	tubaic acid	common	SA59605	NA	MicroSource Discovery Systems Inc.	NA	1600587	CC(=C)C1Cc2c(O1)ccc(C(O)=O)c2O	NA	BRD-A02176148	tubaic-acid
BRD-K09631521-001-02-4	thiotepa	INN	SA59474	NA	MicroSource Discovery Systems Inc.	NA	1503324	S=P(N1CC1)(N1CC1)N1CC1	NA	BRD-K09631521	thiotepa
BRD-K02590140-001-01-2	O-2050	common	SA792576	NA	Tocris Bioscience	NA	1655	CC1=CC[C@@H]2[C@@H](C1)c1c(O)cc(CC#CCCCNS(C)(=O)=O)cc1OC2(C)C	NA	BRD-K02590140	O-2050
BRD-A08187463-001-03-8	racecadotril	INN	SA83465	NA	Prestwick Chemical Inc.	NA	Prestw-626	CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1	NA	BRD-A08187463	racecadotril
BRD-K86301799-001-14-0	dipyridamole	INN	SA792098	NA	Tocris Bioscience	NA	691	OCCN(CCO)c1nc(N2CCCCC2)c2nc(nc(N3CCCCC3)c2n1)N(CCO)CCO	NA	BRD-K86301799	dipyridamole
BRD-A09472452-001-02-8	flecainide	INN	SA82070	NA	Biomol International Inc.	NA	AC-130	FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NCC1CCCCN1	NA	BRD-A09472452	flecainide
BRD-K05464208-001-01-6	JX-401	primary-common	SA792967	NA	Tocris Bioscience	NA	2657	COc1cc(SC)ccc1C(=O)N1CCC(Cc2ccccc2)CC1	NA	BRD-K05464208	JX-401
BRD-K92577649-001-01-6	GBR 13069	to-be-curated	SA82645	NA	Biomol International Inc.	NA	AC-273	Fc1ccc(cc1)C(OCCN1CCN(C\C=C\c2ccccc2)CC1)c1ccc(F)cc1	NA	BRD-K92577649	GBR-13069
BRD-A24122750-001-01-1	SACLOFEN	to-be-curated	SA82542	NA	Biomol International Inc.	NA	AC-490	NCC(CS(O)(=O)=O)c1ccc(Cl)cc1	NA	BRD-A24122750	saclofen
BRD-K89085489-001-02-6	fenretinide	INN	SA63221	NA	EMD Biosciences	NA	390900	CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C\C(=O)Nc1ccc(O)cc1	NA	BRD-K89085489	fenretinide
BRD-A09828896-004-04-5	SKF 81297	common	SA792495	NA	Tocris Bioscience	NA	1447	Oc1cc2C(CNCCc2c(Cl)c1O)c1ccccc1	NA	BRD-A09828896	SKF-81297
BRD-A39522003-001-01-0	OMDM-2	to-be-curated	SA792632	NA	Tocris Bioscience	NA	1797	CCCCCCCCC=CCCCCCCCC(=O)NC(CO)Cc1ccc(O)cc1	NA	BRD-A39522003	OMDM-2
BRD-A41250306-001-03-4	cyclopenthiazide	INN	SA83701	NA	Prestwick Chemical Inc.	NA	Prestw-994	NS(=O)(=O)c1cc2c(NC(CC3CCCC3)NS2(=O)=O)cc1Cl	NA	BRD-A41250306	cyclopenthiazide
BRD-K90333595-001-02-8	phentolamine	INN	SA82099	NA	Biomol International Inc.	NA	AC-121	Cc1ccc(cc1)N(CC1=NCCN1)c1cccc(O)c1	NA	BRD-K90333595	phentolamine
BRD-A45140972-060-02-4	meclocycline sulfosalicylate	USAN	SA83172	NA	Prestwick Chemical Inc.	NA	Prestw-456	CN(C)[C@H]1[C@@H]2[C@@H](O)C3C(C(=O)c4c(O)ccc(Cl)c4C3=C)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O	NA	BRD-A45140972	meclocycline
BRD-K00206590-001-01-2	P1075	to-be-curated	SA792443	NA	Tocris Bioscience	NA	1355	CCC(C)(C)N=C(NC#N)Nc1cccnc1	NA	BRD-K00206590	P-1075
BRD-K87905482-001-02-4	anandamide(18:2,n-6)	common	SA81966	NA	Biomol International Inc.	NA	FA026	CCCCC\C=C/C\C=C/CCCCCCCC(=O)NCCO	NA	BRD-K87905482	anandamide
BRD-A01320529-001-05-9	salmeterol	INN	SA792580	NA	Tocris Bioscience	NA	1660	OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc1ccccc1	NA	BRD-A01320529	salmeterol
BRD-A01295252-001-01-5	TRANS-7-HYDROXY-PIPAT	to-be-curated	SA82600	NA	Biomol International Inc.	NA	D-106	CCCN(C\C=C\I)C1CCc2ccc(O)cc2C1	NA	BRD-A01295252	7-hydroxy-PIPAT
BRD-K03067624-300-02-9	emetine	primary-common	SA82899	NA	Prestwick Chemical Inc.	NA	Prestw-570	CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc12	NA	BRD-K03067624	emetine
BRD-K16195444-001-01-7	oxymetazoline	INN	SA82524	NA	Biomol International Inc.	NA	AC-847	Cc1cc(c(O)c(C)c1CC1=NCCN1)C(C)(C)C	NA	BRD-K16195444	oxymetazoline
BRD-K15616905-001-01-5	carbonyl cyanide m-chlorophenyl hydrazone	primary-common	SA791979	NA	Tocris Bioscience	NA	452	Clc1cccc(NN=C(C#N)C#N)c1	NA	BRD-K15616905	CCCP
BRD-A21858158-001-04-5	praziquantel	INN	SA58430	NA	MicroSource Discovery Systems Inc.	NA	1500494	O=C(C1CCCCC1)N1CC2N(CCc3ccccc23)C(=O)C1	NA	BRD-A21858158	praziquantel
BRD-A31575449-300-01-4	CGP-20712A	common	SA792280	NA	Tocris Bioscience	NA	1024	Cn1cc(nc1-c1ccc(OCC(O)CNCCOc2ccc(O)c(c2)C(N)=O)cc1)C(F)(F)F	NA	BRD-A31575449	CGP-20712
BRD-K05434375-001-04-0	HA-1004	primary-common	SA82258	NA	Biomol International Inc.	NA	EI-184	NC(=N)NCCNS(=O)(=O)c1cccc2cnccc12	NA	BRD-K05434375	HA-1004
BRD-A42571354-300-01-3	cetirizine	INN	SA23196	NA	TimTec LLC	NA	ST024755	OC(=O)COCCN1CCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1	NA	BRD-A42571354	cetirizine
BRD-K89923877-003-02-4	scopolamine	primary-common	SA83551	NA	Prestwick Chemical Inc.	NA	Prestw-877	CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1	NA	BRD-K89923877	scopolamine
BRD-A11813248-001-02-8	AM 92016 hydrochloride	common	SA82055	NA	Biomol International Inc.	NA	AC-115	CN(CCc1ccc(Cl)c(Cl)c1)CC(O)COc1ccc(NS(C)(=O)=O)cc1	NA	BRD-A11813248	AM-92016
BRD-A32949107-001-01-7	MRS 1845	to-be-curated	SA792657	NA	Tocris Bioscience	NA	1866	COC(=O)C1=C(C)N(CC#C)C(C)=C(C1c1cccc(c1)-n1oo1)C(=O)CCO	NA	BRD-A32949107	MRS-1845
BRD-A31521121-001-04-1	methocarbamol	INN	SA58376	NA	MicroSource Discovery Systems Inc.	NA	1500397	COc1ccccc1OCC(O)COC(N)=O	NA	BRD-A31521121	methocarbamol
BRD-K11163873-001-02-8	phenanthridone	primary-common	SA82312	NA	Biomol International Inc.	NA	AP-100	O=c1[nH]c2ccccc2c2ccccc12	NA	BRD-K11163873	phenanthridone
BRD-A58048407-001-06-3	nimodipine	INN	SA82090	NA	Biomol International Inc.	NA	CA-211	COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)C	NA	BRD-A58048407	nimodipine
BRD-A39255369-001-01-5	DCPIB	to-be-curated	SA792535	NA	Tocris Bioscience	NA	1540	CCCCC1(Cc2cc(OCCCC(O)=O)c(Cl)c(Cl)c2C1=O)C1CCCC1	NA	BRD-A39255369	DCPIB
BRD-K16542329-001-05-1	zaprinast	INN	SA82155	NA	Biomol International Inc.	NA	PD-190	CCCOc1ccccc1-c1nc2[nH]nnc2c(=O)[nH]1	NA	BRD-K16542329	zaprinast
BRD-K95435023-001-01-0	PHA-665752	to-be-curated	SA792986	NA	Tocris Bioscience	NA	2693	Cc1[nH]c(\C=C2/C(=O)Nc3ccc(cc23)S(=O)(=O)Cc2c(Cl)cccc2Cl)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1	NA	BRD-K95435023	PHA-665752
BRD-K86958018-001-01-9	olvanil	to-be-curated	SA792234	NA	Tocris Bioscience	NA	934	CCCCCCCCC=CCCCCCCCC(=O)NCc1ccc(O)c(OC)c1	NA	BRD-K86958018	olvanil
BRD-A01593789-001-01-5	chlormadinone acetate	USAN	SA59872	NA	MicroSource Discovery Systems Inc.	NA	1505327	CC(=O)O[C@@]1(CCC2C3C=C(Cl)C4=CC(=O)CC[C@]4(C)C3CC[C@]12C)C(C)=O	NA	BRD-A01593789	chlormadinone-acetate
BRD-A34255068-001-04-8	rolipram	INN	SA82159	NA	Biomol International Inc.	NA	PD-175	COc1ccc(cc1OC1CCCC1)C1CNC(=O)C1	NA	BRD-A34255068	rolipram
BRD-A10977446-001-04-8	carvedilol tartrate	primary-common	SA792982	NA	Tocris Bioscience	NA	2685	COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12	NA	BRD-A10977446	carvedilol
BRD-K15933101-003-01-2	ropinirole	USAN	SA82649	NA	Biomol International Inc.	NA	D-113	CCCN(CCC)CCc1cccc2NC(=O)Cc12	NA	BRD-K15933101	ropinirole
BRD-K01095011-001-03-5	finasteride	INN	SA83603	NA	Prestwick Chemical Inc.	NA	Prestw-717	CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C	NA	BRD-K01095011	finasteride
BRD-K10177585-003-01-6	PSB 11	to-be-curated	SA792705	NA	Tocris Bioscience	NA	2012	CC[C@@H]1CN2C(=N1)c1[nH]c(nc1N(C)C2=O)-c1ccccc1	NA	BRD-K10177585	PSB-11
BRD-A14574269-051-01-4	UB 165	to-be-curated	SA792440	NA	Tocris Bioscience	NA	1348	Clc1ccc(cn1)C1=CCCC2CCC1N2	NA	BRD-A14574269	UB-165
BRD-K97688263-001-02-9	benzamil	primary-common	SA82061	NA	Biomol International Inc.	NA	NA-103	N\C(NCc1ccccc1)=N/C(=O)c1nc(Cl)c(N)nc1N	NA	BRD-K97688263	benzamil
BRD-A38898897-003-01-0	GW 311616	to-be-curated	SA792673	NA	Tocris Bioscience	NA	1959	CC(C)C1[C@H]2[C@@H](CCN2C(=O)\C=C\CN2CCCCC2)N(C1=O)S(C)(=O)=O	NA	BRD-A38898897	GW-311616
BRD-A22032524-074-03-2	amlodipine	INN	SA792925	NA	Tocris Bioscience	NA	2571	CCOC(=O)C1=C(COCCN)NC(C)=C(C1c1ccccc1Cl)C(=O)OC	NA	BRD-A22032524	amlodipine
BRD-A36318220-001-01-3	necrostatin-1	common	SA792817	NA	Tocris Bioscience	NA	2324	CN1C(=S)NC(Cc2c[nH]c3ccccc23)C1=O	NA	BRD-A36318220	necrostatin-1
BRD-K06753942-001-02-0	nobiletin	primary-common	SA37251	NA	AnalytiCon Discovery GmbH	NA	NP-002695	COc1ccc(cc1OC)-c1cc(=O)c2c(OC)c(OC)c(OC)c(OC)c2o1	NA	BRD-K06753942	nobiletin
BRD-K03440695-001-02-6	boldine	primary-common	SA82751	NA	Prestwick Chemical Inc.	NA	Prestw-600	COc1cc-2c(C[C@@H]3N(C)CCc4cc(O)c(OC)c-2c34)cc1O	NA	BRD-K03440695	boldine
BRD-K95785537-001-04-1	PP2	primary-common	SA82340	NA	Biomol International Inc.	NA	EI-297	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc12	NA	BRD-K95785537	PP-2
BRD-K03642198-300-01-7	AY 9944	common	SA792572	NA	Tocris Bioscience	NA	1639	Clc1ccccc1CNCC1CCC(CNCc2ccccc2Cl)CC1	NA	BRD-K03642198	AY-9944
BRD-A09533288-001-02-7	verapamil	INN	SA82118	NA	Biomol International Inc.	NA	CA-215	COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC	NA	BRD-A09533288	verapamil
BRD-A17453586-001-01-9	MDL 72832	to-be-curated	SA82488	NA	Biomol International Inc.	NA	AC-543	O=C1CC2(CCCC2)CC(=O)N1CCCCNCC1COc2ccccc2O1	NA	BRD-A17453586	MDL-72832
BRD-A36471396-003-02-2	biperiden	INN	SA83388	NA	Prestwick Chemical Inc.	NA	Prestw-502	OC(CCN1CCCCC1)(C1C[C@H]2C[C@@H]1C=C2)c1ccccc1	NA	BRD-A36471396	biperiden
BRD-K78692225-001-11-2	leflunomide	INN	SA792771	NA	Tocris Bioscience	NA	2228	Cc1oncc1C(=O)Nc1ccc(cc1)C(F)(F)F	NA	BRD-K78692225	leflunomide
BRD-A06352418-001-03-6	terfenadine	INN	SA83082	NA	Prestwick Chemical Inc.	NA	Prestw-138	CC(C)(C)c1ccc(cc1)C(O)CCCN1CCC(CC1)C(O)(c1ccccc1)c1ccccc1	NA	BRD-A06352418	terfenadine
BRD-K08890269-001-01-5	Co 102862	to-be-curated	SA792958	NA	Tocris Bioscience	NA	2642	NC(=O)NN=Cc1ccc(Oc2ccc(F)cc2)cc1	NA	BRD-K08890269	CO-102862
BRD-A22380646-001-01-5	pantoprazole	INN	SA58780	NA	MicroSource Discovery Systems Inc.	NA	1505818	COc1ccnc(CS(=O)c2nc3cc(OC(F)F)ccc3[nH]2)c1OC	NA	BRD-A22380646	pantoprazole
BRD-K12244279-001-01-7	MEK1/2 inhibitor	primary-common	SA63153	NA	Calbiochem	NA	444939	N\C(Sc1ccc(N)cc1)=C(\C#N)c1ccccc1C(F)(F)F	NA	BRD-K12244279	MEK1-2-inhibitor
BRD-K07325606-001-02-3	hispidin	common	SA63266	NA	Calbiochem	NA	377980	Oc1cc(\C=C\c2ccc(O)c(O)c2)oc(=O)c1	NA	BRD-K07325606	hispidin
BRD-K96799727-001-01-7	pifithrin-mu	primary-common	SA792964	NA	Tocris Bioscience	NA	2653	NS(=O)(=O)C#Cc1ccccc1	NA	BRD-K96799727	pifithrin-mu
BRD-A26384407-001-04-6	chlorthalidone	INN	SA58229	NA	MicroSource Discovery Systems Inc.	NA	1500187	NS(=O)(=O)c1cc(ccc1Cl)C1(O)NC(=O)c2ccccc12	NA	BRD-A26384407	chlorthalidone
BRD-A09056319-003-03-6	alfuzosin	INN	SA83332	NA	Prestwick Chemical Inc.	NA	Prestw-322	COc1cc2nc(nc(N)c2cc1OC)N(C)CCCNC(=O)C1CCCO1	NA	BRD-A09056319	alfuzosin
BRD-K97564742-103-01-9	mepyramine	INN	SA792081	NA	Tocris Bioscience	NA	660	COc1ccc(cc1)CN(CCN(C)C)c1ccccn1	NA	BRD-K97564742	mepyramine
BRD-K82562631-236-02-0	tolmetin	INN	SA58483	NA	MicroSource Discovery Systems Inc.	NA	1500582	Cc1ccc(cc1)C(=O)c1ccc(CC(O)=O)n1C	NA	BRD-K82562631	tolmetin
BRD-K93568044-001-03-1	hydrocortisone	INN	SA82968	NA	Prestwick Chemical Inc.	NA	Prestw-447	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO	NA	BRD-K93568044	hydrocortisone
BRD-A04668240-001-01-5	CGP 52432	to-be-curated	SA82539	NA	Biomol International Inc.	NA	AC-487	CCOC(OCC)P(O)(=O)CCCNCc1ccc(Cl)c(Cl)c1	NA	BRD-A04668240	CGP-52432
BRD-K17796732-001-02-0	JWH-015	primary-common	SA792437	NA	Tocris Bioscience	NA	1341	CCCn1c(C)c(C(=O)c2cccc3ccccc23)c2ccccc12	NA	BRD-K17796732	JWH-015
BRD-A20968261-001-01-3	WAY 213613	to-be-curated	SA792963	NA	Tocris Bioscience	NA	2652	NC(CC(=O)Nc1ccc(Oc2cc(F)c(F)cc2Br)cc1)C(O)=O	NA	BRD-A20968261	WAY-213613
BRD-K12539581-001-06-2	nocodazole	INN	SA82302	NA	Biomol International Inc.	NA	T101	COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c1cccs1	NA	BRD-K12539581	nocodazole
BRD-K08998509-001-01-6	fananserin	to-be-curated	SA792959	NA	Tocris Bioscience	NA	2645	Fc1ccc(cc1)N1CCN(CCCN2c3cccc4cccc(c34)S2(=O)=O)CC1	NA	BRD-K08998509	fananserin
BRD-K17016787-001-03-5	estriol	USP	SA83659	NA	Prestwick Chemical Inc.	NA	Prestw-1096	C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1C[C@@H](O)[C@@H]2O	NA	BRD-K17016787	estriol
BRD-A23072235-050-04-5	pheniramine	INN	SA58640	NA	MicroSource Discovery Systems Inc.	NA	1500478	CN(C)CCC(c1ccccc1)c1ccccn1	NA	BRD-A23072235	pheniramine
BRD-A40639672-234-04-0	ketorolac tromethamine	USAN	SA59855	NA	MicroSource Discovery Systems Inc.	NA	1503925	OC(=O)C1CCn2c1ccc2C(=O)c1ccccc1	NA	BRD-A40639672	ketorolac
BRD-K08132273-001-01-6	AG 825	to-be-curated	SA792547	NA	Tocris Bioscience	NA	1555	COc1cc(C=C(C#N)C(N)=O)cc(CSc2nc3ccccc3s2)c1O	NA	BRD-K08132273	tyrphostin
BRD-K17674993-001-03-1	diflorasone diacetate	USAN	SA83597	NA	Prestwick Chemical Inc.	NA	Prestw-619	C[C@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(C)=O)C(=O)COC(C)=O	NA	BRD-K17674993	diflorasone
BRD-A30590053-003-01-1	MR 16728	to-be-curated	SA792018	NA	Tocris Bioscience	NA	537	O=C(NCCCN1CCCCCC1)C(C1CCCCC1)c1ccccc1	NA	BRD-A30590053	MR-16728
BRD-A22707317-001-02-5	SB-205384	common	SA792525	NA	Tocris Bioscience	NA	1512	CC#CCOC(=O)c1c(C)nc2sc3CC(O)CCc3c2c1N	NA	BRD-A22707317	SB-205384
BRD-A00100033-001-04-8	nifurtimox	common	SA83759	NA	Prestwick Chemical Inc.	NA	Prestw-1024	CC1CS(=O)(=O)CCN1N=Cc1ccc(o1)[N+]([O-])=O	NA	BRD-A00100033	nifurtimox
BRD-A38913120-001-01-0	BH3I-1	common	SA63222	NA	EMD Biosciences	NA	286890	CC(C)C(N1C(=S)S\C(=C/c2ccc(Br)cc2)C1=O)C(O)=O	NA	BRD-A38913120	BH3I-1
BRD-K92731339-227-02-3	perindopril	INN	SA59563	NA	MicroSource Discovery Systems Inc.	NA	1505212	CCC[C@H](N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(O)=O)C(=O)OCC	NA	BRD-K92731339	perindopril
BRD-A04706586-236-01-7	bucladesine	to-be-curated	SA792362	NA	Tocris Bioscience	NA	1141	CCCC(=O)Nc1ncnc2n(cnc12)C1OC2COP(O)(=O)OC2C1OC(=O)CCC	NA	BRD-A04706586	bucladesine
BRD-A29734509-011-02-9	disopyramide	INN	SA58284	NA	MicroSource Discovery Systems Inc.	NA	1500261	CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C	NA	BRD-A29734509	disopyramide
BRD-A39969961-001-01-3	eplerenone	to-be-curated	SA792841	NA	Tocris Bioscience	NA	2397	COC(=O)C1CC2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC22CCC(=O)O2)C13	NA	BRD-A39969961	eplerenone
BRD-A33447119-001-02-5	oxfendazole	INN	SA59852	NA	MicroSource Discovery Systems Inc.	NA	1505296	COC(=O)Nc1nc2ccc(cc2[nH]1)S(=O)c1ccccc1	NA	BRD-A33447119	oxfendazole
BRD-A28318179-003-03-6	AMT (hydrochloride)	common	SA792184	NA	Tocris Bioscience	NA	871	CC1CCN=C(N)S1	NA	BRD-A28318179	aminomethyltransferase
BRD-A35511923-019-01-6	L-803,087	to-be-curated	SA792687	NA	Tocris Bioscience	NA	1979	COC(=O)C(CCCNC(N)=N)NC(=O)CCCc1c([nH]c2c(F)cc(F)cc12)-c1ccccc1	NA	BRD-A35511923	L-803087
BRD-A21723284-066-01-7	naltriben	to-be-curated	SA792201	NA	Tocris Bioscience	NA	892	Oc1ccc2CC3N(CC4CC4)CCC45C(Oc1c24)c1oc2ccccc2c1CC35O	NA	BRD-A21723284	naltriben
BRD-A34751532-001-03-6	homosalate	INN	SA82963	NA	Prestwick Chemical Inc.	NA	Prestw-1090	CC1CC(CC(C)(C)C1)OC(=O)c1ccccc1O	NA	BRD-A34751532	homosalate
BRD-A29289453-001-02-1	PCA 4248	primary-common	SA82308	NA	Biomol International Inc.	NA	L-133	COC(=O)C1=C(C)NC(C)=C(C1C)C(=O)OCCSc1ccccc1	NA	BRD-A29289453	PCA-4248
BRD-A26845397-001-01-4	CGP 361A	to-be-curated	SA82484	NA	Biomol International Inc.	NA	AC-539	CC(C)NCC(O)COc1ccccc1-n1cccc1	NA	BRD-A26845397	isamoltane
BRD-A07440155-003-04-9	labetalol	INN	SA59461	NA	MicroSource Discovery Systems Inc.	NA	1503243	CC(CCc1ccccc1)NCC(O)c1ccc(O)c(c1)C(N)=O	NA	BRD-A07440155	labetalol
BRD-A07875874-001-01-6	cilnidipine	common	SA792949	NA	Tocris Bioscience	NA	2629	COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OCC=Cc1ccccc1	NA	BRD-A07875874	cilnidipine
BRD-A24514565-236-01-6	warfarin	INN	SA39424	NA	ChemBridge Corporation	NA	5103026	CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O	NA	BRD-A24514565	warfarin
BRD-A06726973-001-02-0	dibutyryl cyclic GMP	primary-common	SA82231	NA	Biomol International Inc.	NA	CN-215	CCCC(=O)Nc1nc2n(cnc2c(=O)[nH]1)C1O[C@H]2COP(O)(=O)O[C@@H]2[C@@H]1OC(=O)CCC	NA	BRD-A06726973	dibutyrylcyclic-gmp
BRD-A04553218-050-03-0	chlorphenamine	INN	SA82762	NA	Prestwick Chemical Inc.	NA	Prestw-117	CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1	NA	BRD-A04553218	chlorphenamine
BRD-A35033682-001-01-0	eriodictyol	primary-common	SA36893	NA	AnalytiCon Discovery GmbH	NA	NP-001578	Oc1cc(O)c2C(=O)CC(Oc2c1)c1ccc(O)c(O)c1	NA	BRD-A35033682	eriodictyol
BRD-A15530910-001-01-3	carpindolol	common	SA792528	NA	Tocris Bioscience	NA	1516	CC(C)OC(=O)c1cc2c(OCC(O)CNC(C)(C)C)cccc2[nH]1	NA	BRD-A15530910	SDZ-21009
BRD-A38747044-001-01-5	KU14R	to-be-curated	SA792356	NA	Tocris Bioscience	NA	1131	CCC1(Cc2ccccc2O1)c1ncc[nH]1	NA	BRD-A38747044	KU-14R
BRD-K81839095-001-02-0	estrone	INN	SA38535	NA	AnalytiCon Discovery GmbH	NA	NP-010065	C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	NA	BRD-K81839095	estrone
BRD-A42628519-001-04-1	iopanoic acid	INN	SA82865	NA	Prestwick Chemical Inc.	NA	Prestw-1052	CCC(Cc1c(I)cc(I)c(N)c1I)C(O)=O	NA	BRD-A42628519	iopanoic-acid
BRD-A27143604-001-01-2	DPN	to-be-curated	SA792513	NA	Tocris Bioscience	NA	1494	Oc1ccc(CC(C#N)c2ccc(O)cc2)cc1	NA	BRD-A27143604	diarylpropionitrile
BRD-A39747742-001-02-7	estradiol valerate	INN	SA58302	NA	MicroSource Discovery Systems Inc.	NA	1500284	CCCCC(=O)O[C@H]1CCC2C3CCc4cc(O)ccc4C3CC[C@]12C	NA	BRD-A39747742	estradiol-valerate
BRD-A15435692-003-01-5	BMY-14802	primary-common	SA792492	NA	Tocris Bioscience	NA	1440	OC(CCCN1CCN(CC1)c1ncc(F)cn1)c1ccc(F)cc1	NA	BRD-A15435692	BMY-14802
BRD-A26032986-050-01-3	zaldaride	common	SA792781	NA	Tocris Bioscience	NA	2255	CC1(CN2CCC(CC2)n2c3ccccc3[nH]c2=O)OCc2ccccc2-n2cccc12	NA	BRD-A26032986	zaldaride
BRD-A15070535-323-02-1	bucladesine	INN	SA82738	NA	Prestwick Chemical Inc.	NA	Prestw-813	CCCC(=O)Nc1ncnc2n(cnc12)[C@@H]1O[C@@H]2OP(O)(=O)OC[C@H]2[C@H]1OC(=O)CCC	NA	BRD-A15070535	bucladesine
BRD-A34806832-001-02-7	proscillaridin	INN	SA83626	NA	Prestwick Chemical Inc.	NA	Prestw-986	C[C@@H]1O[C@@H](O[C@H]2CC[C@]3(C)C4CC[C@]5(C)[C@H](CC[C@]5(O)C4CCC3=C2)c2ccc(=O)oc2)[C@H](O)[C@H](O)[C@H]1O	NA	BRD-A34806832	proscillaridin
BRD-A41301928-001-02-5	bongkrekic acid	to-be-curated	SA82189	NA	Biomol International Inc.	NA	CM-113	COC(C\C=C\C=C\CC\C=C/CC(C)\C=C/C(CC(O)=O)=C\C(O)=O)C(\C)=C/C=C(\C)C(O)=O	NA	BRD-A41301928	bongkrek-acid
BRD-A41519720-001-02-2	ezetimibe	INN	SA58885	NA	MicroSource Discovery Systems Inc.	NA	1505203	OC(CC[C@@H]1[C@H](N(C1=O)c1ccc(F)cc1)c1ccc(O)cc1)c1ccc(F)cc1	NA	BRD-A41519720	ezetimibe
BRD-A25775766-001-03-3	securinine	INN	SA82811	NA	Prestwick Chemical Inc.	NA	Prestw-841	O=C1OC23C[C@@H](C=CC2=C1)N1CCCC[C@H]31	NA	BRD-A25775766	securinine
BRD-A37704979-001-02-4	SB-203580	primary-common	SA82333	NA	Biomol International Inc.	NA	EI-286	CS(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccncc1)-c1ccc(F)cc1	NA	BRD-A37704979	SB-203580
BRD-A02006392-001-06-5	nitrendipine	INN	SA82091	NA	Biomol International Inc.	NA	CA-212	CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC	NA	BRD-A02006392	nitrendipine
BRD-A00267231-001-01-1	hemado	to-be-curated	SA792550	NA	Tocris Bioscience	NA	1579	CCCCC#Cc1nc(NC)c2ncn(C3OC(CO)C(O)C3O)c2n1	NA	BRD-A00267231	hemado
BRD-A31007383-001-01-0	SDZ WAG 994	to-be-curated	SA792870	NA	Tocris Bioscience	NA	2465	COC1C(O)C(CO)OC1n1cnc2c(NC3CCCCC3)ncnc12	NA	BRD-A31007383	SDZ-WAG-994
BRD-A06390036-001-02-0	dihydroquinidine	primary-common	SA58157	NA	MicroSource Discovery Systems Inc.	NA	1500657	CC[C@H]1CN2CCC1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12	NA	BRD-A06390036	hydroquinidine
BRD-A18202423-001-01-6	CPCCOEt	to-be-curated	SA792284	NA	Tocris Bioscience	NA	1028	CCOC(=O)C12CC1C(=NO)c1ccccc1O2	NA	BRD-A18202423	CPCCOEt
BRD-A41304429-001-04-9	practolol	INN	SA83303	NA	Prestwick Chemical Inc.	NA	Prestw-332	CC(C)NCC(O)COc1ccc(NC(C)=O)cc1	NA	BRD-A41304429	practolol
BRD-A42553870-001-05-1	L-152,804	to-be-curated	SA792458	NA	Tocris Bioscience	NA	1382	CC1(C)CC(=O)C(C2c3ccccc3OC3=C2C(=O)CC(C)(C)C3)C(=O)C1	NA	BRD-A42553870	L-152804
BRD-K78637815-001-01-4	LY-320135	to-be-curated	SA792835	NA	Tocris Bioscience	NA	2387	COc1ccc(cc1)-c1oc2cc(OC)ccc2c1C(=O)c1ccc(cc1)C#N	NA	BRD-K78637815	LY-320135
BRD-A34706053-003-01-9	CGP 12177	to-be-curated	SA792359	NA	Tocris Bioscience	NA	1134	CC(C)(C)NCC(O)COc1cccc2[nH]c(=O)[nH]c12	NA	BRD-A34706053	CGP-12177
BRD-A23226398-001-02-7	estradiol	to-be-curated	SA59346	NA	MicroSource Discovery Systems Inc.	NA	1501184	CC(=O)OC1CCC2C3CCc4cc(O)ccc4C3CCC12C	NA	BRD-A23226398	estradiol
BRD-A36010170-001-02-4	amcinonide	INN	SA59795	NA	MicroSource Discovery Systems Inc.	NA	1503816	CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1CC1C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C	NA	BRD-A36010170	amcinonide
BRD-A16332958-001-02-4	modafinil	INN	SA58765	NA	MicroSource Discovery Systems Inc.	NA	1505361	NC(=O)CS(=O)C(c1ccccc1)c1ccccc1	NA	BRD-A16332958	modafinil
BRD-A19053259-003-03-3	pseudopelletierine	primary-common	SA83053	NA	Prestwick Chemical Inc.	NA	Prestw-625	CN1C2CCCC1CC(=O)C2	NA	BRD-A19053259	pseudopelletierine
BRD-A05186015-003-04-0	bupropion	INN	SA58524	NA	MicroSource Discovery Systems Inc.	NA	1504174	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	NA	BRD-A05186015	bupropion
BRD-A43940795-001-02-8	tetrahydropalmatine	primary-common	SA36947	NA	AnalytiCon Discovery GmbH	NA	NP-001740	COc1cc2CCN3Cc4c(CC3c2cc1OC)ccc(OC)c4OC	NA	BRD-A43940795	tetrahydropalmatine
BRD-A09094913-001-02-3	strychnine	primary-common	SA58160	NA	MicroSource Discovery Systems Inc.	NA	1500651	O=C1CC2OCC=C3CN4CC[C@@]56C4C[C@@H]3[C@@H]2C5N1c1ccccc61	NA	BRD-A09094913	strychnine
BRD-A10355991-003-01-8	norketamine	to-be-curated	SA792682	NA	Tocris Bioscience	NA	1970	NC1(CCCCC1=O)c1ccccc1Cl	NA	BRD-A10355991	norketamine
BRD-A02710418-003-03-5	meptazinol	INN	SA83743	NA	Prestwick Chemical Inc.	NA	Prestw-1004	CCC1(CCCCN(C)C1)c1cccc(O)c1	NA	BRD-A02710418	meptazinol
BRD-A03623303-045-02-0	metoprolol tartrate	USAN	SA58385	NA	MicroSource Discovery Systems Inc.	NA	1500411	COCCc1ccc(OCC(O)CNC(C)C)cc1	NA	BRD-A03623303	metoprolol
BRD-A37432947-004-02-5	ipratropium	to-be-curated	SA82982	NA	Prestwick Chemical Inc.	NA	Prestw-575	CC(C)[N+]1(C)[C@@H]2CC[C@@H]1C[C@H](C2)OC(=O)C(CO)c1ccccc1	NA	BRD-A37432947	ipratropium
BRD-A43930669-003-01-0	L 368899	to-be-curated	SA792957	NA	Tocris Bioscience	NA	2641	Cc1ccccc1N1CCN(CC1)S(=O)(=O)CC12CCC(C[C@@H]1NC(=O)[C@@H](N)CCS(C)(=O)=O)C2(C)C	NA	BRD-A43930669	L-368899
BRD-A41451487-001-01-3	PK-11195	primary-common	SA82586	NA	Biomol International Inc.	NA	CM-118	CCC(C)N(C)C(=O)c1cc2ccccc2c(n1)-c1ccccc1Cl	NA	BRD-A41451487	PK-11195
BRD-A25234499-001-04-3	aminoglutethimide	INN	SA58176	NA	MicroSource Discovery Systems Inc.	NA	1500115	CCC1(CCC(=O)NC1=O)c1ccc(N)cc1	NA	BRD-A25234499	aminoglutethimide
BRD-A41145729-001-02-7	METHOPRENE ACID	to-be-curated	SA82019	NA	Biomol International Inc.	NA	GR106	COC(C)(C)CCCC(C)C\C=C\C(C)=C\C(O)=O	NA	BRD-A41145729	methoprene-acid
BRD-A31195449-004-01-9	TCB2	to-be-curated	SA792937	NA	Tocris Bioscience	NA	2592	COc1cc(Br)c(OC)c2CC(CN)c12	NA	BRD-A31195449	TCB2
BRD-A23683907-334-01-0	NAS-181	to-be-curated	SA792478	NA	Tocris Bioscience	NA	1413	C(Oc1cccc2C=C(CN3CCOCC3)COc12)C1CNCCO1	NA	BRD-A23683907	NAS-181
BRD-A44133049-001-01-5	azasetron	primary-common	SA82468	NA	Biomol International Inc.	NA	NS-901	CN1C(=O)COc2c1cc(Cl)cc2C(=O)NC1CN2CCC1CC2	NA	BRD-A44133049	azasetron
BRD-A15415227-003-01-1	GW 1929	to-be-curated	SA792584	NA	Tocris Bioscience	NA	1664	CN(CCOc1ccc(CC(Nc2ccccc2C(=O)c2ccccc2)C(O)=O)cc1)c1ccccn1	NA	BRD-A15415227	GW-1929
BRD-A14566392-004-03-5	scopolamine	to-be-curated	SA792479	NA	Tocris Bioscience	NA	1414	CN1C2CC(CC1C1OC21)OC(=O)C(CO)c1ccccc1	NA	BRD-A14566392	scopolamine
BRD-A41833852-001-01-9	naloxone	to-be-curated	SA792484	NA	Tocris Bioscience	NA	1419	Oc1ccc2CC3N(CC=C)CCC45C(Oc1c24)C(CCC35O)=NNC(=O)c1ccccc1	NA	BRD-A41833852	naloxone
BRD-A41722204-003-01-5	sulmazole	INN	SA63259	NA	Calbiochem	NA	419545	COc1cc(ccc1-c1nc2ccncc2[nH]1)S(C)=O	NA	BRD-A41722204	sulmazole
BRD-A35338386-001-04-6	5'-N-Ethylcarboxamidoadenosine	common	SA792593	NA	Tocris Bioscience	NA	1691	CCNC(=O)C1OC(C(O)C1O)n1cnc2c(N)ncnc12	NA	BRD-A35338386	NECA
BRD-A16665823-008-03-3	butoconazole	INN	SA83584	NA	Prestwick Chemical Inc.	NA	Prestw-408	Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1	NA	BRD-A16665823	butoconazole
BRD-A42167015-003-03-7	carteolol	INN	SA83586	NA	Prestwick Chemical Inc.	NA	Prestw-446	CC(C)(C)NCC(O)COc1cccc2NC(=O)CCc12	NA	BRD-A42167015	carteolol
BRD-A14395271-001-01-5	mesoridazine	INN	SA82601	NA	Biomol International Inc.	NA	NS-531	CN1CCCCC1CCN1c2ccccc2Sc2ccc(cc12)S(C)=O	NA	BRD-A14395271	mesoridazine
BRD-A23723433-001-01-2	taxol	to-be-curated	SA792331	NA	Tocris Bioscience	NA	1097	CC(=O)OC1C2=C(C)C(CC(O)(C(OC(=O)c3ccccc3)C3C4(COC4CC(O)C3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)C(O)C(NC(=O)c1ccccc1)c1ccccc1	NA	BRD-A23723433	paclitaxel
BRD-A16694057-001-02-7	BADGE	primary-common	SA82185	NA	Biomol International Inc.	NA	GR-244	CC(C)(c1ccc(OCC2CO2)cc1)c1ccc(OCC2CO2)cc1	NA	BRD-A16694057	BADGE
BRD-A42759514-001-03-1	ornidazole	INN	SA83170	NA	Prestwick Chemical Inc.	NA	Prestw-164	Cc1ncc(n1CC(O)CCl)[N+]([O-])=O	NA	BRD-A42759514	ornidazole
BRD-A36267905-003-02-8	buphenine	INN	SA58409	NA	MicroSource Discovery Systems Inc.	NA	1500445	CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1	NA	BRD-A36267905	buphenine
BRD-A44008656-036-04-3	doxylamine	INN	SA58289	NA	MicroSource Discovery Systems Inc.	NA	1500267	CN(C)CCOC(C)(c1ccccc1)c1ccccn1	NA	BRD-A44008656	doxylamine
BRD-K79124250-001-03-0	ioxaglic acid	INN	SA83731	NA	Prestwick Chemical Inc.	NA	Prestw-1062	CNC(=O)c1c(I)c(N(C)C(C)=O)c(I)c(C(=O)NCC(=O)Nc2c(I)c(C(O)=O)c(I)c(C(=O)NCCO)c2I)c1I	NA	BRD-K79124250	ioxaglic-acid
BRD-A41941932-001-03-0	vitexin	primary-common	SA83558	NA	Prestwick Chemical Inc.	NA	Prestw-661	OC[C@H]1OC([C@H](O)[C@@H](O)[C@@H]1O)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccc(O)cc1	NA	BRD-A41941932	vitexin
BRD-A32164164-048-01-4	methyl-lycaconitine	to-be-curated	SA792285	NA	Tocris Bioscience	NA	1029	CCN1CC2(COC(=O)c3ccccc3N3C(=O)CC(C)C3=O)CCC(OC)C34C5CC6C(OC)C5C(O)(CC6OC)C(O)(C(OC)C23)C14	NA	BRD-A32164164	methyllycaconitine
BRD-A43974499-066-01-1	reboxetine	to-be-curated	SA792688	NA	Tocris Bioscience	NA	1982	CCOc1ccccc1OC(C1CNCCO1)c1ccccc1	NA	BRD-A43974499	reboxetine
BRD-A29426959-050-04-1	carbinoxamine	INN	SA58207	NA	MicroSource Discovery Systems Inc.	NA	1500161	CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1	NA	BRD-A29426959	carbinoxamine
BRD-A36074203-003-03-5	remacemide	to-be-curated	SA792567	NA	Tocris Bioscience	NA	1622	CC(Cc1ccccc1)(NC(=O)CN)c1ccccc1	NA	BRD-A36074203	remacemide
BRD-A29437505-001-01-6	RWJ 21757	to-be-curated	SA792992	NA	Tocris Bioscience	NA	2719	Nc1nc2n(C3OC(CO)C(O)C3O)c(=O)n(CC=C)c2c(=O)[nH]1	NA	BRD-A29437505	RWJ-21757
BRD-K14441456-001-01-2	AG 556	to-be-curated	SA792057	NA	Tocris Bioscience	NA	616	Oc1ccc(C=C(C#N)C(=O)NCCCCc2ccccc2)cc1O	NA	BRD-K14441456	tyrphostin-AG-556
BRD-K62609077-001-02-2	scoulerine	primary-common	SA83125	NA	Prestwick Chemical Inc.	NA	Prestw-601	COc1cc2CCN3Cc4c(C[C@H]3c2cc1O)ccc(OC)c4O	NA	BRD-K62609077	scoulerine
BRD-K16444452-001-03-4	ibudilast	common	SA792595	NA	Tocris Bioscience	NA	1694	CC(C)C(=O)c1c(nn2ccccc12)C(C)C	NA	BRD-K16444452	ibudilast
BRD-K04414442-001-03-4	SB 222200	to-be-curated	SA792463	NA	Tocris Bioscience	NA	1393	CC[C@H](NC(=O)c1c(C)c(nc2ccccc12)-c1ccccc1)c1ccccc1	NA	BRD-K04414442	SB-222200
BRD-A98378129-001-01-4	talniflumate	to-be-curated	SA792902	NA	Tocris Bioscience	NA	2510	FC(F)(F)c1cccc(Nc2ncccc2C(=O)OC2OC(=O)c3ccccc23)c1	NA	BRD-A98378129	talniflumate
BRD-K72703948-001-01-0	ZM447439	primary-common	SA442628	NA	ChemieTek	NA	NA	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1	NA	BRD-K72703948	ZM-447439
BRD-K01292756-001-06-0	pimozide	INN	SA82101	NA	Biomol International Inc.	NA	AC-109	Fc1ccc(cc1)C(CCCN1CCC(CC1)n1c2ccccc2[nH]c1=O)c1ccc(F)cc1	NA	BRD-K01292756	pimozide
BRD-K10974103-001-03-9	diloxanide furoate	USP	SA83707	NA	Prestwick Chemical Inc.	NA	Prestw-903	CN(C(=O)C(Cl)Cl)c1ccc(OC(=O)c2ccco2)cc1	NA	BRD-K10974103	diloxanide
BRD-K66353228-001-05-4	zoxazolamine	INN	SA83440	NA	Prestwick Chemical Inc.	NA	Prestw-328	Nc1nc2cc(Cl)ccc2o1	NA	BRD-K66353228	zoxazolamine
BRD-A98702003-304-02-2	carbenoxolone	INN	SA59362	NA	MicroSource Discovery Systems Inc.	NA	1502005	CC1(C)[C@H](CC[C@@]2(C)C1CC[C@]1(C)C2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C(O)=O)OC(=O)CCC(O)=O	NA	BRD-A98702003	carbenoxolone
BRD-K64341947-003-01-6	CFM 1571	to-be-curated	SA792935	NA	Tocris Bioscience	NA	2586	COc1ccc(NC(=O)c2cc(OCCCN(C)C)nn2Cc2ccccc2)cc1	NA	BRD-K64341947	CFM-1571
BRD-A36151937-001-01-2	genistin	primary-common	SA63240	NA	EMD Biosciences	NA	345836	OCC1OC(Oc2cc(O)c3c(c2)occ(-c2ccc(O)cc2)c3=O)C(O)C(O)C1O	NA	BRD-A36151937	genistein
BRD-K05977355-001-02-6	fluconazole	INN	SA59792	NA	MicroSource Discovery Systems Inc.	NA	1503975	OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F	NA	BRD-K05977355	fluconazole
BRD-K17415526-001-02-7	tyrphostin AG 835	primary-common	SA792039	NA	Tocris Bioscience	NA	579	C[C@H](NC(=O)C(=C\c1ccc(O)c(O)c1)\C#N)c1ccccc1	NA	BRD-K17415526	tyrphostin-AG-835
BRD-K06221026-001-03-5	DuP 697	to-be-curated	SA792489	NA	Tocris Bioscience	NA	1430	CS(=O)(=O)c1ccc(cc1)-c1cc(Br)sc1-c1ccc(F)cc1	NA	BRD-K06221026	DUP-697
BRD-K66944906-001-02-6	fraxidin methyl ether	primary-common	SA57991	NA	MicroSource Discovery Systems Inc.	NA	100572	COc1cc2ccc(=O)oc2c(OC)c1OC	NA	BRD-K66944906	fraxidin
BRD-K64236792-002-03-2	austricine	common	SA82857	NA	Prestwick Chemical Inc.	NA	Prestw-681	C[C@H]1[C@H]2[C@H](OC1=O)[C@H]1C(C)=CC(=O)C1=C(C)C[C@@H]2O	NA	BRD-K64236792	austricine
BRD-K15522385-003-01-0	cinanserin	common	SA791986	NA	Tocris Bioscience	NA	460	CN(C)CCCSc1ccccc1NC(=O)C=Cc1ccccc1	NA	BRD-K15522385	cinanserin
BRD-K13169950-001-04-5	5-nitroso-8-cinnolinol	primary-common	SA792908	NA	Tocris Bioscience	NA	2521	Oc1ccc([N+][O-])c2cccnc12	NA	BRD-K13169950	NSC-3852
BRD-K14821540-001-02-1	FCCP	primary-common	SA82246	NA	Biomol International Inc.	NA	CM120	FC(F)(F)Oc1ccc(NN=C(C#N)C#N)cc1	NA	BRD-K14821540	FCCP
BRD-K66404838-003-03-8	nalbuphine	INN	SA83016	NA	Prestwick Chemical Inc.	NA	Prestw-118	O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CCC1)c45	NA	BRD-K66404838	nalbuphine
BRD-K11107424-001-01-1	tiotidine	to-be-curated	SA792164	NA	Tocris Bioscience	NA	826	CNC(NCCSCc1csc(N=C(N)N)n1)=NC#N	NA	BRD-K11107424	tiotidine
BRD-K64402243-001-01-1	ivachtin	to-be-curated	SA792954	NA	Tocris Bioscience	NA	2636	CC(=O)OCCN1C(=O)c2c(C1=O)c1cc(ccc1nc2C)S(=O)(=O)N1CCOCC1	NA	BRD-K64402243	ivachtin
BRD-K43797669-001-02-3	genistein	primary-common	SA36891	NA	AnalytiCon Discovery GmbH	NA	NP-001561	Oc1ccc(cc1)-c1coc2cc(O)cc(O)c2c1=O	NA	BRD-K43797669	genistein
BRD-K15086322-103-01-0	JNJ 10191584	to-be-curated	SA792857	NA	Tocris Bioscience	NA	2441	CN1CCN(CC1)C(=O)c1nc2ccc(Cl)cc2[nH]1	NA	BRD-K15086322	JNJ-10191584
BRD-K14765469-003-02-3	vesamicol	primary-common	SA83662	NA	Prestwick Chemical Inc.	NA	Prestw-920	O[C@@H]1CCCC[C@H]1N1CCC(CC1)c1ccccc1	NA	BRD-K14765469	vesamicol
BRD-A47633927-001-01-8	NPC 15199	to-be-curated	SA792089	NA	Tocris Bioscience	NA	675	CC(C)CC(NC(=O)OCC1c2ccccc2-c2ccccc12)C(O)=O	NA	BRD-A47633927	NPC-15199
BRD-K62810658-001-05-6	PD 98059	primary-common	SA82309	NA	Biomol International Inc.	NA	EI-360	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N	NA	BRD-K62810658	PD-98059
BRD-K68341547-003-01-6	W-9	to-be-curated	SA791942	NA	Tocris Bioscience	NA	370	NCCCCCCNS(=O)(=O)c1ccc2c(Cl)cccc2c1	NA	BRD-K68341547	W-9
BRD-K65285700-001-01-5	GP 1a	to-be-curated	SA793003	NA	Tocris Bioscience	NA	2764	Cc1ccc-2c(Cc3c(nn(c-23)-c2ccc(Cl)cc2Cl)C(=O)NN2CCCCC2)c1	NA	BRD-K65285700	GP-1a
BRD-K64670467-001-01-2	JNJ 16259685	to-be-curated	SA792821	NA	Tocris Bioscience	NA	2333	COC1CCC(CC1)C(=O)c1ccc2nc3OCCCc3cc2c1	NA	BRD-K64670467	JNJ-16259685
BRD-K10705233-001-01-4	GW-405833	primary-common	SA792831	NA	Tocris Bioscience	NA	2374	COc1ccc2n(C(=O)c3cccc(Cl)c3Cl)c(C)c(CCN3CCOCC3)c2c1	NA	BRD-K10705233	GW-405833
BRD-K67261995-001-03-4	adipiodone	INN	SA83730	NA	Prestwick Chemical Inc.	NA	Prestw-939	OC(=O)c1c(I)cc(I)c(NC(=O)CCCCC(=O)Nc2c(I)cc(I)c(C(O)=O)c2I)c1I	NA	BRD-K67261995	adipiodone
BRD-K37312348-001-05-1	kenpaullone	primary-common	SA753176	NA	Biomol International Inc.	NA	NA	Brc1ccc2[nH]c-3c(CC(=O)Nc4ccccc-34)c2c1	NA	BRD-K37312348	kenpaullone
BRD-K68143200-001-04-2	NSC95397	common	SA792541	NA	Tocris Bioscience	NA	1547	OCCSC1=C(SCCO)C(=O)c2ccccc2C1=O	NA	BRD-K68143200	NSC-95397
BRD-K67080878-001-05-5	milrinone	INN	SA792517	NA	Tocris Bioscience	NA	1504	Cc1[nH]c(=O)c(cc1-c1ccncc1)C#N	NA	BRD-K67080878	milrinone
BRD-K61323504-001-02-4	SB-225002	primary-common	SA792993	NA	Tocris Bioscience	NA	2725	Oc1cc(ccc1NC(=O)Nc1ccccc1Br)[N+]([O-])=O	NA	BRD-K61323504	SB-225002
BRD-K07762753-001-03-6	aminopurvalanol A	common	SA753179	NA	Calbiochem	NA	NA	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1	NA	BRD-K07762753	aminopurvalanol-a
BRD-K14965640-001-03-3	S-(+)-ibuprofen	primary-common	SA83677	NA	Prestwick Chemical Inc.	NA	Prestw-907	CC(C)Cc1ccc(cc1)[C@H](C)C(O)=O	NA	BRD-K14965640	ibuprofen-(S)
BRD-K68336408-001-03-4	tyrphostin AG-1478	primary-common	SA753170	NA	Broad Institute of MIT and Harvard	Steve Haggarty	NA	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC	NA	BRD-K68336408	tyrphostin-AG-1478
BRD-K68873215-001-01-3	phosphodiesterase V inhibitor II	primary-common	SA63498	NA	Calbiochem	NA	524714	CCCCN1C(=O)[C@H]2Cc3c([nH]c4ccccc34)[C@@H](N2C1=O)c1ccc(OC)cc1	NA	BRD-K68873215	phosphodiesterase-V-inhibitor-II
BRD-K04185004-003-03-6	oxybuprocaine	INN	SA83439	NA	Prestwick Chemical Inc.	NA	Prestw-57	CCCCOc1cc(ccc1N)C(=O)OCCN(CC)CC	NA	BRD-K04185004	oxybuprocaine
BRD-K05906022-001-02-8	limonin	primary-common	SA38492	NA	AnalytiCon Discovery GmbH	NA	NP-009924	CC1(C)O[C@H]2CC(=O)OC[C@@]22[C@H]1CC(=O)[C@]1(C)[C@@H]2CC[C@@]2(C)[C@@H](OC(=O)[C@H]3O[C@@]123)c1ccoc1	NA	BRD-K05906022	limonin
BRD-K11911061-003-02-8	GR 127935	to-be-curated	SA792507	NA	Tocris Bioscience	NA	1477	COc1ccc(NC(=O)c2ccc(cc2)-c2ccc(cc2C)-c2noc(C)n2)cc1N1CCN(C)CC1	NA	BRD-K11911061	GR-127935
BRD-K00824317-001-03-0	fludroxycortide	INN	SA83563	NA	Prestwick Chemical Inc.	NA	Prestw-645	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO	NA	BRD-K00824317	fludroxycortide
BRD-K17693482-001-03-9	2-[(3-pyridinylcarbonyl)amino]ethyl acetate	to-be-curated	SA791947	NA	Tocris Bioscience	NA	385	CC(=O)OCCNC(=O)c1cccnc1	NA	BRD-K17693482	BRD-K17693482
BRD-K64044582-001-02-8	linoleamide	to-be-curated	SA82007	NA	Biomol International Inc.	NA	FA023	CCCCC\C=C/C\C=C/CCCCCCCC(N)=O	NA	BRD-K64044582	linoleamide
BRD-K61250553-001-02-9	loperamide	INN	SA82082	NA	Biomol International Inc.	NA	AC-110	CN(C)C(=O)C(CCN1CCC(O)(CC1)c1ccc(Cl)cc1)(c1ccccc1)c1ccccc1	NA	BRD-K61250553	loperamide
BRD-K93201660-001-05-7	ML-7	primary-common	SA753165	NA	Broad Institute of MIT and Harvard	Steve Haggarty	NA	Ic1cccc2c(cccc12)S(=O)(=O)N1CCCNCC1	NA	BRD-K93201660	ML-7
BRD-K09549677-300-01-8	mibefradil	common	SA792761	NA	Tocris Bioscience	NA	2198	COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C	NA	BRD-K09549677	mibefradil
BRD-K76064317-001-04-0	tyrphostin AG 1296	primary-common	SA82172	NA	Biomol International Inc.	NA	EI303	COc1cc2ncc(nc2cc1OC)-c1ccccc1	NA	BRD-K76064317	tyrphostin-AG-1296
BRD-K68246049-001-01-4	TTNPB	to-be-curated	SA792135	NA	Tocris Bioscience	NA	761	CC(=Cc1ccc(cc1)C(O)=O)c1ccc2c(c1)C(C)(C)CCC2(C)C	NA	BRD-K68246049	TTNPB
BRD-K62221994-001-01-8	T 98475	to-be-curated	SA792906	NA	Tocris Bioscience	NA	2519	CC(C)OC(=O)c1cn(Cc2c(F)cccc2F)c2sc(c(CN(C)Cc3ccccc3)c2c1=O)-c1ccc(NC(=O)C(C)C)cc1	NA	BRD-K62221994	T-98475
BRD-K08109516-001-01-1	L-701,324	to-be-curated	SA82422	NA	Biomol International Inc.	NA	AC-405	Oc1c(-c2cccc(Oc3ccccc3)c2)c(=O)[nH]c2cc(Cl)ccc12	NA	BRD-K08109516	L-701324
BRD-K63150726-001-01-3	JTE 907	to-be-curated	SA792882	NA	Tocris Bioscience	NA	2479	CCCCCOc1c(OC)ccc2cc(C(=O)NCc3ccc4OCOc4c3)c(=O)[nH]c12	NA	BRD-K63150726	JTE-907
BRD-K01663662-003-03-8	difenidol	INN	SA83430	NA	Prestwick Chemical Inc.	NA	Prestw-252	OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1	NA	BRD-K01663662	diphenidol
BRD-K63979671-001-03-6	etifenin	INN	SA83392	NA	Prestwick Chemical Inc.	NA	Prestw-504	CCc1cccc(CC)c1NC(=O)CN(CC(O)=O)CC(O)=O	NA	BRD-K63979671	etifenin
BRD-K77947974-001-04-9	fluspirilene	INN	SA82073	NA	Biomol International Inc.	NA	AC-116	Fc1ccc(cc1)C(CCCN1CCC2(CC1)N(CNC2=O)c1ccccc1)c1ccc(F)cc1	NA	BRD-K77947974	fluspirilene
BRD-K71534238-001-03-5	GW9508	primary-common	SA792961	NA	Tocris Bioscience	NA	2649	OC(=O)CCc1ccc(NCc2cccc(Oc3ccccc3)c2)cc1	NA	BRD-K71534238	GW-9508
BRD-K68332390-001-03-3	ponalrestat	INN	SA792177	NA	Tocris Bioscience	NA	847	OC(=O)Cc1nn(Cc2ccc(Br)cc2F)c(=O)c2ccccc12	NA	BRD-K68332390	ponalrestat
BRD-K62353524-001-01-8	DY131	to-be-curated	SA792783	NA	Tocris Bioscience	NA	2266	CCN(CC)c1ccc(C=NNC(=O)c2ccc(O)cc2)cc1	NA	BRD-K62353524	DY-131
BRD-K74913225-001-03-3	brinzolamide	INN	SA83583	NA	Prestwick Chemical Inc.	NA	Prestw-365	CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(cc12)S(N)(=O)=O	NA	BRD-K74913225	brinzolamide
BRD-K09764130-001-02-6	MEAD ethanolamide	primary-common	SA82018	NA	Biomol International Inc.	NA	FA027	CCCCCCCC\C=C/C\C=C/C\C=C/CCCC(=O)NCCO	NA	BRD-K09764130	mead-ethanolamide
BRD-K64729807-001-02-3	AGC	common	SA81962	NA	Biomol International Inc.	NA	G221	CC(=O)N[C@@H](CSC\C=C(/C)CCC=C(C)C)C(O)=O	NA	BRD-K64729807	acetyl-geranyl-cysteine
BRD-K77695569-001-04-5	tiabendazole	INN	SA59287	NA	MicroSource Discovery Systems Inc.	NA	1500570	c1nc(cs1)-c1nc2ccccc2[nH]1	NA	BRD-K77695569	tiabendazole
BRD-K67017579-001-13-3	cilostazol	INN	SA792594	NA	Tocris Bioscience	NA	1692	O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1	NA	BRD-K67017579	cilostazol
BRD-K70799801-311-02-7	quinidine gluconate	USP	SA83173	NA	Prestwick Chemical Inc.	NA	Prestw-280	COc1ccc2nccc([C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1	NA	BRD-K70799801	quinidine
BRD-A97454584-001-02-0	nadolol	INN	SA82812	NA	Prestwick Chemical Inc.	NA	Prestw-818	CC(C)(C)NCC(O)COc1cccc2CC(O)C(O)Cc12	NA	BRD-A97454584	nadolol
BRD-K14221570-236-01-1	benzopurpurine 4B	primary-common	SA63424	NA	Calbiochem	NA	199500	Cc1cc(ccc1N=Nc1cc(c2ccccc2c1N)S(O)(=O)=O)-c1ccc(N=Nc2cc(c3ccccc3c2N)S(O)(=O)=O)c(C)c1	NA	BRD-K14221570	benzopurpurin-4b
BRD-K15715913-001-01-5	fluperlapine	primary-common	SA82456	NA	Biomol International Inc.	NA	NS-109	CN1CCN(CC1)C1=Nc2cc(F)ccc2Cc2ccccc12	NA	BRD-K15715913	fluperlapine
BRD-K16485616-001-01-4	mocetinostat	USAN	SA68084	NA	Broad Institute CMLD	NA	NA	Nc1ccccc1NC(=O)c1ccc(CNc2nccc(n2)-c2cccnc2)cc1	NA	BRD-K16485616	mocetinostat
BRD-K67298865-001-02-5	SB-431542	primary-common	SA82323	NA	Biomol International Inc.	NA	EI314	NC(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccccn1)-c1ccc2OCOc2c1	NA	BRD-K67298865	SB-431542
BRD-K71731651-001-01-9	PNU 120596	to-be-curated	SA792893	NA	Tocris Bioscience	NA	2498	COc1cc(OC)c(NC(=O)Nc2cc(C)on2)cc1Cl	NA	BRD-K71731651	PNU-120596
BRD-K61463582-001-02-3	3-methoxycholanthrene	primary-common	SA59082	NA	MicroSource Discovery Systems Inc.	NA	330007	Cc1ccc2cc3c(ccc4ccccc34)c3CCc1c23	NA	BRD-K61463582	BRD-K61463582
BRD-K05901394-001-01-1	terguride	INN	SA82668	NA	Biomol International Inc.	NA	AC-839	CCN(CC)C(=O)N[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1	NA	BRD-K05901394	terguride
BRD-K23623876-001-01-6	DFB	to-be-curated	SA792568	NA	Tocris Bioscience	NA	1625	Fc1cccc(C=NN=Cc2cccc(F)c2)c1	NA	BRD-K23623876	decafluorobutane
BRD-K71799949-001-04-2	carbamazepine	INN	SA58205	NA	MicroSource Discovery Systems Inc.	NA	1500159	NC(=O)N1c2ccccc2C=Cc2ccccc12	NA	BRD-K71799949	carbamazepine
BRD-K73700643-001-01-3	N-Acetyltryptamine	to-be-curated	SA37368	NA	AnalytiCon Discovery GmbH	NA	NP-003067	CC(=O)NCCc1c[nH]c2ccccc12	NA	BRD-K73700643	BRD-K73700643
BRD-A97730597-003-03-2	hexylcaine	INN	SA83607	NA	Prestwick Chemical Inc.	NA	Prestw-788	CC(CNC1CCCCC1)OC(=O)c1ccccc1	NA	BRD-A97730597	hexylcaine
BRD-K13819402-003-02-9	desoxypeganine	primary-common	SA59038	NA	MicroSource Discovery Systems Inc.	NA	1505243	C1CN2Cc3ccccc3N=C2C1	NA	BRD-K13819402	desoxypeganine
BRD-K12932420-001-01-5	YM 976	to-be-curated	SA792646	NA	Tocris Bioscience	NA	1821	CCc1ccc2c(nc(=O)n(CC)c2n1)-c1cccc(Cl)c1	NA	BRD-K12932420	YM-976
BRD-K73109821-001-05-2	diazoxide	INN	SA82065	NA	Biomol International Inc.	NA	KC-115	CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1	NA	BRD-K73109821	diazoxide
BRD-K17896185-001-01-2	FIT	to-be-curated	SA792509	NA	Tocris Bioscience	NA	1480	CCC(=O)N(C1CCN(CCc2ccc(cc2)N=C=S)CC1)c1ccccc1	NA	BRD-K17896185	FIT
BRD-K71860425-001-01-1	Cdk2/5 inhibitor	common	SA63306	NA	Calbiochem	NA	219448	Nc1cc(Nc2ccc(cc2)S(N)(=O)=O)ncn1	NA	BRD-K71860425	CDK2-5-inhibitor
BRD-K62289640-003-01-9	lylamine	to-be-curated	SA792732	NA	Tocris Bioscience	NA	2139	CC(C)c1ccc2c(CC[C@H]3[C@](C)(CN)CCC[C@]23C)c1	NA	BRD-K62289640	lylamine
BRD-K63089472-001-02-7	farnesylthioacetic acid	common	SA81998	NA	Biomol International Inc.	NA	G222	CC(C)=CCC\C(C)=C\CC\C(C)=C\CSCC(O)=O	NA	BRD-K63089472	farnesylthioacetic-acid
BRD-K71499074-001-03-8	dichlorphenamide	USP	SA83569	NA	Prestwick Chemical Inc.	NA	Prestw-809	NS(=O)(=O)c1cc(Cl)c(Cl)c(c1)S(N)(=O)=O	NA	BRD-K71499074	diclofenamide
BRD-K05361803-001-01-3	SC-10	common	SA63481	NA	Tocris Bioscience	NA	430	CCCCCCCNS(=O)(=O)c1cccc2c(Cl)cccc12	NA	BRD-K05361803	SC-10
BRD-K76274772-001-02-7	D-e-MAPP	common	SA82015	NA	Biomol International Inc.	NA	SL221	CCCCCCCCCCCCCC(=O)N[C@H](C)[C@@H](O)c1ccccc1	NA	BRD-K76274772	MAPP-D-erythro
BRD-K64157027-003-01-9	ZD 2079	to-be-curated	SA792740	NA	Tocris Bioscience	NA	2154	O[C@@H](CNCCOc1ccc(CC(O)=O)cc1)c1ccccc1	NA	BRD-K64157027	ZD-2079
BRD-K63913457-001-02-7	EICOSATRIENOIC ACID (20:3 n-3)	to-be-curated	SA81996	NA	Biomol International Inc.	NA	FA008	CC\C=C/C\C=C/C\C=C/CCCCCCCCCC(O)=O	NA	BRD-K63913457	eicosatrienoic-acid
BRD-K75641298-001-01-5	metaclopramide	INN	SA82669	NA	Biomol International Inc.	NA	AC-840	CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC	NA	BRD-K75641298	metoclopramide
BRD-K67860401-001-02-3	GSK-3beta inhibitor VIII	primary-common	SA753180	NA	Calbiochem	NA	NA	COc1ccc(CNC(=O)Nc2ncc(s2)[N+]([O-])=O)cc1	NA	BRD-K67860401	AR-A014418
BRD-K63606607-001-01-8	bufalin	primary-common	SA63048	NA	Calbiochem	NA	203900	C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@@]1(O)CC[C@@H]2c1ccc(=O)oc1	NA	BRD-K63606607	bufalin
BRD-K63151507-001-01-6	MNITMT	to-be-curated	SA792888	NA	Tocris Bioscience	NA	2492	Cn1cnnc1Sc1c(ncn1C)[N+]([O-])=O	NA	BRD-K63151507	MNITMT
BRD-K13533483-001-03-0	ciclosporin	INN	SA83292	NA	Prestwick Chemical Inc.	NA	Prestw-435	CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C	NA	BRD-K13533483	cyclosporin-a
BRD-K13544237-001-01-0	R(-)-propylnorapomorphine	primary-common	SA82667	NA	Biomol International Inc.	NA	AC-838	CCCN1CCc2cccc-3c2[C@H]1Cc1ccc(O)c(O)c-31	NA	BRD-K13544237	r(-)-propylnorapomorphine
BRD-K74430258-001-01-2	DCB	to-be-curated	SA792667	NA	Tocris Bioscience	NA	1952	Clc1cccc(C=NC=Nc2cccc(Cl)c2)c1	NA	BRD-K74430258	1,2-dichlorobenzene
BRD-K61496577-001-03-8	flumetasone	INN	SA82932	NA	Prestwick Chemical Inc.	NA	Prestw-734	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	NA	BRD-K61496577	flumetasone
BRD-K77925998-001-01-3	quipazine	INN	SA82466	NA	Biomol International Inc.	NA	NS-780	C1CN(CCN1)c1ccc2ccccc2n1	NA	BRD-K77925998	quipazine
BRD-K68095457-001-04-4	palmidrol	INN	SA792190	NA	Tocris Bioscience	NA	879	CCCCCCCCCCCCCCCC(=O)NCCO	NA	BRD-K68095457	palmitoylethanolamide
BRD-K07117950-001-02-6	imperatorin	primary-common	SA36475	NA	AnalytiCon Discovery GmbH	NA	NP-000253	CC(C)=CCOc1c2occc2cc2ccc(=O)oc12	NA	BRD-K07117950	imperatorin
BRD-K71430621-303-01-5	clobenpropit	common	SA792130	NA	Tocris Bioscience	NA	752	Clc1ccc(CNC(=N)SCCCc2c[nH]cn2)cc1	NA	BRD-K71430621	clobenpropit
BRD-K69556541-001-02-6	ryanodine	common	SA82108	NA	Biomol International Inc.	NA	CA-450	CC(C)[C@]1(O)[C@@H](OC(=O)c2ccc[nH]2)[C@@]2(O)[C@@]3(C)C[C@]4(O)O[C@@]5([C@H](O)[C@@H](C)CC[C@]35O)[C@@]2(O)[C@@]14C	NA	BRD-K69556541	ryanodine
BRD-K06024458-001-01-4	N-ArachidonylGABA	to-be-curated	SA792643	NA	Tocris Bioscience	NA	1814	CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCCCC(O)=O	NA	BRD-K06024458	N-arachidonyl-GABA
BRD-K02581333-001-01-8	protein tyrosine phosphatase inhibitor IV	common	SA63383	NA	Calbiochem	NA	540211	CC(C)(c1ccc(NS(=O)(=O)C(F)(F)F)cc1)c1ccc(cc1)C(C)(C)c1cccc(NS(=O)(=O)C(F)(F)F)c1	NA	BRD-K02581333	protein-tyrosine-phosphatase-inhibitor-IV
BRD-K67277431-002-03-0	picotamide	primary-common	SA83135	NA	Prestwick Chemical Inc.	NA	Prestw-119	COc1ccc(cc1C(=O)NCc1cccnc1)C(=O)NCc1cccnc1	NA	BRD-K67277431	picotamide
BRD-K77554836-001-03-3	triamcinolone	INN	SA83065	NA	Prestwick Chemical Inc.	NA	Prestw-120	C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO	NA	BRD-K77554836	triamcinolone
BRD-K72726508-001-01-3	arcyriaflavin A	common	SA792865	NA	Tocris Bioscience	NA	2457	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21	NA	BRD-K72726508	arcyriaflavin-a
BRD-K72895815-001-01-4	SSR 69071	to-be-curated	SA792899	NA	Tocris Bioscience	NA	2506	COc1cc2c(C(=O)N(COc3cc(=O)n4cccc(OCCN5CCCCC5)c4n3)S2(=O)=O)c(c1)C(C)C	NA	BRD-K72895815	SSR-69071
BRD-K76293260-001-02-6	N-LINOLEOYLGLYCINE	to-be-curated	SA82024	NA	Biomol International Inc.	NA	FA-030	CCCCC\C=C/C\C=C/CCCCCCCC(=O)NCC(O)=O	NA	BRD-K76293260	BRD-K76293260
BRD-K70881766-001-02-3	solanine alpha	primary-common	SA83123	NA	Prestwick Chemical Inc.	NA	Prestw-640	C[C@@H]1[C@H]2CC[C@H](C)CN2[C@H]2C[C@H]3[C@@H]4CC=C5C[C@H](CC[C@]5(C)[C@H]4CC[C@]3(C)[C@@H]12)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O	NA	BRD-K70881766	solanine
BRD-K63828191-003-07-3	raloxifene	INN	SA792790	NA	Tocris Bioscience	NA	2280	Oc1ccc(cc1)-c1sc2cc(O)ccc2c1C(=O)c1ccc(OCCN2CCCCC2)cc1	NA	BRD-K63828191	raloxifene
BRD-K73290745-003-01-8	ICI-199,441	to-be-curated	SA792142	NA	Tocris Bioscience	NA	778	CN([C@H](CN1CCCC1)c1ccccc1)C(=O)Cc1ccc(Cl)c(Cl)c1	NA	BRD-K73290745	ICI-199441
BRD-K63874012-103-01-5	thioperamide	common	SA792072	NA	Tocris Bioscience	NA	644	S=C(NC1CCCCC1)N1CCC(CC1)c1c[nH]cn1	NA	BRD-K63874012	thioperamide
BRD-K52620403-001-01-8	STO 609	primary-common	SA753181	NA	Calbiochem	NA	NA	OC(=O)c1ccc2c3nc4ccccc4n3c(=O)c3cccc1c23	NA	BRD-K52620403	STO-609
BRD-K73395020-001-01-5	ARP 101	to-be-curated	SA792944	NA	Tocris Bioscience	NA	2622	CC(C)ON([C@H](C(C)C)C(=O)NO)S(=O)(=O)c1ccc(cc1)-c1ccccc1	NA	BRD-K73395020	ARP-101
BRD-K73397362-001-01-7	purmorphamine	common	SA63333	NA	Calbiochem	NA	540220	C1CCC(CC1)n1cnc2c(Nc3ccc(cc3)N3CCOCC3)nc(Oc3cccc4ccccc34)nc12	NA	BRD-K73397362	purmorphamine
BRD-K67013324-001-01-5	luzindole	primary-common	SA792188	NA	Tocris Bioscience	NA	877	CC(=O)NCCc1c(Cc2ccccc2)[nH]c2ccccc12	NA	BRD-K67013324	luzindole
BRD-K75516118-001-01-7	(R)-(-)-Rolipram	to-be-curated	SA792441	NA	Tocris Bioscience	NA	1349	COc1ccc(cc1OC1CCCC1)[C@@H]1CNC(=O)C1	NA	BRD-K75516118	rolipram
BRD-K71726959-001-05-9	N9-isopropylolomoucine	primary-common	SA82278	NA	Biomol International Inc.	NA	CC-202	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCO)nc12	NA	BRD-K71726959	BRD-K71726959
BRD-K06854232-001-03-3	AM-580	common	SA792134	NA	Tocris Bioscience	NA	760	CC1(C)CCC(C)(C)c2cc(ccc12)C(=O)Nc1ccc(cc1)C(O)=O	NA	BRD-K06854232	AM-580
BRD-K76587808-001-02-0	fraxetin	primary-common	SA36829	NA	AnalytiCon Discovery GmbH	NA	NP-001364	COc1cc2ccc(=O)oc2c(O)c1O	NA	BRD-K76587808	fraxetin
BRD-K67439147-001-01-7	SIB 1893	to-be-curated	SA792377	NA	Tocris Bioscience	NA	1214	Cc1cccc(C=Cc2ccccc2)n1	NA	BRD-K67439147	SIB-1893
BRD-K06208435-001-02-9	YS-035	primary-common	SA82120	NA	Biomol International Inc.	NA	AC-106	COc1ccc(CCN(C)CCc2ccc(OC)c(OC)c2)cc1OC	NA	BRD-K06208435	YS-035
BRD-K01902415-001-03-4	pirinixic acid	INN	SA792427	NA	Tocris Bioscience	NA	1312	Cc1cccc(Nc2cc(Cl)nc(SCC(O)=O)n2)c1C	NA	BRD-K01902415	pirinixic-acid
BRD-A75455249-001-02-0	(+/-)-kavain	primary-common	SA82353	NA	Biomol International Inc.	NA	NA136	COC1=CC(=O)OC(C1)\C=C\c1ccccc1	NA	BRD-A75455249	kavain
BRD-K02607075-333-03-6	tubocurarine chloride	INN	SA83098	NA	Prestwick Chemical Inc.	NA	Prestw-561	COc1cc2CCN(C)[C@H]3Cc4cccc(Oc5c(O)c(OC)cc6CC[N+](C)(C)[C@H](Cc7ccc(O)c(Oc1cc23)c7)c56)c4	NA	BRD-K02607075	tubocurarine
BRD-K68620903-001-03-1	dydrogesterone	INN	SA83601	NA	Prestwick Chemical Inc.	NA	Prestw-671	CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C	NA	BRD-K68620903	dydrogesterone
BRD-K15025317-001-04-5	BAY 11-7082	primary-common	SA82280	NA	Biomol International Inc.	NA	EI-278	Cc1ccc(cc1)S(=O)(=O)\C=C\C#N	NA	BRD-K15025317	BAY-11-7082
BRD-K62310379-001-03-0	fluticasone propionate	USAN	SA83721	NA	Prestwick Chemical Inc.	NA	Prestw-997	CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF	NA	BRD-K62310379	fluticasone-propionate
BRD-K65814004-001-02-3	diphenyleneiodonium	to-be-curated	SA82235	NA	Biomol International Inc.	NA	CN-240	[I+]1c2ccccc2-c2ccccc12	NA	BRD-K65814004	diphenyleneiodonium
BRD-K70914287-300-01-0	BIBX-1382	to-be-curated	SA792848	NA	Tocris Bioscience	NA	2416	CN1CCC(CC1)Nc1ncc2ncnc(Nc3ccc(F)c(Cl)c3)c2n1	NA	BRD-K70914287	BIBX-1382
BRD-K63750851-001-03-3	mycophenolic acid	INN	SA36917	NA	AnalytiCon Discovery GmbH	NA	NP-001642	COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)CCC(O)=O	NA	BRD-K63750851	mycophenolic-acid
BRD-K76133116-001-01-2	benzylamine	primary-common	SA38898	NA	Harvard University	Tim Briggs and Derek Martyn	NA	NCc1ccccc1	NA	BRD-K76133116	benzydamine
BRD-K04010869-001-02-6	prostaglandin A1	primary-common	SA82030	NA	Biomol International Inc.	NA	PG001	CCCCC[C@H](O)\C=C\[C@H]1C=CC(=O)[C@@H]1CCCCCCC(O)=O	NA	BRD-K04010869	prostaglandin-a1
BRD-K66707493-001-02-6	lawsone	primary-common	SA59418	NA	MicroSource Discovery Systems Inc.	NA	1502250	O=C1CC(=O)c2ccccc2C1=O	NA	BRD-K66707493	lawsone
BRD-K08438429-001-01-0	BRD-K08438429	BROAD_CPD_ID	SA792856	NA	Tocris Bioscience	NA	2440	Clc1ccc(CN(CCCNC(=S)NCCCc2c[nH]cn2)c2ccc(Br)cn2)cc1Cl	NA	BRD-K08438429	BRD-K08438429
BRD-K76304753-003-04-7	phenazopyridine	common	SA58424	NA	MicroSource Discovery Systems Inc.	NA	1500473	Nc1ccc(\N=N\c2ccccc2)c(N)n1	NA	BRD-K76304753	phenazopyridine
BRD-K75089421-001-02-5	procainamide	INN	SA82103	NA	Biomol International Inc.	NA	AC-127	CCN(CC)CCNC(=O)c1ccc(N)cc1	NA	BRD-K75089421	procainamide
BRD-K66782112-001-01-2	ICI-162,846	to-be-curated	SA792168	NA	Tocris Bioscience	NA	833	NC(=O)CCCCn1ccc(N=C(N)NCC(F)(F)F)n1	NA	BRD-K66782112	ICI-162846
BRD-K69763916-001-01-7	LY-341495	to-be-curated	SA792372	NA	Tocris Bioscience	NA	1209	N[C@@](CC1c2ccccc2Oc2ccccc12)([C@H]1C[C@@H]1C(O)=O)C(O)=O	NA	BRD-K69763916	LY-341495
BRD-K62206109-303-01-1	VUF 5681	to-be-curated	SA792889	NA	Tocris Bioscience	NA	2493	C(CC1CCNCC1)Cc1c[nH]cn1	NA	BRD-K62206109	VUF-5681
BRD-K75958195-001-01-7	pizotifen	INN	SA82465	NA	Biomol International Inc.	NA	NS-740	CN1CCC(CC1)=C1c2ccsc2CCc2ccccc12	NA	BRD-K75958195	pizotifen
BRD-K74195153-050-03-0	irsogladine	to-be-curated	SA792898	NA	Tocris Bioscience	NA	2504	Nc1nc(N)nc(n1)-c1cc(Cl)ccc1Cl	NA	BRD-K74195153	irsogladine
BRD-K15588452-003-01-9	R-96544	to-be-curated	SA792609	NA	Tocris Bioscience	NA	1742	COc1cccc(CCc2ccccc2OCC[C@@H]2C[C@@H](O)CN2C)c1	NA	BRD-K15588452	R-96544
BRD-K66874953-001-02-7	pifithrin-alpha	primary-common	SA82314	NA	Biomol International Inc.	NA	GR-325	Cc1ccc(cc1)C(=O)Cn1c2CCCCc2sc1=N	NA	BRD-K66874953	pifithrin-alpha
BRD-K65786282-001-02-6	CGP-7930	primary-common	SA792526	NA	Tocris Bioscience	NA	1513	CC(C)(CO)Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C	NA	BRD-K65786282	CGP-7930
BRD-K77171813-050-01-4	proxyfan	to-be-curated	SA792880	NA	Tocris Bioscience	NA	2477	C(COCc1ccccc1)Cc1cnc[nH]1	NA	BRD-K77171813	proxyfan
BRD-K71266197-236-01-9	PSB 06126	to-be-curated	SA792927	NA	Tocris Bioscience	NA	2574	Nc1c2C(=O)c3ccccc3C(=O)c2c(Nc2cccc3ccccc23)cc1S(O)(=O)=O	NA	BRD-K71266197	PSB-06126
BRD-K68507560-003-04-8	dicycloverine	INN	SA58268	NA	MicroSource Discovery Systems Inc.	NA	1500240	CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1	NA	BRD-K68507560	dicycloverine
BRD-K74284736-001-01-5	L-689,560	to-be-curated	SA82421	NA	Biomol International Inc.	NA	AC-404	OC(=O)[C@H]1C[C@H](NC(=O)Nc2ccccc2)c2c(Cl)cc(Cl)cc2N1	NA	BRD-K74284736	L-689560
BRD-K76568384-001-01-4	PHTPP	to-be-curated	SA792969	NA	Tocris Bioscience	NA	2662	Oc1ccc(cc1)-c1c(nn2c(cc(nc12)C(F)(F)F)C(F)(F)F)-c1ccccc1	NA	BRD-K76568384	PHTPP
BRD-K77641333-003-04-0	naphazoline	INN	SA58393	NA	MicroSource Discovery Systems Inc.	NA	1500424	C(C1=NCCN1)c1cccc2ccccc12	NA	BRD-K77641333	naphazoline
BRD-K78280988-001-02-2	anandamide(20:3,n-6)	primary-common	SA81967	NA	Biomol International Inc.	NA	FA019	CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(=O)NCCO	NA	BRD-K78280988	anandamide
BRD-K70330367-001-02-4	amantadine	INN	SA82056	NA	Biomol International Inc.	NA	AC-133	NC12CC3CC(CC(C3)C1)C2	NA	BRD-K70330367	amantadine
BRD-K65503129-001-01-4	CCT018159	primary-common	SA792853	NA	Tocris Bioscience	NA	2435	CCc1cc(-c2n[nH]c(C)c2-c2ccc3OCCOc3c2)c(O)cc1O	NA	BRD-K65503129	CCT-018159
BRD-K74305673-001-01-3	IMD-0354	primary-common	SA792942	NA	Tocris Bioscience	NA	2611	Oc1ccc(Cl)cc1C(=O)Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F	NA	BRD-K74305673	IKK-2-inhibitor-V
BRD-K63938928-001-02-5	7-desoxypurpurogallin-7-carboxylic acid, methyl ester, trimethyl ether	to-be-curated	SA58131	NA	MicroSource Discovery Systems Inc.	NA	210522	COC(=O)c1cc(OC)c(=O)c2c(OC)c(OC)ccc2c1	NA	BRD-K63938928	BRD-K63938928
BRD-K67511046-003-03-7	naloxone	INN	SA83423	NA	Prestwick Chemical Inc.	NA	Prestw-111	Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O	NA	BRD-K67511046	naloxone
BRD-K72024482-001-01-3	MRS 1754	to-be-curated	SA793000	NA	Tocris Bioscience	NA	2752	CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1ccc(OCC(=O)Nc2ccc(cc2)C#N)cc1	NA	BRD-K72024482	MRS-1754
BRD-K75181824-001-02-3	AGGC	common	SA81963	NA	Biomol International Inc.	NA	G220	CC(=O)N[C@@H](CSC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=O	NA	BRD-K75181824	acetyl-geranygeranyl-cysteine
BRD-K68392338-003-01-2	ZK-93426	primary-common	SA792692	NA	Tocris Bioscience	NA	1996	CCOC(=O)c1ncc2[nH]c3cccc(OC(C)C)c3c2c1C	NA	BRD-K68392338	ZK-93426
BRD-K11696279-003-01-5	BU 239	to-be-curated	SA792113	NA	Tocris Bioscience	NA	726	C1CN=C(N1)c1cnc2ccccc2n1	NA	BRD-K11696279	BU-239
BRD-K77987382-001-05-8	mebendazole	primary-common	SA59319	NA	MicroSource Discovery Systems Inc.	NA	1501110	COC(=O)Nc1nc2ccc(cc2[nH]1)C(=O)c1ccccc1	NA	BRD-K77987382	mebendazole
BRD-K08640512-003-01-5	RS 100329	to-be-curated	SA792433	NA	Tocris Bioscience	NA	1325	Cc1c[nH]c(=O)n(CCCN2CCN(CC2)c2ccccc2OCC(F)(F)F)c1=O	NA	BRD-K08640512	RS-100329
BRD-K75478907-001-01-5	GS39783	to-be-curated	SA792696	NA	Tocris Bioscience	NA	2001	CSc1nc(NC2CCCC2)c(c(NC2CCCC2)n1)[N+]([O-])=O	NA	BRD-K75478907	GS-39783
BRD-K09635134-001-02-4	L-erythro-MAPP	primary-common	SA82016	NA	Biomol International Inc.	NA	SL222	CCCCCCCCCCCCCC(=O)N[C@@H](C)[C@H](O)c1ccccc1	NA	BRD-K09635134	L-erythro-MAPP
BRD-K65639003-001-02-5	icariin	primary-common	SA59010	NA	MicroSource Discovery Systems Inc.	NA	1505257	COc1ccc(cc1)-c1oc2c(CC=C(C)C)c(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc(O)c2c(=O)c1O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O	NA	BRD-K65639003	icariin
BRD-K73391359-003-03-7	quinisocaine	INN	SA83598	NA	Prestwick Chemical Inc.	NA	Prestw-630	CCCCc1cc2ccccc2c(OCCN(C)C)n1	NA	BRD-K73391359	quinisocaine
BRD-K68558722-001-02-4	deracoxib	primary-common	SA59557	NA	MicroSource Discovery Systems Inc.	NA	1505222	COc1ccc(cc1F)-c1cc(nn1-c1ccc(cc1)S(N)(=O)=O)C(F)F	NA	BRD-K68558722	deracoxib
BRD-K24132293-001-02-0	piperlongumine	primary-common	SA37589	NA	AnalytiCon Discovery GmbH	NA	NP-003716	COc1cc(cc(OC)c1OC)\C=C\C(=O)N1CCC=CC1=O	NA	BRD-K24132293	piperlongumine
BRD-K18816859-001-01-4	2-[5-[3-(4-methylsulphonylamino)benzyl-1,2,4-oxadiazol-5-yl]-1H-indole-3-yl]ethylamine	to-be-curated	SA792145	NA	Tocris Bioscience	NA	781	CS(=O)(=O)Nc1ccc(Cc2noc(n2)-c2ccc3[nH]cc(CCN)c3c2)cc1	NA	BRD-K18816859	L-694247
BRD-K64245000-001-01-7	GW 4064	to-be-curated	SA792876	NA	Tocris Bioscience	NA	2473	CC(C)c1onc(c1COc1ccc(C=Cc2cccc(c2)C(O)=O)c(Cl)c1)-c1c(Cl)cccc1Cl	NA	BRD-K64245000	GW-4064
BRD-K21853356-001-04-4	RG-14620	primary-common	SA82348	NA	Biomol International Inc.	NA	EI-253	Clc1cc(Cl)cc(c1)\C=C(/C#N)c1cccnc1	NA	BRD-K21853356	RG-14620
BRD-K22031190-001-04-6	diflunisal	INN	SA58272	NA	MicroSource Discovery Systems Inc.	NA	1500245	OC(=O)c1cc(ccc1O)-c1ccc(F)cc1F	NA	BRD-K22031190	diflunisal
BRD-K70241288-001-01-1	L-692,585	to-be-curated	SA792782	NA	Tocris Bioscience	NA	2261	C[C@@H](O)CNC(C)(C)CC(=O)N[C@@H]1CCc2ccccc2N(Cc2ccc(cc2)-c2ccccc2-c2nn[nH]n2)C1=O	NA	BRD-K70241288	L-692585
BRD-K22134346-001-04-1	simvastatin	INN	SA58549	NA	MicroSource Discovery Systems Inc.	NA	1504236	CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12	NA	BRD-K22134346	simvastatin
BRD-K20655524-003-04-7	mefexamide	INN	SA83171	NA	Prestwick Chemical Inc.	NA	Prestw-215	CCN(CC)CCNC(=O)COc1ccc(OC)cc1	NA	BRD-K20655524	mefexamide
BRD-K09963420-066-03-4	saquinavir	INN	SA83794	NA	Prestwick Chemical Inc.	NA	Prestw-1114	CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1	NA	BRD-K09963420	saquinavir
BRD-K21667562-001-01-4	AM 404	to-be-curated	SA792345	NA	Tocris Bioscience	NA	1116	CCCCCC=CCC=CCC=CCC=CCCCC(=O)Nc1ccc(O)cc1	NA	BRD-K21667562	AM-404
BRD-K21733600-001-02-6	rofecoxib	INN	SA59033	NA	MicroSource Discovery Systems Inc.	NA	1504235	CS(=O)(=O)c1ccc(cc1)C1=C(C(=O)OC1)c1ccccc1	NA	BRD-K21733600	rofecoxib
BRD-K32292990-001-01-0	CGP-53353	primary-common	SA792858	NA	Tocris Bioscience	NA	2442	Fc1ccc(Nc2cc3C(=O)NC(=O)c3cc2Nc2ccc(F)cc2)cc1	NA	BRD-K32292990	CGP-53353
BRD-K21450440-001-04-7	benzthiazide	INN	SA58195	NA	MicroSource Discovery Systems Inc.	NA	1500141	NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O	NA	BRD-K21450440	benzthiazide
BRD-K76805682-001-05-0	SB-415286	primary-common	SA792564	NA	Tocris Bioscience	NA	1617	Oc1ccc(NC2=C(C(=O)NC2=O)c2ccccc2[N+]([O-])=O)cc1Cl	NA	BRD-K76805682	SB-415286
BRD-K22385716-001-01-7	LY-303511	common	SA792850	NA	Tocris Bioscience	NA	2418	O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCNCC1	NA	BRD-K22385716	LY-303511
BRD-K24526313-001-08-6	levcromakalim	to-be-curated	SA792454	NA	Tocris Bioscience	NA	1378	CC1(C)Oc2ccc(cc2[C@H]([C@@H]1O)N1CCCC1=O)C#N	NA	BRD-K24526313	levcromakalim
BRD-K29673530-001-03-9	hypericin	common	SA81853	NA	Biomol International Inc.	NA	EI-226	Cc1cc(O)c2c3c1c1c(C)cc(O)c4c1c1c3c3c(c(O)cc(O)c3c2=O)c2c(O)cc(O)c(c12)c4=O	NA	BRD-K29673530	hypericin
BRD-K24240364-003-02-1	GYKI-52466	to-be-curated	SA792498	NA	Tocris Bioscience	NA	1454	CC1=NN=C(c2ccc(N)cc2)c2cc3OCOc3cc2C1	NA	BRD-K24240364	GYKI-52466
BRD-K23383398-001-01-6	T-0901317	primary-common	SA792830	NA	Tocris Bioscience	NA	2373	OC(c1ccc(cc1)N(CC(F)(F)F)S(=O)(=O)c1ccccc1)(C(F)(F)F)C(F)(F)F	NA	BRD-K23383398	T-0901317
BRD-K29582677-001-02-7	flunarizine	INN	SA82072	NA	Biomol International Inc.	NA	CA-225	Fc1ccc(cc1)C(N1CCN(C\C=C\c2ccccc2)CC1)c1ccc(F)cc1	NA	BRD-K29582677	flunarizine
BRD-K37270826-001-03-7	mifepristone	INN	SA63478	NA	EMD Biosciences	NA	475838	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C	NA	BRD-K37270826	mifepristone
BRD-K24201553-003-02-4	SB 269970	common	SA792560	NA	Tocris Bioscience	NA	1612	CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(O)c2)CC1	NA	BRD-K24201553	SB-269970
BRD-K33308633-001-01-6	INCA-6	primary-common	SA792745	NA	Tocris Bioscience	NA	2162	O=C1C=CC(=O)C2=C1C1c3ccccc3C2c2ccccc12	NA	BRD-K33308633	INCA-6
BRD-K30240666-051-05-0	clemastine	INN	SA83250	NA	Prestwick Chemical Inc.	NA	Prestw-306	CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1	NA	BRD-K30240666	clemastine
BRD-K09537769-001-01-6	NU7026	primary-common	SA63332	NA	Calbiochem	NA	260961	O=c1cc(oc2c3ccccc3ccc12)N1CCOCC1	NA	BRD-K09537769	NU-7026
BRD-K23583188-001-05-6	lavendustin A	common	SA82277	NA	Biomol International Inc.	NA	EI185	OC(=O)c1cc(ccc1O)N(Cc1ccccc1O)Cc1cc(O)ccc1O	NA	BRD-K23583188	lavendustin-a
BRD-K38197229-001-06-7	bumetanide	INN	SA82195	NA	Biomol International Inc.	NA	EI-168	CCCCNc1cc(cc(c1Oc1ccccc1)S(N)(=O)=O)C(O)=O	NA	BRD-K38197229	bumetanide
BRD-K27351809-001-02-0	nomegestrol	USAN	SA83760	NA	Prestwick Chemical Inc.	NA	Prestw-1033	CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C(C)=O	NA	BRD-K27351809	nomegestrol-acetate
BRD-K37289225-001-07-5	clozapine	INN	SA82216	NA	Biomol International Inc.	NA	D107	CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12	NA	BRD-K37289225	clozapine
BRD-K22193694-001-04-5	dioxybenzone	INN	SA58279	NA	MicroSource Discovery Systems Inc.	NA	1500255	COc1ccc(C(=O)c2ccccc2O)c(O)c1	NA	BRD-K22193694	dioxybenzone
BRD-K26548821-001-01-8	quinpirole	INN	SA82602	NA	Biomol International Inc.	NA	D-109	CCCN1CCC[C@@H]2Cc3n[nH]cc3C[C@@H]12	NA	BRD-K26548821	quinpirol-(-)
BRD-K32247306-001-04-7	primidone	INN	SA58433	NA	MicroSource Discovery Systems Inc.	NA	1500501	CCC1(C(=O)NCNC1=O)c1ccccc1	NA	BRD-K32247306	primidone
BRD-K74141488-003-03-9	naftifine	INN	SA83756	NA	Prestwick Chemical Inc.	NA	Prestw-1063	CN(C\C=C\c1ccccc1)Cc1cccc2ccccc12	NA	BRD-K74141488	naftifine
BRD-K39987650-001-04-3	bisacodyl	INN	SA58198	NA	MicroSource Discovery Systems Inc.	NA	1500147	CC(=O)Oc1ccc(cc1)C(c1ccc(OC(C)=O)cc1)c1ccccn1	NA	BRD-K39987650	bisacodyl
BRD-K33396764-001-02-0	alpha-linolenic acid	primary-common	SA82009	NA	Biomol International Inc.	NA	FA005	CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O	NA	BRD-K33396764	alpha-linolenic-acid
BRD-K18316707-001-01-9	O-1918	to-be-curated	SA792794	NA	Tocris Bioscience	NA	2288	COc1cc(C)cc(OC)c1[C@@H]1C=C(C)CC[C@H]1C(C)=C	NA	BRD-K18316707	O-1918
BRD-K33459542-001-02-5	ditolylguanidine	primary-common	SA792175	NA	Tocris Bioscience	NA	841	Cc1ccccc1NC(=N)Nc1ccccc1C	NA	BRD-K33459542	ditolylguanidine
BRD-K19605405-001-01-9	ZM-241,385	primary-common	SA792292	NA	Tocris Bioscience	NA	1036	Nc1nc(NCCc2ccc(O)cc2)nc2nc(nn12)-c1ccco1	NA	BRD-K19605405	ZM-241385
BRD-K28183345-003-05-6	proguanil	INN	SA83781	NA	Prestwick Chemical Inc.	NA	Prestw-999	CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1	NA	BRD-K28183345	proguanil
BRD-K35960502-001-04-4	niclosamide	INN	SA58547	NA	MicroSource Discovery Systems Inc.	NA	1503265	Oc1ccc(Cl)cc1C(=O)Nc1ccc(cc1Cl)[N+]([O-])=O	NA	BRD-K35960502	niclosamide
BRD-K38305202-001-01-8	domperidone	INN	SA58785	NA	MicroSource Discovery Systems Inc.	NA	2300212	Clc1ccc2n(C3CCN(CCCn4c5ccccc5[nH]c4=O)CC3)c(=O)[nH]c2c1	NA	BRD-K38305202	domperidone
BRD-K39733634-001-01-8	L 161982	to-be-curated	SA792904	NA	Tocris Bioscience	NA	2514	CCCCc1nn(-c2ccccc2C(F)(F)F)c(=O)n1Cc1ccc(cc1)-c1ccccc1S(=O)(=O)NC(=O)c1sccc1C	NA	BRD-K39733634	L-161982
BRD-K40656405-001-01-5	L-165,041	to-be-curated	SA792653	NA	Tocris Bioscience	NA	1856	CCCc1c(OCCCOc2ccc(OCC(O)=O)cc2)ccc(CC=O)c1O	NA	BRD-K40656405	L-165041
BRD-K32501161-001-01-7	vanoxerine	INN	SA82598	NA	Biomol International Inc.	NA	D-104	Fc1ccc(cc1)C(OCCN1CCN(CCCc2ccccc2)CC1)c1ccc(F)cc1	NA	BRD-K32501161	vanoxerine
BRD-K36864847-303-01-7	BD-1047	primary-common	SA792245	NA	Tocris Bioscience	NA	956	CN(C)CCN(C)CCc1ccc(Cl)c(Cl)c1	NA	BRD-K36864847	BD-1047
BRD-K12184470-300-01-8	flunarizine	common	SA792014	NA	Tocris Bioscience	NA	522	Fc1ccc(cc1)C(N1CCN(CC=Cc2ccccc2)CC1)c1ccc(F)cc1	NA	BRD-K12184470	flunarizine
BRD-K40255344-001-05-1	tyrphostin A9	primary-common	SA82361	NA	Biomol International Inc.	NA	EI-215	CC(C)(C)c1cc(C=C(C#N)C#N)cc(c1O)C(C)(C)C	NA	BRD-K40255344	tyrphostin-A9
BRD-K76723084-001-05-9	isotretinoin	INN	SA81917	NA	Biomol International Inc.	NA	GR102	CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C/C(O)=O	NA	BRD-K76723084	isotretinoin
BRD-K14993104-001-03-4	bemegride	INN	SA83654	NA	Prestwick Chemical Inc.	NA	Prestw-882	CCC1(C)CC(=O)NC(=O)C1	NA	BRD-K14993104	bemegride
BRD-K37865504-001-01-7	LY-2183240	common	SA792863	NA	Tocris Bioscience	NA	2452	CN(C)C(=O)n1nnnc1Cc1ccc(cc1)-c1ccccc1	NA	BRD-K37865504	LY-2183240
BRD-K18619710-001-03-7	digoxigenin	primary-common	SA83657	NA	Prestwick Chemical Inc.	NA	Prestw-883	C[C@@]12[C@H](CC[C@]1(O)[C@@H]1CC[C@@H]3C[C@@H](O)CC[C@]3(C)[C@H]1C[C@H]2O)C1=CC(=O)OC1	NA	BRD-K18619710	digoxigenin
BRD-K33211335-337-03-7	dextromethorphan	INN	SA83256	NA	Prestwick Chemical Inc.	NA	Prestw-359	COc1ccc2C[C@H]3[C@H]4CCCC[C@@]4(CCN3C)c2c1	NA	BRD-K33211335	dextromethorphan
BRD-K39965020-001-02-6	doconexent	INN	SA81990	NA	Biomol International Inc.	NA	FA-002	CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O	NA	BRD-K39965020	doconexent
BRD-K25394294-001-04-0	oxaprozin	INN	SA58958	NA	MicroSource Discovery Systems Inc.	NA	1505267	OC(=O)CCc1nc(c(o1)-c1ccccc1)-c1ccccc1	NA	BRD-K25394294	oxaprozin
BRD-K02265150-001-04-2	amoxapine	INN	SA58947	NA	MicroSource Discovery Systems Inc.	NA	2300161	Clc1ccc2Oc3ccccc3N=C(N3CCNCC3)c2c1	NA	BRD-K02265150	amoxapine
BRD-K39188321-001-03-9	betamethasone	INN	SA83269	NA	Prestwick Chemical Inc.	NA	Prestw-362	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	NA	BRD-K39188321	betamethasone
BRD-K25906698-303-01-9	immepip	to-be-curated	SA792232	NA	Tocris Bioscience	NA	932	C(C1CCNCC1)c1c[nH]cn1	NA	BRD-K25906698	immepip
BRD-K23913458-001-02-5	coumarin	primary-common	SA59652	NA	MicroSource Discovery Systems Inc.	NA	1400208	O=c1ccc2ccccc2o1	NA	BRD-K23913458	coumarin
BRD-K39670393-303-01-3	amthamine	primary-common	SA792086	NA	Tocris Bioscience	NA	668	Cc1nc(N)sc1CCN	NA	BRD-K39670393	amthamine
BRD-K23922020-075-01-1	arecaidine propargyl ester	primary-common	SA791946	NA	Tocris Bioscience	NA	383	CN1CCC=C(C1)C(=O)OCC#C	NA	BRD-K23922020	arecaidine-propargyl-ester
BRD-K36638830-001-02-2	anabasine	primary-common	SA82885	NA	Prestwick Chemical Inc.	NA	Prestw-669	C1CC[C@@H](NC1)c1cccnc1	NA	BRD-K36638830	anabasine
BRD-K36258877-001-01-5	AZ-10417808	to-be-curated	SA792746	NA	Tocris Bioscience	NA	2172	[O-][N+](=O)c1cc(C(=O)NCC=C)c2nc(Nc3ccc(Cl)c(Cl)c3)[nH]c(=O)c2c1	NA	BRD-K36258877	AZ-10417808
BRD-K27871032-001-02-6	lysergol	primary-common	SA38493	NA	AnalytiCon Discovery GmbH	NA	NP-009925	CN1C[C@H](CO)C=C2[C@H]1Cc1c[nH]c3cccc2c13	NA	BRD-K27871032	lysergol
BRD-K76617868-001-02-2	fasudil	INN	SA62843	NA	LC Laboratories	NA	H-2330	O=S(=O)(N1CCCNCC1)c1cccc2cnccc12	NA	BRD-K76617868	fasudil
BRD-K34170797-001-01-1	fexaramine	to-be-curated	SA792923	NA	Tocris Bioscience	NA	2563	COC(=O)C=Cc1cccc(c1)N(Cc1ccc(cc1)-c1ccc(cc1)N(C)C)C(=O)C1CCCCC1	NA	BRD-K34170797	fexaramine
BRD-K32526544-001-01-2	DCEBIO	to-be-curated	SA792485	NA	Tocris Bioscience	NA	1422	CCn1c2cc(Cl)c(Cl)cc2[nH]c1=O	NA	BRD-K32526544	DCEBIO
BRD-K33864865-001-01-7	LY-225910	to-be-curated	SA792279	NA	Tocris Bioscience	NA	1018	CC(C)Oc1cccc(c1)-n1c(CCc2c[nH]c3ccc(Br)cc23)nc2ccccc2c1=O	NA	BRD-K33864865	LY-225910
BRD-K34034388-300-01-0	GBR 12783	to-be-curated	SA792010	NA	Tocris Bioscience	NA	513	C(CN1CCN(CC=Cc2ccccc2)CC1)OC(c1ccccc1)c1ccccc1	NA	BRD-K34034388	GBR-12783
BRD-K38903228-001-02-8	hesperidin	primary-common	SA82961	NA	Prestwick Chemical Inc.	NA	Prestw-400	COc1ccc(cc1O)[C@@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1	NA	BRD-K38903228	hesperidin
BRD-K36198571-001-01-2	WAY 170523	to-be-curated	SA792951	NA	Tocris Bioscience	NA	2633	Cc1cc(C)c(N(Cc2ccccc2)S(=O)(=O)c2ccc(OCCNC(=O)c3cc4ccccc4o3)cc2)c(c1)C(=O)NO	NA	BRD-K36198571	WAY-170523
BRD-K38323065-001-05-8	phenacetin	INN	SA83409	NA	Prestwick Chemical Inc.	NA	Prestw-533	CCOc1ccc(NC(C)=O)cc1	NA	BRD-K38323065	phenacetin
BRD-K32830106-003-11-3	guanfacine	INN	SA792286	NA	Tocris Bioscience	NA	1030	NC(=N)NC(=O)Cc1c(Cl)cccc1Cl	NA	BRD-K32830106	guanfacine
BRD-K35941380-001-01-7	methysergide	INN	SA82518	NA	Biomol International Inc.	NA	AC-577	CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3cn(C)c4cccc(C2=C1)c34	NA	BRD-K35941380	methysergide
BRD-K27499107-001-02-6	carbacyclin	to-be-curated	SA81978	NA	Biomol International Inc.	NA	PG035	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2C\C(C[C@H]12)=C/CCCC(O)=O	NA	BRD-K27499107	carbacyclin
BRD-K38775274-001-02-3	dexamethasone	INN	SA82229	NA	Biomol International Inc.	NA	EI-126	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	NA	BRD-K38775274	dexamethasone
BRD-K31912990-003-01-0	CGP 71683	to-be-curated	SA792762	NA	Tocris Bioscience	NA	2199	Nc1nc(NCC2CCC(CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12	NA	BRD-K31912990	CGP-71683
BRD-K40887525-001-02-9	ritanserin	INN	SA58903	NA	MicroSource Discovery Systems Inc.	NA	1503421	Cc1nc2sccn2c(=O)c1CCN1CCC(CC1)=C(c1ccc(F)cc1)c1ccc(F)cc1	NA	BRD-K40887525	ritanserin
BRD-K46652470-001-02-6	nizatidine	INN	SA82902	NA	Prestwick Chemical Inc.	NA	Prestw-921	CN\C(NCCSCc1csc(CN(C)C)n1)=C\[N+]([O-])=O	NA	BRD-K46652470	nizatidine
BRD-K38756014-001-02-8	farnesylcysteine methyl ester	common	SA82043	NA	Biomol International Inc.	NA	G-201	COC(=O)[C@@H](N)CSC\C=C(/C)CC\C=C(/C)CCC=C(C)C	NA	BRD-K38756014	farnesylcysteine-methyl-ester
BRD-K42452249-001-01-7	EO-1428	primary-common	SA793008	NA	Tocris Bioscience	NA	2908	Cc1ccccc1C(=O)c1ccc(Nc2ccc(Br)cc2N)cc1Cl	NA	BRD-K42452249	EO-1428
BRD-K57033106-048-02-8	tripelannamine	INN	SA59576	NA	MicroSource Discovery Systems Inc.	NA	1500597	CN(C)CCN(Cc1ccccc1)c1ccccn1	NA	BRD-K57033106	tripelennamine
BRD-K38055836-001-03-9	etamivan	INN	SA83449	NA	Prestwick Chemical Inc.	NA	Prestw-500	CCN(CC)C(=O)c1ccc(O)c(OC)c1	NA	BRD-K38055836	etamivan
BRD-K40578143-001-01-8	GR 79236	to-be-curated	SA792671	NA	Tocris Bioscience	NA	1957	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N[C@H]3CCC[C@@H]3O)ncnc12	NA	BRD-K40578143	GR-79236
BRD-K45117373-001-01-1	Y-26763	to-be-curated	SA792719	NA	Tocris Bioscience	NA	2076	CC(=O)N(O)[C@H]1[C@H](O)C(C)(C)Oc2ccc(cc12)C#N	NA	BRD-K45117373	Y-26763
BRD-K34092021-001-02-3	arvanil	primary-common	SA82165	NA	Biomol International Inc.	NA	VR101	CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCc1ccc(O)c(OC)c1	NA	BRD-K34092021	arvanil
BRD-K32164935-001-06-8	tolazamide	INN	SA82114	NA	Biomol International Inc.	NA	KC-135	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN1CCCCCC1	NA	BRD-K32164935	tolazamide
BRD-K39339537-001-03-8	epirizole	INN	SA82904	NA	Prestwick Chemical Inc.	NA	Prestw-32	COc1cc(C)nn1-c1nc(C)cc(OC)n1	NA	BRD-K39339537	epirizole
BRD-K54142781-001-02-1	cirazoline	INN	SA82214	NA	Biomol International Inc.	NA	AC-136	C(Oc1ccccc1C1CC1)C1=NCCN1	NA	BRD-K54142781	cirazoline
BRD-K38477985-001-01-8	malonoben	to-be-curated	SA791993	NA	Tocris Bioscience	NA	479	CC(C)(C)c1cc(C=C(C#N)[N+]#[C-])cc(c1O)C(C)(C)C	NA	BRD-K38477985	malonoben
BRD-K57545991-050-03-3	enalapril	INN	SA59358	NA	MicroSource Discovery Systems Inc.	NA	1501214	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O	NA	BRD-K57545991	enalapril
BRD-K28761384-003-03-6	zuclopenthixol	INN	SA83809	NA	Prestwick Chemical Inc.	NA	Prestw-998	OCCN1CCN(CC\C=C2\c3ccccc3Sc3ccc(Cl)cc23)CC1	NA	BRD-K28761384	zuclopenthixol
BRD-K43860855-065-03-6	iobenguane	primary-common	SA83354	NA	Prestwick Chemical Inc.	NA	Prestw-490	NC(=N)NCc1cccc(I)c1	NA	BRD-K43860855	iobenguane
BRD-K52721684-001-02-2	PCO-400	primary-common	SA82096	NA	Biomol International Inc.	NA	KC-131	CC1(C)Oc2ccc(cc2[C@@H](OC2=CC(=O)CC2)[C@@H]1O)C#N	NA	BRD-K52721684	PCO-400
BRD-K54704028-001-01-3	Bay 36-7620	to-be-curated	SA792896	NA	Tocris Bioscience	NA	2501	C=C1C[C@@H]2COC(=O)[C@]2(Cc2ccc3ccccc3c2)C1	NA	BRD-K54704028	BAY-36-7620
BRD-K41567364-001-01-2	SB-334,867	primary-common	SA792674	NA	Tocris Bioscience	NA	1960	Cc1nc2ccc(NC(=O)Nc3ccnc4cccnc34)cc2o1	NA	BRD-K41567364	SB-334867
BRD-K26573499-300-01-3	DMAB-anabaseine	to-be-curated	SA792776	NA	Tocris Bioscience	NA	2241	CN(C)c1ccc(cc1)\C=C1CCCN=C/1c1cccnc1	NA	BRD-K26573499	DMAB-anabaseine
BRD-K56515112-001-03-4	medrysone	INN	SA82793	NA	Prestwick Chemical Inc.	NA	Prestw-743	C[C@H]1C[C@H]2[C@@H]3CC[C@H](C(C)=O)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)CCC(=O)C=C12	NA	BRD-K56515112	medrysone
BRD-K37392901-003-01-7	NSC632839	common	SA792960	NA	Tocris Bioscience	NA	2647	Cc1ccc(C=C2CNCC(=Cc3ccc(C)cc3)C2=O)cc1	NA	BRD-K37392901	NSC-632839
BRD-K39187410-001-01-7	R(-)-2,10,11-trihydroxyaporphine	primary-common	SA82660	NA	Biomol International Inc.	NA	AC-830	CN1CCc2cc(O)cc-3c2[C@H]1Cc1ccc(O)c(O)c-31	NA	BRD-K39187410	BRD-K39187410
BRD-K44849676-001-03-0	capsazepine	common	SA82206	NA	Biomol International Inc.	NA	NK101	Oc1cc2CCCN(Cc2cc1O)C(=S)NCCc1ccc(Cl)cc1	NA	BRD-K44849676	capsazepine
BRD-K53318339-001-04-1	vinpocetine	INN	SA58841	NA	MicroSource Discovery Systems Inc.	NA	1503115	CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c([C@H]23)n1c1ccccc41	NA	BRD-K53318339	vinpocetine
BRD-K28680267-001-01-8	3-Carbomethoxy-beta-carboline	to-be-curated	SA82572	NA	Biomol International Inc.	NA	AC-977	COC(=O)c1cc2c(cn1)[nH]c1ccccc21	NA	BRD-K28680267	BRD-K28680267
BRD-K60476892-001-02-1	YC-1	primary-common	SA82225	NA	Biomol International Inc.	NA	CN-223	OCc1ccc(o1)-c1nn(Cc2ccccc2)c2ccccc12	NA	BRD-K60476892	YC-1
BRD-K21565985-001-04-3	xylazine	INN	SA59352	NA	MicroSource Discovery Systems Inc.	NA	1501200	Cc1cccc(C)c1NC1=NCCCS1	NA	BRD-K21565985	xylazine
BRD-K40901640-001-01-0	cinanserin	primary-common	SA82455	NA	Biomol International Inc.	NA	NS-102	CN(C)CCCSc1ccccc1NC(=O)\C=C\c1ccccc1	NA	BRD-K40901640	cinanserin
BRD-K49577446-001-03-1	flunisolide	INN	SA82926	NA	Prestwick Chemical Inc.	NA	Prestw-643	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO	NA	BRD-K49577446	flunisolide
BRD-K49519092-303-01-4	immethridine	common	SA792813	NA	Tocris Bioscience	NA	2315	C(c1cnc[nH]1)c1ccncc1	NA	BRD-K49519092	immethridine
BRD-K50398167-236-02-9	meclofenamic acid	INN	SA58366	NA	MicroSource Discovery Systems Inc.	NA	1500377	Cc1ccc(Cl)c(Nc2ccccc2C(O)=O)c1Cl	NA	BRD-K50398167	meclofenamic-acid
BRD-K48692744-001-01-2	NU 1025	primary-common	SA792471	NA	Tocris Bioscience	NA	1401	Cc1nc2c(O)cccc2c(=O)[nH]1	NA	BRD-K48692744	NU-1025
BRD-K47943470-001-02-8	tyrphostin 51	primary-common	SA63269	NA	Calbiochem	NA	658410	NC(=C(C#N)C#N)C(\C#N)=C\c1cc(O)c(O)c(O)c1	NA	BRD-K47943470	tyrphostin-51
BRD-K28542495-003-03-6	benzydamine	INN	SA83045	NA	Prestwick Chemical Inc.	NA	Prestw-297	CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12	NA	BRD-K28542495	benzydamine
BRD-K57304726-003-03-6	PRE-084	to-be-curated	SA792045	NA	Tocris Bioscience	NA	589	O=C(OCCN1CCOCC1)C1(CCCCC1)c1ccccc1	NA	BRD-K57304726	PRE-084
BRD-K50388907-001-04-9	fenofibrate	INN	SA59311	NA	MicroSource Discovery Systems Inc.	NA	1501010	CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c1ccc(Cl)cc1	NA	BRD-K50388907	fenofibrate
BRD-K43068349-001-01-9	AMG 9810	to-be-curated	SA792814	NA	Tocris Bioscience	NA	2316	CC(C)(C)c1ccc(C=CC(=O)Nc2ccc3OCCOc3c2)cc1	NA	BRD-K43068349	AMG-9810
BRD-K42500029-001-01-9	CGP 57380	common	SA792994	NA	Tocris Bioscience	NA	2731	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12	NA	BRD-K42500029	CGP-57380
BRD-K51751936-001-03-4	alfadolone acetate	primary-common	SA83684	NA	Prestwick Chemical Inc.	NA	Prestw-1001	CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C	NA	BRD-K51751936	alfadolone-acetate
BRD-K33818169-003-01-2	GW 3965	to-be-curated	SA792877	NA	Tocris Bioscience	NA	2474	OC(=O)Cc1cccc(OCCCN(CC(c2ccccc2)c2ccccc2)Cc2cccc(c2Cl)C(F)(F)F)c1	NA	BRD-K33818169	GW-3965
BRD-K45542189-048-04-9	diethylcarbamazine	INN	SA58270	NA	MicroSource Discovery Systems Inc.	NA	1500242	CCN(CC)C(=O)N1CCN(C)CC1	NA	BRD-K45542189	diethylcarbamazine
BRD-K52397688-001-01-9	amperozide	common	SA82507	NA	Biomol International Inc.	NA	AC-1367	CCNC(=O)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1	NA	BRD-K52397688	amperozide
BRD-K40530731-001-02-5	L-hyoscyamine	primary-common	SA82976	NA	Prestwick Chemical Inc.	NA	Prestw-233	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)c1ccccc1	NA	BRD-K40530731	hyoscyamine
BRD-K46142322-003-01-6	RS 67333	to-be-curated	SA792259	NA	Tocris Bioscience	NA	989	CCCCN1CCC(CCC(=O)c2cc(Cl)c(N)cc2OC)CC1	NA	BRD-K46142322	RS-67333
BRD-K31542390-001-01-5	mycophenolic acid	INN	SA792518	NA	Tocris Bioscience	NA	1505	COc1c(C)c2COC(=O)c2c(O)c1CC=C(C)CCC(O)=O	NA	BRD-K31542390	mycophenolic-acid
BRD-K36965586-001-01-7	m-chlorophenylbiguanide	primary-common	SA82501	NA	Biomol International Inc.	NA	AC-557	NC(=N)NC(=N)Nc1cccc(Cl)c1	NA	BRD-K36965586	m-chlorophenylbiguanide
BRD-K48059230-003-01-1	YM 298198, Desmethyl-	to-be-curated	SA792860	NA	Tocris Bioscience	NA	2447	Cc1c(sc2nc3ccc(N)cc3n12)C(=O)NC1CCCCC1	NA	BRD-K48059230	YM-298198
BRD-K53523901-001-01-0	arctigenin	primary-common	SA38551	NA	AnalytiCon Discovery GmbH	NA	NP-010113	COc1cc(C[C@@H]2[C@@H](Cc3ccc(OC)c(OC)c3)COC2=O)ccc1O	NA	BRD-K53523901	arctigenin
BRD-K52989797-001-01-1	clomipramine	INN	SA82514	NA	Biomol International Inc.	NA	AC-572	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc12	NA	BRD-K52989797	clomipramine
BRD-K59469039-001-04-9	AG-879	common	SA82170	NA	Biomol International Inc.	NA	EI-258	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)\C=C(/C#N)C(N)=S	NA	BRD-K59469039	tyrphostin-AG-879
BRD-K37991163-050-05-1	paroxetine	INN	SA792733	NA	Tocris Bioscience	NA	2141	Fc1ccc(cc1)[C@@H]1CCNC[C@H]1COc1ccc2OCOc2c1	NA	BRD-K37991163	paroxetine
BRD-K23478508-001-03-7	digoxin	INN	SA82874	NA	Prestwick Chemical Inc.	NA	Prestw-437	C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CC[C@@H]5[C@@H]4C[C@@H](O)[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C	NA	BRD-K23478508	digoxin
BRD-K53857191-001-04-5	risperidone	INN	SA82616	NA	Biomol International Inc.	NA	AC-758	Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12	NA	BRD-K53857191	risperidone
BRD-K52662033-001-02-6	lidocaine	INN	SA82081	NA	Biomol International Inc.	NA	AC-128	CCN(CC)CC(=O)Nc1c(C)cccc1C	NA	BRD-K52662033	lidocaine
BRD-K45296539-003-01-0	ZD 7114	to-be-curated	SA792230	NA	Tocris Bioscience	NA	930	COCCNC(=O)COc1ccc(OCCNC[C@@H](O)COc2ccccc2)cc1	NA	BRD-K45296539	ZD-7114
BRD-K39356024-001-02-4	Pregnenolone 16a carbonitrile	to-be-curated	SA82243	NA	Biomol International Inc.	NA	S620	CC(=O)[C@H]1[C@@H](C[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C#N	NA	BRD-K39356024	pregnenolone
BRD-K43330982-001-01-5	JTE 013	to-be-curated	SA792837	NA	Tocris Bioscience	NA	2392	CC(C)c1cc(NNC(=O)Nc2cc(Cl)nc(Cl)c2)nc2n(C)nc(C)c12	NA	BRD-K43330982	JTE-013
BRD-K31843556-001-01-7	T-0070907	primary-common	SA792803	NA	Tocris Bioscience	NA	2301	[O-][N+](=O)c1ccc(Cl)c(c1)C(=O)Nc1ccncc1	NA	BRD-K31843556	T-0070907
BRD-K59037100-001-04-8	oxybenzone	INN	SA58418	NA	MicroSource Discovery Systems Inc.	NA	1500451	COc1ccc(C(=O)c2ccccc2)c(O)c1	NA	BRD-K59037100	oxybenzone
BRD-K34154330-003-04-9	tracazolate	INN	SA792548	NA	Tocris Bioscience	NA	1558	CCCCNc1c(C(=O)OCC)c(C)nc2n(CC)ncc12	NA	BRD-K34154330	tracazolate
BRD-K31920458-001-03-8	mestranol	INN	SA83475	NA	Prestwick Chemical Inc.	NA	Prestw-846	COc1ccc2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@@H]3CCc2c1	NA	BRD-K31920458	mestranol
BRD-K60640630-001-03-7	mometasone furoate	USAN	SA83463	NA	Prestwick Chemical Inc.	NA	Prestw-572	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl	NA	BRD-K60640630	mometasone
BRD-K26429091-051-01-9	J 104129	to-be-curated	SA792900	NA	Tocris Bioscience	NA	2507	CC(C)=CCCN1CCC(CC1)NC(=O)[C@@](O)(C1CCCC1)c1ccccc1	NA	BRD-K26429091	J-104129
BRD-K44067360-001-06-3	flufenamic acid	INN	SA82071	NA	Biomol International Inc.	NA	AC-123	OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F	NA	BRD-K44067360	flufenamic-acid
BRD-K34415467-003-04-9	trimethobenzamide	INN	SA59257	NA	MicroSource Discovery Systems Inc.	NA	1500594	COc1cc(cc(OC)c1OC)C(=O)NCc1ccc(OCCN(C)C)cc1	NA	BRD-K34415467	trimethobenzamide
BRD-K49111258-001-02-8	prazosin	INN	SA82319	NA	Biomol International Inc.	NA	AC-146	COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)c1ccco1	NA	BRD-K49111258	prazosin
BRD-K57569181-001-04-4	pentoxifylline	INN	SA59700	NA	MicroSource Discovery Systems Inc.	NA	1503611	CC(=O)CCCCn1c(=O)n(C)c2ncn(C)c2c1=O	NA	BRD-K57569181	pentoxifylline
BRD-K28936863-051-04-1	ketotifen	INN	SA59262	NA	MicroSource Discovery Systems Inc.	NA	1500668	CN1CCC(CC1)=C1c2ccsc2C(=O)Cc2ccccc12	NA	BRD-K28936863	ketotifen
BRD-K46556543-237-03-0	canrenoic acid	INN	SA83450	NA	Prestwick Chemical Inc.	NA	Prestw-148	C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]2(O)CCC(O)=O	NA	BRD-K46556543	potassium-canrenoate
BRD-K14200658-001-02-6	syrosingopine	INN	SA83079	NA	Prestwick Chemical Inc.	NA	Prestw-564	CCOC(=O)Oc1c(OC)cc(cc1OC)C(=O)O[C@@H]1C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@H]3C[C@@H]2[C@@H]([C@H]1OC)C(=O)OC	NA	BRD-K14200658	syrosingopine
BRD-K25224017-001-04-5	pirenperone	INN	SA59535	NA	MicroSource Discovery Systems Inc.	NA	1504188	Cc1nc2ccccn2c(=O)c1CCN1CCC(CC1)C(=O)c1ccc(F)cc1	NA	BRD-K25224017	pirenperone
BRD-K52394958-001-01-9	GR 159897	to-be-curated	SA792414	NA	Tocris Bioscience	NA	1274	COC1(C[S@@](=O)c2ccccc2)CCN(CCc2c[nH]c3ccc(F)cc23)CC1	NA	BRD-K52394958	GR-159897
BRD-K43245338-001-02-4	MDL-28170	primary-common	SA82130	NA	Biomol International Inc.	NA	PI-130	CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C=O	NA	BRD-K43245338	MDL-28170
BRD-K47693913-001-02-4	evoxine	common	SA82864	NA	Prestwick Chemical Inc.	NA	Prestw-665	COc1c(OC[C@@H](O)C(C)(C)O)ccc2c(OC)c3ccoc3nc12	NA	BRD-K47693913	evoxine
BRD-K26997899-001-01-4	D-64131	to-be-curated	SA792574	NA	Tocris Bioscience	NA	1643	COc1ccc2[nH]c(cc2c1)C(=O)c1ccccc1	NA	BRD-K26997899	D-64131
BRD-K51276371-001-01-8	aloisine	primary-common	SA63356	NA	Calbiochem	NA	128135	CCCCc1c([nH]c2nccnc12)-c1ccc(OC)cc1	NA	BRD-K51276371	aloisine
BRD-K26521938-001-04-9	dinoprostone	INN	SA792801	NA	Tocris Bioscience	NA	2296	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O	NA	BRD-K26521938	dinoprostone
BRD-K50135270-001-01-9	GBR 12935	primary-common	SA82644	NA	Biomol International Inc.	NA	AC-272	C(CN1CCN(CCOC(c2ccccc2)c2ccccc2)CC1)Cc1ccccc1	NA	BRD-K50135270	GBR-12935
BRD-K57926513-001-02-9	tyrphostin AG 1295	primary-common	SA63249	NA	Calbiochem	NA	658550	Cc1cc2ncc(nc2cc1C)-c1ccccc1	NA	BRD-K57926513	tyrphostin-AG-1295
BRD-K28806945-001-01-9	L-750,667	to-be-curated	SA82650	NA	Biomol International Inc.	NA	AC-818	Ic1ccc(cc1)N1CCN(Cc2c[nH]c3ncccc23)CC1	NA	BRD-K28806945	L-750667
BRD-K23566484-001-04-5	nilutamide	INN	SA59513	NA	MicroSource Discovery Systems Inc.	NA	1504152	CC1(C)NC(=O)N(C1=O)c1ccc(c(c1)C(F)(F)F)[N+]([O-])=O	NA	BRD-K23566484	nilutamide
BRD-K28863208-001-01-2	PNU 282987	to-be-curated	SA792804	NA	Tocris Bioscience	NA	2303	Clc1ccc(cc1)C(=O)N[C@H]1CN2CCC1CC2	NA	BRD-K28863208	PNU-282987
BRD-K36007650-300-02-3	puromycin	INN	SA83205	NA	Prestwick Chemical Inc.	NA	Prestw-480	COc1ccc(C[C@H](N)C(=O)N[C@@H]2[C@@H](CO)O[C@H]([C@@H]2O)n2cnc3c(ncnc23)N(C)C)cc1	NA	BRD-K36007650	puromycin
BRD-K33204703-001-04-6	AG-370	common	SA82168	NA	Biomol International Inc.	NA	EI-229	NC(=C(C#N)C#N)C(\C#N)=C\c1ccc2[nH]ccc2c1	NA	BRD-K33204703	AG-370
BRD-K39120595-304-02-1	bithionol	INN	SA58199	NA	MicroSource Discovery Systems Inc.	NA	1500148	Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O	NA	BRD-K39120595	bithionol
BRD-K42693031-001-01-8	glimepiride	common	SA792840	NA	Tocris Bioscience	NA	2396	CCC1=C(C)CN(C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC2CCC(C)CC2)C1=O	NA	BRD-K42693031	glimepiride
BRD-K20742498-001-01-5	RS 39604	to-be-curated	SA82512	NA	Biomol International Inc.	NA	AC-570	COc1cc(COc2cc(N)c(Cl)cc2C(=O)CCC2CCN(CCNS(C)(=O)=O)CC2)cc(OC)c1	NA	BRD-K20742498	RS-39604
BRD-K29668683-300-01-4	BD-1063	common	SA792194	NA	Tocris Bioscience	NA	883	CN1CCN(CCc2ccc(Cl)c(Cl)c2)CC1	NA	BRD-K29668683	BD-1063
BRD-K60511616-236-01-4	pravastatin	primary-common	SA792815	NA	Tocris Bioscience	NA	2318	CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12	NA	BRD-K60511616	pravastatin
BRD-K59574735-001-02-7	ubenimex	INN	SA82128	NA	Biomol International Inc.	NA	EI-212	CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(O)=O	NA	BRD-K59574735	ubenimex
BRD-K57179821-001-04-8	crotamiton	INN	SA58961	NA	MicroSource Discovery Systems Inc.	NA	1505271	CCN(C(=O)\C=C\C)c1ccccc1C	NA	BRD-K57179821	crotamiton
BRD-K50859149-001-04-7	sulfafurazole	INN	SA59608	NA	MicroSource Discovery Systems Inc.	NA	1500555	Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C	NA	BRD-K50859149	sulfafurazole
BRD-K41713976-001-02-0	E 4031	common	SA82068	NA	Biomol International Inc.	NA	KC-158	Cc1cccc(CCN2CCC(CC2)C(=O)c2ccc(NS(C)(=O)=O)cc2)n1	NA	BRD-K41713976	E-4031
BRD-K43389675-003-02-7	daunorubicin	INN	SA83348	NA	Prestwick Chemical Inc.	NA	Prestw-487	COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(C)=O	NA	BRD-K43389675	daunorubicin
BRD-K60174629-001-02-2	Z-prolyl-prolinal	primary-common	SA82124	NA	Biomol International Inc.	NA	PI-112	O=C[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)OCc1ccccc1	NA	BRD-K60174629	z-prolyl-prolinal
BRD-K32412559-001-01-7	morphothebaine	primary-common	SA82658	NA	Biomol International Inc.	NA	AC-827	COc1ccc2C[C@H]3N(C)CCc4cc(O)cc(c34)-c2c1O	NA	BRD-K32412559	morphothebaine
BRD-K54771420-001-03-2	glycocholic acid	primary-common	SA83326	NA	Prestwick Chemical Inc.	NA	Prestw-521	C[C@H](CCC(=O)NCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C	NA	BRD-K54771420	glycocholic-acid
BRD-K60184833-001-02-3	tyrphostin 46	primary-common	SA63239	NA	Calbiochem	NA	658430	NC(=O)C(=C\c1ccc(O)c(O)c1)\C#N	NA	BRD-K60184833	tyrphostin-AG-99
BRD-K54233340-300-01-0	dorsomorphin	primary-common	SA793015	NA	Tocris Bioscience	NA	3093	C(CN1CCCCC1)Oc1ccc(cc1)-c1cnc2c(cnn2c1)-c1ccncc1	NA	BRD-K54233340	dorsomorphin
BRD-K54790157-001-03-1	trioxysalen	INN	SA38652	NA	AnalytiCon Discovery GmbH	NA	NP-010961	Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1	NA	BRD-K54790157	trioxsalen
BRD-K27737647-001-03-4	H-89	primary-common	SA81856	NA	Biomol International Inc.	NA	EI-196	Brc1ccc(\C=C\CNCCNS(=O)(=O)c2cccc3cnccc23)cc1	NA	BRD-K27737647	H-89
BRD-K45330754-001-04-3	diethylstilbestrol	INN	SA58271	NA	MicroSource Discovery Systems Inc.	NA	1500244	CC\C(c1ccc(O)cc1)=C(\CC)c1ccc(O)cc1	NA	BRD-K45330754	diethylstilbestrol
BRD-K56064827-001-04-7	HBDDE	common	SA82259	NA	Biomol International Inc.	NA	EI-273	COCc1cc(O)c(O)c(O)c1-c1c(COC)cc(O)c(O)c1O	NA	BRD-K56064827	EI-273
BRD-K55191674-236-03-7	benzylpenicillin	INN	SA83692	NA	Prestwick Chemical Inc.	NA	Prestw-1078	CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(O)=O	NA	BRD-K55191674	benzylpenicillin
BRD-K47105409-001-05-3	AG 490	common	SA82169	NA	Biomol International Inc.	NA	EI-272	Oc1ccc(cc1O)\C=C(/C#N)C(=O)NCc1ccccc1	NA	BRD-K47105409	AG-490
BRD-K31792052-004-01-9	cyclic PFT-alpha	primary-common	SA63195	NA	Calbiochem	NA	506134	Cc1ccc(cc1)-c1cn2c3CCCCc3sc2n1	NA	BRD-K31792052	pifithrin
BRD-K47639036-003-03-3	flavoxate	INN	SA83428	NA	Prestwick Chemical Inc.	NA	Prestw-242	Cc1c(oc2c(cccc2c1=O)C(=O)OCCN1CCCCC1)-c1ccccc1	NA	BRD-K47639036	flavoxate
BRD-K43290182-001-01-9	Ro 04-6790	to-be-curated	SA82527	NA	Biomol International Inc.	NA	AC-842	CNc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(NC)n1	NA	BRD-K43290182	Ro-04-6790
BRD-K36055864-001-04-4	cicloheximide	INN	SA59390	NA	MicroSource Discovery Systems Inc.	NA	1502112	C[C@H]1C[C@H](C)C(=O)[C@@H](C1)[C@H](O)CC1CC(=O)NC(=O)C1	NA	BRD-K36055864	cycloheximide
BRD-K51918615-303-01-1	iodophenpropit	to-be-curated	SA792143	NA	Tocris Bioscience	NA	779	Ic1ccc(CCNC(=N)SCCCc2c[nH]cn2)cc1	NA	BRD-K51918615	iodophenpropit
BRD-K54462405-003-03-3	doxepin	INN	SA82890	NA	Prestwick Chemical Inc.	NA	Prestw-263	CN(C)CC\C=C1/c2ccccc2COc2ccccc12	NA	BRD-K54462405	doxepin
BRD-K42635745-001-02-4	suloctidil	INN	SA83455	NA	Prestwick Chemical Inc.	NA	Prestw-421	CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1	NA	BRD-K42635745	suloctidil
BRD-K46137903-001-03-3	prednicarbate	INN	SA83779	NA	Prestwick Chemical Inc.	NA	Prestw-1044	CCOC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(=O)CC	NA	BRD-K46137903	prednicarbate
BRD-K25433859-003-11-4	maprotiline	INN	SA792235	NA	Tocris Bioscience	NA	935	CNCCCC12CCC(c3ccccc13)c1ccccc21	NA	BRD-K25433859	maprotiline
BRD-K46469693-001-01-8	SCH-442,416	primary-common	SA792869	NA	Tocris Bioscience	NA	2463	COc1ccc(CCCn2ncc3c2nc(N)n2nc(nc32)-c2ccco2)cc1	NA	BRD-K46469693	SCH-442416
BRD-K47635719-001-03-9	dexamethasone acetate	primary-common	SA82861	NA	Prestwick Chemical Inc.	NA	Prestw-130	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O	NA	BRD-K47635719	dexamethasone
BRD-K57718010-001-06-9	pentetrazol	INN	SA83035	NA	Prestwick Chemical Inc.	NA	Prestw-162	C1CCc2nnnn2CC1	NA	BRD-K57718010	pentylenetetrazol
BRD-K60060639-005-01-4	N-methyllidocaine iodide	to-be-curated	SA792295	NA	Tocris Bioscience	NA	1042	CC[N+](C)(CC)CC(=O)Nc1c(C)cccc1C	NA	BRD-K60060639	N-methyllidocaine-iodide
BRD-K18787491-001-05-2	U0126	primary-common	SA82363	NA	Biomol International Inc.	NA	EI282	N\C(Sc1ccccc1N)=C(C#N)/C(C#N)=C(\N)Sc1ccccc1N	NA	BRD-K18787491	U-0126
BRD-K42098891-003-03-1	protriptyline	INN	SA83673	NA	Prestwick Chemical Inc.	NA	Prestw-930	CNCCCC1c2ccccc2C=Cc2ccccc12	NA	BRD-K42098891	protriptyline
BRD-K59163477-001-02-1	cisapride	INN	SA83343	NA	Prestwick Chemical Inc.	NA	Prestw-430	CO[C@@H]1CN(CCCOc2ccc(F)cc2)CC[C@@H]1NC(=O)c1cc(Cl)c(N)cc1OC	NA	BRD-K59163477	cisapride
BRD-K34608650-001-01-6	GP 2a	to-be-curated	SA792978	NA	Tocris Bioscience	NA	2678	Cc1ccc-2c(Cc3c(nn(c-23)-c2ccc(Cl)cc2Cl)C(=O)NC2CCCCC2)c1	NA	BRD-K34608650	GP-2a
BRD-K18910433-001-04-4	estradiol	INN	SA82244	NA	Biomol International Inc.	NA	BL-093	C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	NA	BRD-K18910433	estradiol
BRD-K53737926-003-04-7	amitriptyline	INN	SA58178	NA	MicroSource Discovery Systems Inc.	NA	1500117	CN(C)CCC=C1c2ccccc2CCc2ccccc12	NA	BRD-K53737926	amitriptyline
BRD-K52850071-001-01-2	NA	NA	NA	NA	NA	NA	NA	NA	NA	BRD-K52850071	WHI-P154
BRD-K19533706-001-01-9	tranilast	to-be-curated	SA792332	NA	Tocris Bioscience	NA	1098	COc1ccc(C=CC(=O)Nc2ccccc2C(O)=O)cc1OC	NA	BRD-K19533706	tranilast
BRD-K51465424-003-03-6	ritodrine	INN	SA83322	NA	Prestwick Chemical Inc.	NA	Prestw-349	C[C@H](NCCc1ccc(O)cc1)[C@H](O)c1ccc(O)cc1	NA	BRD-K51465424	ritodrine
BRD-K34157611-001-03-8	cimetidine	INN	SA59269	NA	MicroSource Discovery Systems Inc.	NA	1500684	CN\C(NCCSCc1nc[nH]c1C)=N/C#N	NA	BRD-K34157611	cimetidine
BRD-K29950728-048-02-6	clomifene	INN	SA58237	NA	MicroSource Discovery Systems Inc.	NA	1500196	CCN(CC)CCOc1ccc(cc1)C(=C(/Cl)c1ccccc1)\c1ccccc1	NA	BRD-K29950728	clomifene
BRD-K30197592-001-01-5	5-methoxytryptamine	primary-common	SA82519	NA	Biomol International Inc.	NA	AC-841	COc1ccc2[nH]cc(CCN)c2c1	NA	BRD-K30197592	5-methoxytryptamine
BRD-K49759007-001-03-6	antipyrine	to-be-curated	SA82973	NA	Prestwick Chemical Inc.	NA	Prestw-30	Cc1c(O)c(=O)n(-c2ccccc2)n1C	NA	BRD-K49759007	phenazone
BRD-K33882852-003-01-0	ZK-93423	primary-common	SA792690	NA	Tocris Bioscience	NA	1994	CCOC(=O)c1ncc2[nH]c3ccc(OCc4ccccc4)cc3c2c1COC	NA	BRD-K33882852	ZK-93423
BRD-K49807096-003-02-3	benazepril	INN	SA59554	NA	MicroSource Discovery Systems Inc.	NA	1505200	CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(O)=O)C1=O	NA	BRD-K49807096	benazepril
BRD-K46018455-001-06-0	bezafibrate	INN	SA82148	NA	Biomol International Inc.	NA	GR-211	CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(O)=O	NA	BRD-K46018455	bezafibrate
BRD-K50660797-001-02-8	epicatechin monogallate	primary-common	SA58126	NA	MicroSource Discovery Systems Inc.	NA	210238	Oc1cc(O)c2C[C@@H](OC(=O)c3cc(O)c(O)c(O)c3)[C@H](Oc2c1)c1ccc(O)c(O)c1	NA	BRD-K50660797	epicatechin-gallate-(-)
BRD-K18757346-001-02-9	U-46619	primary-common	SA82048	NA	Biomol International Inc.	NA	PG023	CCCCC[C@H](O)\C=C\[C@H]1[C@H]2C[C@H](CO2)[C@@H]1C\C=C/CCCC(O)=O	NA	BRD-K18757346	U-46619
BRD-K50325075-001-01-3	UCL 2077	to-be-curated	SA792968	NA	Tocris Bioscience	NA	2661	C(NC(c1ccccc1)(c1ccccc1)c1ccccc1)c1cccnc1	NA	BRD-K50325075	UCL-2077
BRD-K35586044-001-02-6	yohimbine hydrochloride	USP	SA82369	NA	Biomol International Inc.	NA	AC-161	COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12	NA	BRD-K35586044	yohimbine
BRD-K58938839-001-03-8	cyclopamine	primary-common	SA82317	NA	Biomol International Inc.	NA	GR334	C[C@@H]1[C@@H]2NC[C@@H](C)C[C@H]2O[C@]11CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC2=C1C	NA	BRD-K58938839	cyclopamine
BRD-K61097567-001-03-6	SB-218795	to-be-curated	SA792452	NA	Tocris Bioscience	NA	1376	COC(=O)[C@H](NC(=O)c1cc(nc2ccccc12)-c1ccccc1)c1ccccc1	NA	BRD-K61097567	SB-218795
BRD-K48970916-001-03-0	danazol	INN	SA82854	NA	Prestwick Chemical Inc.	NA	Prestw-105	C[C@]12CC[C@H]3[C@@H](CCC4=Cc5oncc5C[C@]34C)[C@@H]1CC[C@@]2(O)C#C	NA	BRD-K48970916	danazol
BRD-K42352790-001-03-8	anandamide	primary-common	SA81968	NA	Biomol International Inc.	NA	FA017	CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCO	NA	BRD-K42352790	anandamide
BRD-K34014345-001-02-6	naproxol	INN	SA58853	NA	MicroSource Discovery Systems Inc.	NA	1503801	COc1ccc2cc(ccc2c1)[C@H](C)CO	NA	BRD-K34014345	naproxol
BRD-K54708045-001-01-3	nTZDpa	to-be-curated	SA792737	NA	Tocris Bioscience	NA	2150	OC(=O)c1n(Cc2ccc(Cl)cc2)c2ccc(Cl)cc2c1Sc1ccccc1	NA	BRD-K54708045	nTZDpa
BRD-K52459643-001-10-2	alprostadil	INN	SA792565	NA	Tocris Bioscience	NA	1620	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O	NA	BRD-K52459643	alprostadil
BRD-K43744935-048-01-6	tamoxifen	to-be-curated	SA792269	NA	Tocris Bioscience	NA	999	CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1	NA	BRD-K43744935	tamoxifen
BRD-K42748308-300-01-2	XE 991	to-be-curated	SA792695	NA	Tocris Bioscience	NA	2000	O=C1c2ccccc2C(Cc2ccncc2)(Cc2ccncc2)c2ccccc12	NA	BRD-K42748308	XE-991
BRD-K40990712-001-02-4	hexamethyleneamiloride	primary-common	SA59542	NA	MicroSource Discovery Systems Inc.	NA	1504215	NC(=N)NC(=O)c1nc(Cl)c(nc1N)N1CCCCCC1	NA	BRD-K40990712	hexamethyleneamiloride
BRD-K42679050-001-01-3	Y-27152	to-be-curated	SA792720	NA	Tocris Bioscience	NA	2077	CC(=O)N(OCc1ccccc1)[C@H]1[C@H](O)C(C)(C)Oc2ccc(cc12)C#N	NA	BRD-K42679050	Y-27152
BRD-K52930707-001-04-8	rescinnamine	INN	SA83147	NA	Prestwick Chemical Inc.	NA	Prestw-568	CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)\C=C\c1cc(OC)c(OC)c(OC)c1	NA	BRD-K52930707	rescinnamine
BRD-K59197931-001-02-9	naproxen	INN	SA58394	NA	MicroSource Discovery Systems Inc.	NA	1500425	COc1ccc2cc(ccc2c1)[C@H](C)C(O)=O	NA	BRD-K59197931	naproxen
BRD-K49657628-001-02-3	tyrphostin AG 18	primary-common	SA63217	NA	Calbiochem	NA	658395	Oc1ccc(C=C(C#N)C#N)cc1O	NA	BRD-K49657628	tyrphostin-AG-18
BRD-K47717570-304-01-5	NBQX	common	SA792297	NA	Tocris Bioscience	NA	1044	NS(=O)(=O)c1cccc2c1c(cc1nc(O)c(O)nc21)[N+]([O-])=O	NA	BRD-K47717570	NBQX
BRD-K49890030-236-01-6	gavestinel	common	SA792828	NA	Tocris Bioscience	NA	2348	OC(=O)c1[nH]c2cc(Cl)cc(Cl)c2c1C=CC(=O)Nc1ccccc1	NA	BRD-K49890030	gavestinel
BRD-K24023109-001-02-5	diltiazem	INN	SA82067	NA	Biomol International Inc.	NA	CA-205	COc1ccc(cc1)[C@@H]1Sc2ccccc2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O	NA	BRD-K24023109	diltiazem
BRD-K49945136-001-03-5	GR 113808	to-be-curated	SA792430	NA	Tocris Bioscience	NA	1322	Cn1cc(C(=O)OCC2CCN(CCNS(C)(=O)=O)CC2)c2ccccc12	NA	BRD-K49945136	GR-113808
BRD-K54759182-003-02-3	dosulepin	INN	SA83350	NA	Prestwick Chemical Inc.	NA	Prestw-488	CN(C)CC\C=C1/c2ccccc2CSc2ccccc12	NA	BRD-K54759182	dosulepin
BRD-K46384212-001-01-1	o-3M3FBS	to-be-curated	SA792664	NA	Tocris Bioscience	NA	1942	Cc1cc(C)c(c(C)c1)S(=O)(=O)Nc1ccccc1C(F)(F)F	NA	BRD-K46384212	O-3M3FBS
BRD-K56558538-003-02-8	ambroxol	INN	SA83281	NA	Prestwick Chemical Inc.	NA	Prestw-366	Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1	NA	BRD-K56558538	ambroxol
BRD-K53061490-003-03-0	ozagrel	INN	SA83814	NA	Prestwick Chemical Inc.	NA	Prestw-979	OC(=O)\C=C\c1ccc(Cn2ccnc2)cc1	NA	BRD-K53061490	ozagrel
BRD-K29555132-001-02-2	arachidonamide	to-be-curated	SA81970	NA	Biomol International Inc.	NA	FA022	CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(N)=O	NA	BRD-K29555132	arachidonamide
BRD-K60230970-001-04-3	MG-132	primary-common	SA82146	NA	Biomol International Inc.	NA	PI-102	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O	NA	BRD-K60230970	MG-132
BRD-K60923938-001-02-8	veratridine	primary-common	SA82119	NA	Biomol International Inc.	NA	NA-125	COc1ccc(cc1OC)C(=O)O[C@H]1CC[C@@]2(C)[C@@H]3CC[C@H]4[C@]5(O)C[C@H](O)[C@@]6(O)[C@@H](CN7C[C@@H](C)CC[C@H]7[C@@]6(C)O)[C@]5(O)C[C@]24O[C@]13O	NA	BRD-K60923938	veratridine
BRD-K59650319-003-01-7	YM 298198	to-be-curated	SA792861	NA	Tocris Bioscience	NA	2448	CN(C1CCCCC1)C(=O)c1sc2nc3ccc(N)cc3n2c1C	NA	BRD-K59650319	YM-298198
BRD-K55468218-001-04-8	spiperone	INN	SA59340	NA	MicroSource Discovery Systems Inc.	NA	1501152	Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)c1ccccc1	NA	BRD-K55468218	spiperone
BRD-K44899736-003-02-1	RO-16-6941	primary-common	SA59483	NA	MicroSource Discovery Systems Inc.	NA	1503638	NCCNC(=O)c1ccc(Cl)cc1	NA	BRD-K44899736	Ro-16-6941
BRD-K47659338-003-01-0	EMD 386088	to-be-curated	SA792832	NA	Tocris Bioscience	NA	2382	Cc1[nH]c2ccc(Cl)cc2c1C1=CCNCC1	NA	BRD-K47659338	EMD-386088
BRD-K45861246-001-04-3	azaperone	INN	SA59846	NA	MicroSource Discovery Systems Inc.	NA	1505332	Fc1ccc(cc1)C(=O)CCCN1CCN(CC1)c1ccccn1	NA	BRD-K45861246	azaperone
BRD-K50018155-003-01-3	RS 67506	to-be-curated	SA792260	NA	Tocris Bioscience	NA	990	COc1cc(N)c(Cl)cc1C(=O)CCC1CCN(CCNS(C)(=O)=O)CC1	NA	BRD-K50018155	RS-67506
BRD-K59851896-001-02-4	calycanthine	primary-common	SA83287	NA	Prestwick Chemical Inc.	NA	Prestw-595	CN1CC[C@@]23[C@@H]4Nc5ccccc5[C@]2(CCN4C)[C@@H]1Nc1ccccc31	NA	BRD-K59851896	calycanthine
BRD-K59753853-001-01-5	3-(2-carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid	to-be-curated	SA82423	NA	Biomol International Inc.	NA	AC-406	OC(=O)CCc1c([nH]c2cc(Cl)cc(Cl)c12)C(O)=O	NA	BRD-K59753853	MDL-29951
BRD-K45158365-001-02-3	valsartan	INN	SA59711	NA	MicroSource Discovery Systems Inc.	NA	1505209	CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1)[C@@H](C(C)C)C(O)=O	NA	BRD-K45158365	valsartan
BRD-K35708212-331-03-1	ouabain	primary-common	SA83030	NA	Prestwick Chemical Inc.	NA	Prestw-471	C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C2=CC(=O)OC2)[C@H](O)[C@H](O)[C@H]1O	NA	BRD-K35708212	ouabain
BRD-K26373640-001-02-8	SC-514	common	SA81897	NA	Biomol International Inc.	NA	EI-343	NC(=O)c1sc(cc1N)-c1ccsc1	NA	BRD-K26373640	IKK-2-inhibitor
BRD-K19352500-332-03-7	prochlorperazine	INN	SA83050	NA	Prestwick Chemical Inc.	NA	Prestw-399	CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc23)CC1	NA	BRD-K19352500	prochlorperazine
BRD-K27316855-001-02-6	calcitriol	INN	SA81905	NA	Biomol International Inc.	NA	DM200	C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C	NA	BRD-K27316855	calcitriol
BRD-K45033733-001-02-3	famciclovir	INN	SA59555	NA	MicroSource Discovery Systems Inc.	NA	1505201	CC(=O)OCC(CCn1cnc2cnc(N)nc12)COC(C)=O	NA	BRD-K45033733	famciclovir
BRD-K41996876-001-05-5	tyrphostin 1	primary-common	SA82360	NA	Biomol International Inc.	NA	EI-190	COc1ccc(C=C(C#N)C#N)cc1	NA	BRD-K41996876	tyrphostin-1
BRD-K45068323-003-01-3	W-13	primary-common	SA63431	NA	Calbiochem	NA	681636	NCCCCNS(=O)(=O)c1ccc2c(Cl)cccc2c1	NA	BRD-K45068323	W-13
BRD-K46937689-001-05-1	phenazone	INN	SA82733	NA	Prestwick Chemical Inc.	NA	Prestw-29	Cc1cc(=O)n(-c2ccccc2)n1C	NA	BRD-K46937689	phenazone
BRD-K47869605-001-04-9	podophyllotoxin	BAN	SA58786	NA	MicroSource Discovery Systems Inc.	NA	2300332	COc1cc(cc(OC)c1OC)[C@H]1[C@@H]2[C@H](COC2=O)[C@@H](O)c2cc3OCOc3cc12	NA	BRD-K47869605	podophyllotoxin
BRD-K51318897-001-04-7	fenbendazole	INN	SA82916	NA	Prestwick Chemical Inc.	NA	Prestw-210	COC(=O)Nc1nc2ccc(Sc3ccccc3)cc2[nH]1	NA	BRD-K51318897	fenbendazole
BRD-K51095933-231-03-2	estropipate	USP	SA83602	NA	Prestwick Chemical Inc.	NA	Prestw-688	C[C@]12CC[C@H]3[C@@H](CCc4cc(OS(O)(=O)=O)ccc34)[C@@H]1CCC2=O	NA	BRD-K51095933	estropipate
BRD-K50422030-001-01-2	clomethiazole	primary-common	SA82560	NA	Biomol International Inc.	NA	AC-482	Cc1ncsc1CCCl	NA	BRD-K50422030	clomethiazole
BRD-K53878242-001-02-4	8-methoxymethyl-IBMX	primary-common	SA792026	NA	Tocris Bioscience	NA	552	COCc1nc2c([nH]1)n(CC(C)C)c(=O)n(C)c2=O	NA	BRD-K53878242	MMPX
BRD-K52219182-001-01-6	ICI 63197	to-be-curated	SA792644	NA	Tocris Bioscience	NA	1816	CCCn1c2nc(N)nn2cc(C)c1=O	NA	BRD-K52219182	ICI-63197
BRD-K60932973-001-01-7	R(+)-6-bromo-APB	primary-common	SA82652	NA	Biomol International Inc.	NA	AC-821	Oc1cc2[C@H](CN(CC=C)CCc2c(Br)c1O)c1ccccc1	NA	BRD-K60932973	BRD-K60932973
BRD-K60298136-001-01-7	ITE	to-be-curated	SA792635	NA	Tocris Bioscience	NA	1803	COC(=O)c1csc(n1)C(=O)c1c[nH]c2ccccc12	NA	BRD-K60298136	ITE
BRD-K56596464-004-02-4	QX 314	primary-common	SA82107	NA	Biomol International Inc.	NA	NA-134	CC[N+](CC)(CC)CC(=O)Nc1c(C)cccc1C	NA	BRD-K56596464	QX-314
BRD-K56699285-001-03-7	metergoline	INN	SA82497	NA	Biomol International Inc.	NA	AC-553	CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@H]2[C@H]1Cc1cn(C)c3cccc2c13	NA	BRD-K56699285	metergoline
BRD-K98991361-001-02-7	BRD-K98991361	BROAD_CPD_ID	SA1852966	NA	Broad Institute of MIT and Harvard	NA	NA	CC(=O)Nc1cccc(NC(=O)c2ccccc2Cl)c1	NA	BRD-K98991361	BRD-K98991361
BRD-K63175663-001-02-3	BRD-K63175663	BROAD_CPD_ID	SA1852965	NA	Broad Institute of MIT and Harvard	NA	NA	COc1ccc(cc1)C(=O)Nc1cccc(NC(C)=O)c1	NA	BRD-K63175663	BRD-K63175663
BRD-K49403449-001-02-9	BRD-K49403449	BROAD_CPD_ID	SA1852962	NA	Broad Institute of MIT and Harvard	NA	NA	CC(=O)Nc1ccc(cc1)\C=N\NC(=O)CC1CCCCC1	NA	BRD-K49403449	BRD-K49403449
BRD-A99518825-001-02-9	BRD-A99518825	BROAD_CPD_ID	SA1853708	NA	Broad Institute of MIT and Harvard	NA	NA	COc1ccc(CN2CCCC(C2)C(=O)N2CCCC2)c(OC)c1OC	NA	BRD-A99518825	BRD-A99518825
BRD-K21788104-001-08-8	BRD-K21788104	BROAD_CPD_ID	SA1854412	NA	Maybridge	NA	MWP 00339	O=C(NNC(=O)c1ccccc1)c1csc(n1)-c1cccnc1	NA	BRD-K21788104	BRD-K21788104
BRD-K25774147-001-02-6	BRD-K25774147	BROAD_CPD_ID	SA1853730	NA	Broad Institute of MIT and Harvard	NA	NA	COc1ccc(C)cc1-n1nnnc1SCc1nc(N)nc(n1)N(C)C	NA	BRD-K25774147	BRD-K25774147
BRD-K40094191-001-02-5	BRD-K40094191	BROAD_CPD_ID	SA1853731	NA	Broad Institute of MIT and Harvard	NA	NA	CN(C)c1nc(N)nc(CSc2nnnn2-c2c(C)cccc2C)n1	NA	BRD-K40094191	BRD-K40094191
BRD-K31553917-001-02-4	BRD-K31553917	BROAD_CPD_ID	SA1853728	NA	Broad Institute of MIT and Harvard	NA	NA	CC(C)c1ccc(cc1)-n1nnnc1SCc1nc(N)nc(N)n1	NA	BRD-K31553917	BRD-K31553917
BRD-K09549677-311-05-6	mibefradil	common	SA1857495	NA	Sigma-Aldrich	NA	M5441	COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C	NA	BRD-K09549677	mibefradil
BRD-A93893742-001-11-3	BRD-A93893742	BROAD_CPD_ID	SA1859325	NA	ChemBridge Corporation	NA	7773201	[O-][N+](=O)c1cc(ccc1S(=O)CC(=O)Oc1ccc(Cl)cc1)C(F)(F)F	NA	BRD-A93893742	EMF-sumo1-2
BRD-A06352418-001-17-6	terfenadine	INN	SA1853017	NA	Sigma-Aldrich	NA	T9652	CC(C)(C)c1ccc(cc1)C(O)CCCN1CCC(CC1)C(O)(c1ccccc1)c1ccccc1	NA	BRD-A06352418	terfenadine
BRD-K02421873-001-08-8	BRD-K02421873	BROAD_CPD_ID	SA1858529	NA	UkrOrgSynthesis Ltd.	NA	PB-01930921	[O-][N+](=O)c1ccc(o1)C(=O)OCc1nnc(o1)-c1ccccc1	NA	BRD-K02421873	EMF-sumo1-12
BRD-K17343332-001-08-2	BRD-K17343332	BROAD_CPD_ID	SA1853958	NA	InterBioScreen Ltd.	NA	STOCK3S-10593	Oc1c(Br)cc(Br)cc1C=NN1CCN(Cc2ccccc2)CC1	NA	BRD-K17343332	EMF-sumo1-4
BRD-K32644160-001-12-3	ML163	common	SA1860623	NA	Asinex Ltd.	NA	BAS 07778946	N(c1nnc(s1)-c1ccncc1)c1cccc2ccccc12	NA	BRD-K32644160	BRD-K32644160
BRD-A67748489-001-05-0	BRD-A67748489	BROAD_CPD_ID	SA1856707	NA	Asinex Ltd.	NA	BAS 06574958	CC(=O)NC1=NN(C(C)=O)C(C)(S1)c1ccccc1	NA	BRD-A67748489	K-858
BRD-A97833537-001-09-8	BRD-A97833537	BROAD_CPD_ID	SA1860129	NA	ChemDiv Inc.	NA	C076-0680	Fc1ccccc1C(=O)N1CC(=O)Nc2ccc(Cl)cc2C1c1ccccc1	NA	BRD-A97833537	EMF-sumo1-1
BRD-K03857568-001-12-4	BRD-K03857568	BROAD_CPD_ID	SA1857691	NA	Asinex Ltd.	NA	BAS 01060307	Cc1ccc(Sc2c([N+]([O-])=O)c(=O)n(C)c3ccccc23)cc1	NA	BRD-K03857568	BRD-K03857568
BRD-K94018295-001-09-9	BRD-K94018295	BROAD_CPD_ID	SA1856084	NA	InterBioScreen Ltd.	NA	STOCK2S-79598	Cn1c(SCC(=O)NN=Cc2ccc(s2)[N+]([O-])=O)nnc1-c1ccc(Cl)cc1	NA	BRD-K94018295	EMF-sumo1-3
BRD-K14232336-001-09-4	BRD-K14232336	BROAD_CPD_ID	SA1855968	NA	ChemDiv Inc.	NA	K048-0112	Cc1c(cccc1C(O)=O)N=Cc1cc(Br)cc(Br)c1O	NA	BRD-K14232336	EMF-sumo1-5
BRD-A61666925-001-09-4	BRD-A61666925	BROAD_CPD_ID	SA1853529	NA	Asinex Ltd.	NA	BAS 07330735	NC(=O)C1CCN(CC1)C1CC(=O)N(C1=O)c1ccc(F)c(Cl)c1	NA	BRD-A61666925	EMF-sumo1-6
BRD-K37270826-001-15-1	mifepristone	INN	SA1857173	NA	Sigma-Aldrich	NA	M8046	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C	NA	BRD-K37270826	mifepristone
BRD-K97764662-001-06-6	PD 173074	common	SA1861520	NA	Sigma-Aldrich	NA	P2499	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1	NA	BRD-K97764662	PD-173074
BRD-K49181186-001-07-7	BRD-K49181186	BROAD_CPD_ID	SA1856522	NA	Enamine Ltd.	NA	T5223000	Fc1cc(F)c(c(F)c1Cl)S(=O)(=O)NNC(=O)C12CC3CC(CC(C3)C1)C2	NA	BRD-K49181186	EMF-sumo1-7
BRD-K48576794-001-07-3	BRD-K48576794	BROAD_CPD_ID	SA1852697	NA	Asinex Ltd.	NA	BAS 10738766	Cc1cc(NC(=O)CCl)no1	NA	BRD-K48576794	BRD-K48576794
BRD-A78322124-003-09-0	dobutamine	INN	SA1855043	NA	Prestwick Chemical Inc.	NA	Prestw-352	CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1	NA	BRD-A78322124	dobutamine
BRD-K17561142-003-19-2	amiodarone	INN	SA1855016	NA	Prestwick Chemical Inc.	NA	Prestw-409	CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1	NA	BRD-K17561142	amiodarone
BRD-A50311610-003-13-8	meclozine	INN	SA1854924	NA	Prestwick Chemical Inc.	NA	Prestw-457	Cc1cccc(CN2CCN(CC2)C(c2ccccc2)c2ccc(Cl)cc2)c1	NA	BRD-A50311610	meclizine
BRD-K38324426-001-08-4	BRD-K38324426	BROAD_CPD_ID	SA1860750	NA	ChemBridge Corporation	NA	6104683	Cc1ccc(cc1)S(=O)(=O)NC1CCCCCCC1	NA	BRD-K38324426	EMF-sumo1-8
BRD-K67258146-001-01-2	BRD-K67258146	BROAD_CPD_ID	SA1850628	NA	Sanford-Burnham Medical Research Institute	NA	MLS-0315771.0001	Cc1ccc(C)c(c1)-n1sc2cc(F)ccc2c1=O	NA	BRD-K67258146	BRD-K67258146
BRD-K37160541-001-01-8	BRD-K37160541	BROAD_CPD_ID	SA1850604	NA	Sanford-Burnham Medical Research Institute	NA	MLS-0390932.0001	[O-][N+](=O)c1c(Br)cccc1\N=c1\ssnc1Cl	NA	BRD-K37160541	BRD-K37160541
BRD-K64610608-001-02-6	BRD-K64610608	BROAD_CPD_ID	SA1447215	NA	Broad Institute of MIT and Harvard	Erin Forbeck	NA	COc1ccc(cc1)S(=O)(=O)N(C)C[C@@H]1Oc2c(NC(=O)Nc3cccc4ccccc34)cccc2C(=O)N(C[C@H]1C)[C@@H](C)CO	NA	BRD-K64610608	EMF-BCA1-57
BRD-K89626439-001-01-0	BRD-K89626439	BROAD_CPD_ID	SA1901306	NA	University of New Mexico MLSC	NA	5284616	CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C/C=C/C=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1O	NA	BRD-K89626439	sirolimus
BRD-K44432556-001-01-4	ML228	common	SA1433031	NA	Vanderbilt Screening Center for GPCRs, Ion Channels, and Transporters	NA	NA	C(Nc1nc(nnc1-c1ccccc1)-c1ccccn1)c1ccc(cc1)-c1ccccc1	NA	BRD-K44432556	VU-0418946-1
BRD-K98896788-001-02-3	BRD-K98896788	BROAD_CPD_ID	SA879138	NA	Broad Institute of MIT and Harvard	Danny Hung-Chieh Chou	NA	C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)S(=O)(=O)c2ccccc2F)Oc2c(NC(=O)Nc3cccc4ccccc34)cccc2C1=O	NA	BRD-K98896788	BRD-K98896788
BRD-K42541148-001-01-9	BRD-K42541148	BROAD_CPD_ID	SA1850592	NA	Sanford-Burnham Medical Research Institute	NA	MLS-0091939.0001	OC(=O)c1ccc(cc1)-c1ccc(\C=c2/sc3nc4ccccc4n3c2=O)o1	NA	BRD-K42541148	BRD-K42541148
BRD-A17718497-001-01-3	BRD-A17718497	BROAD_CPD_ID	SA1443230	NA	Broad Institute of MIT and Harvard	Willmen Youngsaye	NA	CC1CN(CCN1C(=O)c1ccc(Cl)cc1)c1ccnc2cc(Cl)ccc12	NA	BRD-A17718497	BRD-A17718497
BRD-K91047982-001-01-6	BRD-K91047982	BROAD_CPD_ID	SA858369	NA	ChemBridge Corporation	NA	6302217	Cc1ccc(NC(=O)CCC(=O)N\N=C\c2ccco2)c(C)c1	NA	BRD-K91047982	BRD-K91047982
BRD-A82913781-001-01-5	BRD-A82913781	BROAD_CPD_ID	SA1850608	NA	Sanford-Burnham Medical Research Institute	NA	MLS-0425590.0001	CCOC(=O)C1=C(C)N=c2s\c(=C/c3cc(Cl)c(OCC(O)=O)c(Cl)c3)c(=O)n2C1c1cccc(OC)c1	NA	BRD-A82913781	BRD-A82913781
BRD-K19146323-001-01-3	BRD-K19146323	BROAD_CPD_ID	SA1014538	NA	Vitas-M Laboratory Ltd.	NA	STK661558	Clc1ccc2c(ccnc2c1)N1CCN(CC1)C(=O)c1ccc(Cl)c(Cl)c1	NA	BRD-K19146323	STK-661558
BRD-K68535470-001-01-8	BRD-K68535470	BROAD_CPD_ID	SA1014537	NA	Vitas-M Laboratory Ltd.	NA	STK222600	Clc1ccc(cc1)C(=O)N1CCN(CC1)c1ccccn1	NA	BRD-K68535470	STK-222600
BRD-K69516039-001-01-1	BRD-K69516039	BROAD_CPD_ID	SA1850621	NA	Sanford-Burnham Medical Research Institute	NA	MLS-0435541.0001	O=C(Nc1cc(ccc1N1CCCC1)S(=O)(=O)N1CCOCC1)c1cc2CCCCc2s1	NA	BRD-K69516039	BRD-K69516039
BRD-A95937159-001-01-3	BRD-A95937159	BROAD_CPD_ID	SA1850622	NA	Sanford-Burnham Medical Research Institute	NA	MLS-0435542.0001	CCC1CCc2sc(cc2C1)C(=O)Nc1cc(ccc1OC)S(=O)(=O)N1CCOCC1	NA	BRD-A95937159	BRD-A95937159
BRD-K74710236-001-02-2	BRD-K74710236	BROAD_CPD_ID	SA1433045	NA	Vanderbilt Screening Center for GPCRs, Ion Channels, and Transporters	NA	NA	CC(C)(C)CCNc1nc(nnc1-c1ccccc1)-c1ccccn1	NA	BRD-K74710236	VU-0410183-2
BRD-K32010074-001-01-5	BRD-K32010074	BROAD_CPD_ID	SA1443155	NA	Broad Institute of MIT and Harvard	Michel Weiwer	NA	[O-][N+](=O)c1cnc2ccccc2c1Sc1ccccc1	NA	BRD-K32010074	MW-A1-14
BRD-K33586157-001-01-3	BRD-K33586157	BROAD_CPD_ID	SA1850614	NA	Sanford-Burnham Medical Research Institute	NA	MLS-0425637.0001	Cc1ccc(cc1)-c1nn(cc1\C=C1/SC(=S)N(CCS(O)(=O)=O)C1=O)-c1ccccc1	NA	BRD-K33586157	BRD-K33586157
BRD-K66902379-001-01-4	BRD-K66902379	BROAD_CPD_ID	SA1850617	NA	Sanford-Burnham Medical Research Institute	NA	MLS-0435526.0001	CN(C)S(=O)(=O)c1cccc(c1)C(=O)N1CCN(CC1)c1cccc(C)c1C	NA	BRD-K66902379	BRD-K66902379
BRD-K64058329-001-01-8	BRD-K64058329	BROAD_CPD_ID	SA92061	SnAr 8-ortho	Broad Institute of MIT and Harvard	NA	NA	COc1ccc(cc1)S(=O)(=O)N(C)C[C@@H]1Oc2c(NC(=O)Nc3ccccc3)cccc2C(=O)N(C[C@H]1C)[C@@H](C)CO	NA	BRD-K64058329	BRD-K64058329
BRD-K98381590-001-01-6	BRD-K98381590	BROAD_CPD_ID	SA768012	NA	Broad Institute of MIT and Harvard	Tim Lewis	NA	C[C@@H](Nc1nc(Cl)nc2ccccc12)c1ccccc1	NA	BRD-K98381590	RAN-07
BRD-K04188046-003-01-4	BRD-K04188046	BROAD_CPD_ID	SA1850631	NA	Sanford-Burnham Medical Research Institute	NA	MLS-0315813.0002	Oc1ccc(cc1O)C(=O)Cn1ccnc1	NA	BRD-K04188046	BRD-K04188046
BRD-K32111336-001-01-5	BRD-K32111336	BROAD_CPD_ID	SA1850623	NA	Sanford-Burnham Medical Research Institute	NA	MLS-0435554.0001	Cc1cc2cc3OCCOc3cc2n2c(SCC(=O)Nc3nc(cs3)-c3ccccc3)nnc12	NA	BRD-K32111336	BRD-K32111336
BRD-A03946276-001-01-3	BRD-A03946276	BROAD_CPD_ID	SA1850599	NA	Sanford-Burnham Medical Research Institute	NA	MLS-0315868.0001	[O-][N+](=O)c1ccc2NC(=O)C3(NNc4ccccc4O3)c2c1	NA	BRD-A03946276	BRD-A03946276
BRD-K63511615-001-01-0	BRD-K63511615	BROAD_CPD_ID	SA1443192	NA	Broad Institute of MIT and Harvard	Sara Buhrlage	NA	Clc1cccc(c1)C(=O)N1CCN(CC1)c1ccnc2cc(Cl)ccc12	NA	BRD-K63511615	SJB-AF-2
BRD-A26962727-001-01-8	BRD-A26962727	BROAD_CPD_ID	SA1850607	NA	Sanford-Burnham Medical Research Institute	NA	MLS-0425579.0001	CCOC(=O)C1=C(C)N=c2s\c(=C\c3cc(Cl)c(OCC(O)=O)c(OC)c3)c(=O)n2C1c1ccccc1Cl	NA	BRD-A26962727	BRD-A26962727
BRD-A80788753-001-01-7	BRD-A80788753	BROAD_CPD_ID	SA1435077	NA	ChemDiv Inc.	NA	D163-0113	CCCCC(O)(C(CN1CCOCC1)c1ccc(Cl)cc1)c1ccc(F)cc1	NA	BRD-A80788753	EMF-sumo1-10
BRD-K09191212-001-01-5	BRD-K09191212	BROAD_CPD_ID	SA1850594	NA	Sanford-Burnham Medical Research Institute	NA	MLS-0091943.0001	Cc1cc(C)c2nc3s\c(=C/c4ccc(o4)-c4ccccc4C(O)=O)c(=O)n3c2c1	NA	BRD-K09191212	BRD-K09191212
BRD-K76304753-003-11-2	phenazopyridine	common	SA1854809	NA	Prestwick Chemical Inc.	NA	Prestw-752	Nc1ccc(\N=N\c2ccccc2)c(N)n1	NA	BRD-K76304753	phenazopyridine
